A Phase 3 interventional study of Niraparib and Pembrolizumab in Lung Cancer, Non-Small Cell, sponsored by GlaxoSmithKline. Completed at 188 sites in 27 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-18.
Sponsored by GlaxoSmithKline · Phase 3, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 54 studies in Carcinoma, Non-Small-Cell Lung by GlaxoSmithKline — 1 open to participants now, 7 under way, 3 of them phase 3. Carcinoma, Non-Small-Cell Lung · GlaxoSmithKline.
Among the 54 studies in Carcinoma, Non-Small-Cell Lung by GlaxoSmithKline, this one is the 5th largest by enrollment of the 47 interventional ones that give a count, is one of 3 that started in 2020, is one of 7 in phase 3, and was the 44th registered.
7,628 studies on the registry are indexed under Carcinoma, Non-Small-Cell Lung; 1,837 are open to participants now.
Browse Carcinoma, Non-Small-Cell Lung studies →1 of the 54 studies in Carcinoma, Non-Small-Cell Lung by GlaxoSmithKline is open now, in 12 countries. Recruiting first, the newest first:
Nuvalent Inc. · Sites in United States, Argentina, Australia and 26 more countries
Ages 18+
By country, each count listing its studies:
Of the 1,326 Carcinoma, Non-Small-Cell Lung studies recruiting now, 988 (75%) set no upper age limit and 225 (17%) stop at 75 or younger; 34 take children under 18; 40 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
54 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 22 · Phase 2 24 · Phase 3 8
First in 2000; this study’s year is marked. 3 started in 2020.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 666 is above the median of 62 across 6,023 interventional studies indexed under Carcinoma, Non-Small-Cell Lung.
Median enrollment 88 across the 47 interventional studies, 1 across the 3 observational. Of the 42 that completed or were terminated, 23 (55%) have results posted.
This tab as a report to print or save as PDF → With an account.
GlaxoSmithKline is the lead sponsor of 3,650 studies on the registry; 117 are open to participants now.
Of its 265 completed or terminated interventional studies of FDA-regulated products, 241 (91%) have results posted.
1 of the studies in Carcinoma, Non-Small-Cell Lung by GlaxoSmithKline that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT02817633Tesaro, Inc.A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER) | 2027-03-01 |
Add it to your calendar (.ics) → With an account.
Among the 54 studies in Carcinoma, Non-Small-Cell Lung by GlaxoSmithKline, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This is a multicenter, randomized, double-blind, placebo-controlled study of niraparib plus pembrolizumab versus placebo plus pembrolizumab as maintenance therapy in participants with advanced or metastatic non-small cell lung cancer (NSCLC) who have achieved stable disease (SD), partial response (PR), or complete response (CR) following completion of standard of care first-line (SoC 1L) platinum-based induction chemotherapy with pembrolizumab. The primary hypotheses are: participants with confirmed diagnosis of NSCLC could benefit from niraparib plus pembrolizumab versus placebo plus pembrolizumab with respect to Progression-free survival (PFS) and Overall survival (OS).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The diagnosis was confirmed by looking at a sample under a microscope: tissue from a biopsy or surgery (histology), or cells from a fluid or needle sample (cytology).
Your pathology report is the document that shows this.
Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.
A scale of how much an illness limits everyday activity. For people being assessed to join a study, scores run from 0 (fully active) to 4; lower is more active.
Studies most often ask for 0–1 or 0–2. Your doctor gives the score; the WHO scale uses the same steps. The full scale also has 5, which records death.
The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A line of therapy is one course of treatment, which may combine several drugs. First-line is the first course given; second-line follows when that stops working or is not tolerated.
“Two prior lines” means two courses that count separately under the study’s rules — not simply two drugs. Ask the study team if you are unsure how yours are counted.
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Cancer that has spread to the leptomeninges, the thin layers covering the brain and spinal cord, and the fluid between them. It is not the same as brain metastases.
Criteria often treat it separately, and many studies leave it out even where treated brain metastases are allowed.
Cancer deposits in the brain from a cancer that started elsewhere in the body (CNS metastases include the spinal cord).
Studies differ: some leave out any brain metastases, some accept ones treated and stable for some weeks. Check what this study allows.
A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.
Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Histologically or cytologically confirmed
The diagnosis was confirmed by looking at a sample under a microscope: tissue from a biopsy or surgery (histology), or cells from a fluid or needle sample (cytology).
Your pathology report is the document that shows this.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Metastases
Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
ECOG performance status
A scale of how much an illness limits everyday activity. For people being assessed to join a study, scores run from 0 (fully active) to 4; lower is more active.
Studies most often ask for 0–1 or 0–2. Your doctor gives the score; the WHO scale uses the same steps. The full scale also has 5, which records death.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Life expectancy
The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraception
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Line of therapy
A line of therapy is one course of treatment, which may combine several drugs. First-line is the first course given; second-line follows when that stops working or is not tolerated.
“Two prior lines” means two courses that count separately under the study’s rules — not simply two drugs. Ask the study team if you are unsure how yours are counted.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Clinically significant
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Leptomeningeal disease
Cancer that has spread to the leptomeninges, the thin layers covering the brain and spinal cord, and the fluid between them. It is not the same as brain metastases.
Criteria often treat it separately, and many studies leave it out even where treated brain metastases are allowed.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Brain metastases
Cancer deposits in the brain from a cancer that started elsewhere in the body (CNS metastases include the spinal cord).
Studies differ: some leave out any brain metastases, some accept ones treated and stable for some weeks. Check what this study allows.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Autoimmune disease
A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.
Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Eligible participants will receive niraparib along with pembrolizumab.
Drug: Niraparib · Biological: Pembrolizumab
Eligible participants will receive matching placebo along with pembrolizumab.
Biological: Pembrolizumab · Drug: Placebo
Niraparib will be administered.
Pembrolizumab will be administered
Matching placebo will be administered
Progression-free Survival (PFS) Assessed by Blinded Independent Central Review (BICR) - Complete and Partial Response (CR/PR) Population
PFS is defined as the time from the date of randomization to the date of first objectively documented disease progression (PD) as determined by blinded independent central review (BICR) using Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST v1.1) or death from any cause in the absence of progression, whichever occurs first. PD is defined as at least a 20% increase in the sum of the diameters of target lesions, taking as reference the smallest sum on study (this includes the baseline sum if that is the smallest on study).
Time frame: Up to 52 months
Progression-free Survival (PFS) Assessed by BICR - Intent-to-Treat (ITT) Population
PFS is defined as the time from the date of randomization to the date of first objectively documented PD as determined by BICR using RECIST v1.1 or death from any cause in the absence of progression, whichever occurs first. PD is defined as at least a 20% increase in the sum of the diameters of target lesions, taking as reference the smallest sum on study (this includes the baseline sum if that is the smallest on study).
Time frame: Up to 52 months
Overall Survival (OS) - CR/PR Population
OS is defined as the interval of time from the date of randomization to the date of death due to any cause.
Time frame: Up to 52 months
Overall Survival (OS) - ITT Population
OS is defined as the interval of time from the date of randomization to the date of death due to any cause.
Time frame: Up to 52 months
Time to Progression (TTP) in the Central Nervous System (CNS) Assessed by BICR Using RANO-BM Criteria
TTP in the CNS is defined as the time from the date of randomization until the earliest date of documented PD in the CNS as assessed by BICR using Response Assessment in Neuro-Oncology Brain Metastases (RANO-BM) criteria. This endpoint was analysed using a cumulative incidence competing-risk analysis, and the cumulative incidence rate was reported.
Time frame: At Month 6, 12, 18, 24, 30, 36, 42 and 48
Progression-free Survival (PFS) as Assessed by the Investigator Using RECIST v1.1
PFS is defined as the time from the date of randomization to the date of first objectively documented PD as determined by investigators using RECIST v1.1 or death from any cause in the absence of progression, whichever occurs first. PD is defined as at least a 20% increase in the sum of the diameters of target lesions, taking as reference the smallest sum on study (this includes the baseline sum if that is the smallest on study).
Time frame: Up to 52 months
CNS-PFS as Assessed by BICR Using RANO-BM Criteria
PFS is defined as the time from the date of randomization to the date of first radiographic progression in the CNS as determined by BICR using RANO-BM criteria or until death due to any cause (whichever occurs first). This endpoint was analysed using a cumulative incidence competing-risk analysis, and the cumulative incidence rate was reported.
Time frame: At Month 6, 12, 18, 24, 30, 36, 42 and 48
Progression-free Survival (PFS) by Programmed Cell Death-ligand 1 (PD-L1) Status
PFS is defined as the time from the date of randomization to the date of first objectively documented PD as determined by BICR using RECIST v1.1 or death from any cause in the absence of progression, whichever occurs first. PD is defined as at least a 20% increase in the sum of the diameters of target lesions, taking as reference the smallest sum on study (this includes the baseline sum if that is the smallest on study). Participants were evaluated by PD-L1 status: Tumor Cells (TCs) ≥1% and TCs \<1%/Not Evaluable.
Time frame: Up to 52 months
Overall Survival by Programmed Cell Death-ligand 1 (PD-L1) Status
OS is defined as the interval of time from the date of randomization to the date of death due to any cause. Participants were evaluated by PD-L1 status: Tumor Cells (TCs) ≥1% and TCs \<1%/Not Evaluable.
Time frame: Up to 52 months
Number of Participants With Minimally Clinically Important Difference (MCID) Status in European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30 (EORTC-QLQ-C30)
The EORTC QLQ-C30 includes 30-items with single and multi-item scales. These included five functional scales (physical functioning \[PF\], role functioning \[RF\], cognitive functioning \[CF\], emotional functioning \[EF\] and social functioning \[SF\]), three symptom scales (fatigue, pain and nausea/vomiting \[N/V\]), a global health status (GHS)/ Quality-of-Life (QoL) scale, and six single items (constipation, diarrhoea, insomnia, dyspnoea, appetite loss \[AL\] and financial difficulties \[FD\]). Response options are 1 to 4. Scores were averaged and transformed to 0 to 100, a high score for functional scales/ GHS/QoL represent better functioning ability or health-related quality-of-life (HRQoL), whereas a high score for symptom scales/ single items represent significant symptomatology. MCID status: Functional scales \& GHS/QoL (Improved: ≥ +10; Stable: \> -10 and \< +10; Worsened: ≤ -10) and Symptom scales (Improved: ≤ -10; Stable: \> -10 and \< +10; Worsened: ≥ +10)
Time frame: Baseline (Predose); Day (D) 1 of Cycle (C)2, C3, C4, C5-C67 (odd cycles only); End of Treatment (EoT, up to approx 49 months); Safety follow-up (SFU) 1 & 2 (up to approx 50 & 52 months)
Changes From Baseline (CFB) in the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire 13-item Lung Cancer-specific Module (EORTC QLQ-LC13)
EORTC QLQ-LC13 is a 13-items questionnaire used in clinical research to assess health-related quality of life in lung cancer patients. The QLQ-LC13 includes questions assessing lung cancer-associated symptoms (Coughing, hemoptysis, dyspnea and site specific pain), treatment-related side effects (sore mouth, dysphagia, peripheral neuropathy and alopecia) and pain medication. Scores are calculated and transformed to range from 0 to 100. For the disease symptoms and side-effects of treatment scales a higher score represents a higher level of symptoms/problems and a negative change from baseline value indicates reduction (i.e. improvement) in symptoms.
Time frame: Baseline (Predose); Day (D) 1 of Cycle (C)2, C3, C4, C5-C67 (odd cycles only); EoT (up to approx 49 months); Safety follow-up (SFU) 1 & 2 (up to approx 50 & 52 months)
Time to Deterioration (TTD) in EORTC Cancer Quality of Life Questionnaire LC13 (EORTC QLQ-LC13)
TTD in lung symptoms is defined as the time from randomization to first onset of ≥10 point increase from baseline with confirmation by a second adjacent ≥10 point increase in the same symptom domain for any of the three symptoms: dyspnea, chest pain, and cough, on the EORTC QLQ-LC13 were scored on a 4-point scale (1=Not at All to 4=Very Much). Using linear transformation, raw scores are standardized, so that scores range from 0-100. A lower score indicates a better outcome. A longer TTD indicates a better outcome.
Time frame: Up to 52 months
Number of Participants With Treatment Emergent (TE) Adverse Events (AEs), Serious TEAEs and Adverse Events of Special Interest (AESIs)
An AE is any untoward medical occurrence in a participant or clinical investigation participant, temporally associated with the use of a medicinal product, whether or not considered related to the medicinal product. SAE is defined as any untoward medical occurrence that, at any dose resulted in death, is life threatening, required hospitalization or prolongation of existing hospitalization, resulted in disability/incapacity, is a congenital anomaly/birth defect, other situations and is associated with liver injury or impaired liver function. SAEs are subsets of AEs. TEAE is an event that emerged during treatment having been absent pretreatment or worsened relative to the pretreatment state. AESI is any AE (serious or nonserious) that is of scientific and medical concern specific to niraparib for which ongoing monitoring and rapid communication by the Investigator to the Sponsor is warranted. AEs were coded using the Medical Dictionary for Regulatory Activities (MedDRA) coding system.
Time frame: Up to 52 months
Plasma Concentrations of Niraparib
Blood samples were collected for plasma concentrations of niraparib.
Time frame: Cycle 1 Day 1 (pre-dose, 3 h), Cycle 1 Day 15 (pre-dose, 3 h), Cycle 2 Day 1 (pre-dose, 3 h), Cycle 4 Day 1 (pre-dose), Cycle 7 Day 1 (pre-dose), and End of Treatment (pre-dose); up to approximately 49 months
| Milestone | Niraparib + Pembrolizumab | Placebo + Pembrolizumab |
|---|---|---|
| Started | 331 | 335 |
| Safety population | 329 | 329 |
| Cr/pr population | 200 | 201 |
| Pk population | 323 | 0 |
| Completed | 0 | 0 |
| Not completed | 331 | 335 |
| Withdrew: Death | 196 | 177 |
| Withdrew: Lost to follow-up | 2 | 0 |
| Withdrew: Physician decision | 4 | 2 |
| Withdrew: Withdrawal by subject | 27 | 28 |
| Withdrew: Disease progression | 1 | 1 |
| Withdrew: Ongoing at the time of analysis | 99 | 124 |
| Withdrew: Other | 2 | 3 |
PFS is defined as the time from the date of randomization to the date of first objectively documented disease progression (PD) as determined by blinded independent central review (BICR) using Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST v1.1) or death from any cause in the absence of progression, whichever occurs first. PD is defined as at least a 20% increase in the sum of the diameters of target lesions, taking as reference the smallest sum on study (this includes the baseline sum if that is the smallest on study).
| Months | Niraparib + Pembrolizumab | Placebo + Pembrolizumab |
|---|---|---|
| Progression-free Survival (PFS) Assessed by Blinded Independent Central Review (BICR) - Complete and Partial Response (CR/PR) Population | 5.55 (4.14 to 8.28) | 5.55 (4.21 to 7.16) |
PFS is defined as the time from the date of randomization to the date of first objectively documented PD as determined by BICR using RECIST v1.1 or death from any cause in the absence of progression, whichever occurs first. PD is defined as at least a 20% increase in the sum of the diameters of target lesions, taking as reference the smallest sum on study (this includes the baseline sum if that is the smallest on study).
| Months | Niraparib + Pembrolizumab | Placebo + Pembrolizumab |
|---|---|---|
| Progression-free Survival (PFS) Assessed by BICR - Intent-to-Treat (ITT) Population | 4.40 (4.17 to 5.62) | 4.37 (4.14 to 5.52) |
OS is defined as the interval of time from the date of randomization to the date of death due to any cause.
| Months | Niraparib + Pembrolizumab | Placebo + Pembrolizumab |
|---|---|---|
| Overall Survival (OS) - CR/PR Population | 24.77 (20.11 to 31.44) | 32.49 (24.67 to NA) |
OS is defined as the interval of time from the date of randomization to the date of death due to any cause.
| Months | Niraparib + Pembrolizumab | Placebo + Pembrolizumab |
|---|---|---|
| Overall Survival (OS) - ITT Population | 21.36 (18.23 to 23.23) | 25.26 (21.22 to 28.71) |
TTP in the CNS is defined as the time from the date of randomization until the earliest date of documented PD in the CNS as assessed by BICR using Response Assessment in Neuro-Oncology Brain Metastases (RANO-BM) criteria. This endpoint was analysed using a cumulative incidence competing-risk analysis, and the cumulative incidence rate was reported.
| Proportion of participants | Niraparib + Pembrolizumab | Placebo + Pembrolizumab |
|---|---|---|
| 6-months | 0.11 (0.07 to 0.14) | 0.10 (0.07 to 0.14) |
| 12-months | 0.12 (0.08 to 0.16) | 0.11 (0.08 to 0.15) |
| 18-months | 0.12 (0.09 to 0.16) | 0.12 (0.08 to 0.15) |
| 24-months | 0.13 (0.09 to 0.17) | 0.12 (0.09 to 0.16) |
| 30-months | 0.13 (0.09 to 0.17) | 0.13 (0.10 to 0.17) |
| 36-months | 0.13 (0.09 to 0.17) | 0.13 (0.10 to 0.17) |
| 42-months | 0.13 (0.09 to 0.17) | 0.13 (0.10 to 0.17) |
| 48-months | 0.13 (0.09 to 0.17) | 0.13 (0.10 to 0.17) |
PFS is defined as the time from the date of randomization to the date of first objectively documented PD as determined by investigators using RECIST v1.1 or death from any cause in the absence of progression, whichever occurs first. PD is defined as at least a 20% increase in the sum of the diameters of target lesions, taking as reference the smallest sum on study (this includes the baseline sum if that is the smallest on study).
| Months | Niraparib + Pembrolizumab | Placebo + Pembrolizumab |
|---|---|---|
| Progression-free Survival (PFS) as Assessed by the Investigator Using RECIST v1.1 | 7.10 (5.55 to 8.80) | 6.67 (5.52 to 8.15) |
PFS is defined as the time from the date of randomization to the date of first radiographic progression in the CNS as determined by BICR using RANO-BM criteria or until death due to any cause (whichever occurs first). This endpoint was analysed using a cumulative incidence competing-risk analysis, and the cumulative incidence rate was reported.
| Proportion of participants | Niraparib + Pembrolizumab | Placebo + Pembrolizumab |
|---|---|---|
| 6-months | 0.12 (0.09 to 0.16) | 0.14 (0.10 to 0.18) |
| 12-months | 0.13 (0.10 to 0.18) | 0.16 (0.12 to 0.20) |
| 18-months | 0.14 (0.10 to 0.18) | 0.17 (0.13 to 0.21) |
| 24-months | 0.15 (0.11 to 0.19) | 0.17 (0.13 to 0.22) |
| 30-months | 0.15 (0.11 to 0.19) | 0.19 (0.15 to 0.24) |
| 36-months | 0.15 (0.11 to 0.19) | 0.19 (0.15 to 0.24) |
| 42-months | 0.16 (0.11 to 0.21) | 0.19 (0.15 to 0.24) |
| 48-months | 0.16 (0.11 to 0.21) | 0.19 (0.15 to 0.24) |
PFS is defined as the time from the date of randomization to the date of first objectively documented PD as determined by BICR using RECIST v1.1 or death from any cause in the absence of progression, whichever occurs first. PD is defined as at least a 20% increase in the sum of the diameters of target lesions, taking as reference the smallest sum on study (this includes the baseline sum if that is the smallest on study). Participants were evaluated by PD-L1 status: Tumor Cells (TCs) ≥1% and TCs \<1%/Not Evaluable.
| Months | Niraparib + Pembrolizumab | Placebo + Pembrolizumab |
|---|---|---|
| Tumor Cells (TCs) >=1% | 5.85 (4.17 to 10.22) | 6.80 (4.76 to 11.07) |
| TCs <1%/Not Evaluable | 4.17 (3.71 to 5.55) | 4.01 (2.79 to 4.34) |
OS is defined as the interval of time from the date of randomization to the date of death due to any cause. Participants were evaluated by PD-L1 status: Tumor Cells (TCs) ≥1% and TCs \<1%/Not Evaluable.
| Months | Niraparib + Pembrolizumab | Placebo + Pembrolizumab |
|---|---|---|
| TCs >=1% | 21.75 (18.46 to 27.04) | 33.48 (27.14 to NA) |
| TCs <1%/Not Evaluable | 20.11 (15.93 to 23.23) | 20.11 (17.22 to 23.92) |
The EORTC QLQ-C30 includes 30-items with single and multi-item scales. These included five functional scales (physical functioning \[PF\], role functioning \[RF\], cognitive functioning \[CF\], emotional functioning \[EF\] and social functioning \[SF\]), three symptom scales (fatigue, pain and nausea/vomiting \[N/V\]), a global health status (GHS)/ Quality-of-Life (QoL) scale, and six single items (constipation, diarrhoea, insomnia, dyspnoea, appetite loss \[AL\] and financial difficulties \[FD\]). Response options are 1 to 4. Scores were averaged and transformed to 0 to 100, a high score for functional scales/ GHS/QoL represent better functioning ability or health-related quality-of-life (HRQoL), whereas a high score for symptom scales/ single items represent significant symptomatology. MCID status: Functional scales \& GHS/QoL (Improved: ≥ +10; Stable: \> -10 and \< +10; Worsened: ≤ -10) and Symptom scales (Improved: ≤ -10; Stable: \> -10 and \< +10; Worsened: ≥ +10)
| Participants | Niraparib + Pembrolizumab | Placebo + Pembrolizumab |
|---|---|---|
| GHS/QoL, Cycle 2 Day 1, Improved | 34 | 50 |
| GHS/QoL, Cycle 2 Day 1, Stable | 122 | 129 |
| GHS/QoL, Cycle 2 Day 1, Worsened | 53 | 43 |
| GHS/QoL, Cycle 3 Day 1, Improved | 41 | 44 |
| GHS/QoL, Cycle 3 Day 1, Stable | 105 | 113 |
| GHS/QoL, Cycle 3 Day 1, Worsened | 49 | 39 |
| GHS/QoL, Cycle 4 Day 1, Improved | 33 | 40 |
| GHS/QoL, Cycle 4 Day 1, Stable | 93 | 87 |
| GHS/QoL, Cycle 4 Day 1, Worsened | 40 | 39 |
| GHS/QoL, Cycle 5 Day 1, Improved | 29 | 41 |
| GHS/QoL, Cycle 5 Day 1, Stable | 84 | 83 |
| GHS/QoL, Cycle 5 Day 1, Worsened | 46 | 32 |
| GHS/QoL, Cycle 7 Day 1, Improved | 22 | 39 |
| GHS/QoL, Cycle 7 Day 1, Stable | 79 | 60 |
| GHS/QoL, Cycle 7 Day 1, Worsened | 33 | 29 |
| GHS/QoL, Cycle 9 Day 1, Improved | 30 | 22 |
| GHS/QoL, Cycle 9 Day 1, Stable | 56 | 64 |
| GHS/QoL, Cycle 9 Day 1, Worsened | 32 | 26 |
| GHS/QoL, Cycle 11 Day 1, Improved | 21 | 23 |
| GHS/QoL, Cycle 11 Day 1, Stable | 48 | 51 |
| GHS/QoL, Cycle 11 Day 1, Worsened | 29 | 22 |
| GHS/QoL, Cycle 13 Day 1, Improved | 21 | 24 |
| GHS/QoL, Cycle 13 Day 1, Stable | 44 | 40 |
| GHS/QoL, Cycle 13 Day 1, Worsened | 25 | 17 |
| GHS/QoL, Cycle 15 Day 1, Improved | 20 | 27 |
| GHS/QoL, Cycle 15 Day 1, Stable | 43 | 35 |
| GHS/QoL, Cycle 15 Day 1, Worsened | 18 | 16 |
| GHS/QoL, Cycle 17 Day 1, Improved | 19 | 21 |
| GHS/QoL, Cycle 17 Day 1, Stable | 33 | 38 |
| GHS/QoL, Cycle 17 Day 1, Worsened | 18 | 13 |
| GHS/QoL, Cycle 19 Day 1, Improved | 18 | 24 |
| GHS/QoL, Cycle 19 Day 1, Stable | 37 | 34 |
| GHS/QoL, Cycle 19 Day 1, Worsened | 14 | 7 |
| GHS/QoL, Cycle 21 Day 1, Improved | 15 | 13 |
| GHS/QoL, Cycle 21 Day 1, Stable | 38 | 38 |
| GHS/QoL, Cycle 21 Day 1, Worsened | 10 | 15 |
| GHS/QoL, Cycle 23 Day 1, Improved | 15 | 18 |
| GHS/QoL, Cycle 23 Day 1, Stable | 30 | 36 |
| GHS/QoL, Cycle 23 Day 1, Worsened | 11 | 8 |
| GHS/QoL, Cycle 25 Day 1, Improved | 13 | 15 |
| GHS/QoL, Cycle 25 Day 1, Stable | 30 | 29 |
| GHS/QoL, Cycle 25 Day 1, Worsened | 11 | 12 |
| GHS/QoL, Cycle 27 Day 1, Improved | 9 | 13 |
| GHS/QoL, Cycle 27 Day 1, Stable | 28 | 31 |
| GHS/QoL, Cycle 27 Day 1, Worsened | 12 | 10 |
| GHS/QoL, Cycle 29 Day 1, Improved | 10 | 15 |
| GHS/QoL, Cycle 29 Day 1, Stable | 26 | 22 |
| GHS/QoL, Cycle 29 Day 1, Worsened | 11 | 11 |
| GHS/QoL, Cycle 31 Day 1, Improved | 7 | 9 |
| GHS/QoL, Cycle 31 Day 1, Stable | 22 | 20 |
| GHS/QoL, Cycle 31 Day 1, Worsened | 11 | 10 |
| GHS/QoL, Cycle 33 Day 1, Improved | 8 | 10 |
| GHS/QoL, Cycle 33 Day 1, Stable | 17 | 21 |
| GHS/QoL, Cycle 33 Day 1, Worsened | 7 | 9 |
| GHS/QoL, Cycle 35 Day 1, Improved | 5 | 9 |
| GHS/QoL, Cycle 35 Day 1, Stable | 17 | 17 |
| GHS/QoL, Cycle 35 Day 1, Worsened | 9 | 8 |
| GHS/QoL, Cycle 37 Day 1, Improved | 7 | 11 |
| GHS/QoL, Cycle 37 Day 1, Stable | 16 | 11 |
| GHS/QoL, Cycle 37 Day 1, Worsened | 3 | 11 |
| GHS/QoL, Cycle 39 Day 1, Improved | 5 | 8 |
| GHS/QoL, Cycle 39 Day 1, Stable | 13 | 14 |
| GHS/QoL, Cycle 39 Day 1, Worsened | 7 | 11 |
| GHS/QoL, Cycle 41 Day 1, Improved | 3 | 8 |
| GHS/QoL, Cycle 41 Day 1, Stable | 12 | 15 |
| GHS/QoL, Cycle 41 Day 1, Worsened | 6 | 7 |
| GHS/QoL, Cycle 43 Day 1, Improved | 3 | 4 |
| GHS/QoL, Cycle 43 Day 1, Stable | 15 | 14 |
| GHS/QoL, Cycle 43 Day 1, Worsened | 2 | 10 |
| GHS/QoL, Cycle 45 Day 1, Improved | 3 | 5 |
| GHS/QoL, Cycle 45 Day 1, Stable | 10 | 9 |
| GHS/QoL, Cycle 45 Day 1, Worsened | 3 | 9 |
| GHS/QoL, Cycle 47 Day 1, Improved | 1 | 4 |
| GHS/QoL, Cycle 47 Day 1, Stable | 7 | 12 |
| GHS/QoL, Cycle 47 Day 1, Worsened | 3 | 3 |
| GHS/QoL, Cycle 49 Day 1, Improved | 1 | 3 |
| GHS/QoL, Cycle 49 Day 1, Stable | 8 | 8 |
| GHS/QoL, Cycle 49 Day 1, Worsened | 2 | 4 |
| GHS/QoL, Cycle 51 Day 1, Improved | 1 | 2 |
| GHS/QoL, Cycle 51 Day 1, Stable | 5 | 4 |
| GHS/QoL, Cycle 51 Day 1, Worsened | 1 | 7 |
| GHS/QoL, Cycle 53 Day 1, Improved | 1 | 1 |
| GHS/QoL, Cycle 53 Day 1, Stable | 4 | 5 |
| GHS/QoL, Cycle 53 Day 1, Worsened | 0 | 1 |
| GHS/QoL, Cycle 55 Day 1, Improved | 3 | 0 |
| GHS/QoL, Cycle 55 Day 1, Stable | 2 | 6 |
| GHS/QoL, Cycle 55 Day 1, Worsened | 0 | 0 |
| GHS/QoL, Cycle 57 Day 1, Improved | 2 | 1 |
| GHS/QoL, Cycle 57 Day 1, Stable | 3 | 2 |
| GHS/QoL, Cycle 57 Day 1, Worsened | 0 | 1 |
| GHS/QoL, Cycle 59 Day 1, Improved | 1 | 1 |
| GHS/QoL, Cycle 59 Day 1, Stable | 2 | 2 |
| GHS/QoL, Cycle 59 Day 1, Worsened | 1 | 1 |
| GHS/QoL, Cycle 61 Day 1, Improved | 2 | 0 |
| GHS/QoL, Cycle 61 Day 1, Stable | 0 | 2 |
| GHS/QoL, Cycle 61 Day 1, Worsened | 1 | 2 |
| GHS/QoL, Cycle 63 Day 1, Improved | 0 | 0 |
| GHS/QoL, Cycle 63 Day 1, Stable | 2 | 1 |
| GHS/QoL, Cycle 63 Day 1, Worsened | 0 | 0 |
| GHS/QoL, Cycle 65 Day 1, Improved | 1 | — |
| GHS/QoL, Cycle 65 Day 1, Stable | 0 | — |
| GHS/QoL, Cycle 65 Day 1, Worsened | 0 | — |
| GHS/QoL, Cycle 67 Day 1, Improved | 0 | — |
| GHS/QoL, Cycle 67 Day 1, Stable | 1 | — |
| GHS/QoL, Cycle 67 Day 1, Worsened | 0 | — |
| GHS/QoL, End of Treatment, Improved | 33 | 30 |
| GHS/QoL, End of Treatment, Stable | 72 | 73 |
| GHS/QoL, End of Treatment, Worsened | 69 | 56 |
| GHS/QoL, Safety Follow-up 1, Improved | 14 | 16 |
| GHS/QoL, Safety Follow-up 1, Stable | 36 | 47 |
| GHS/QoL Safety Follow-up 1, Worsened | 48 | 36 |
| GHS/QoL, Safety Follow-up 2, Improved | 13 | 24 |
| GHS/QoL, Safety Follow-up 2, Stable | 38 | 39 |
| GHS/QoL, Safety Follow-up 2, Worsened | 37 | 30 |
| Physical Functioning, Cycle 2 Day 1, Improved | 49 | 55 |
| Physical Functioning, Cycle 2 Day 1, Stable | 130 | 140 |
| Physical Functioning, Cycle 2 Day 1, Worsened | 30 | 24 |
| Physical Functioning, Cycle 3 Day 1, Improved | 48 | 52 |
| Physical Functioning, Cycle 3 Day 1, Stable | 122 | 122 |
| Physical Functioning, Cycle 3 Day 1, Worsened | 25 | 21 |
| Physical Functioning, Cycle 4 Day 1, Improved | 42 | 50 |
| Physical Functioning, Cycle 4 Day 1, Stable | 98 | 87 |
| Physical Functioning, Cycle 4 Day 1, Worsened | 24 | 28 |
| Physical Functioning, Cycle 5 Day 1, Improved | 41 | 51 |
| Physical Functioning, Cycle 5 Day 1, Stable | 93 | 77 |
| Physical Functioning, Cycle 5 Day 1, Worsened | 23 | 26 |
| Physical Functioning, Cycle 7 Day 1, Improved | 34 | 46 |
| Physical Functioning, Cycle 7 Day 1, Stable | 79 | 66 |
| Physical Functioning, Cycle 7 Day 1, Worsened | 19 | 16 |
| Physical Functioning, Cycle 9 Day 1, Improved | 36 | 40 |
| Physical Functioning, Cycle 9 Day 1, Stable | 62 | 57 |
| Physical Functioning, Cycle 9 Day 1, Worsened | 17 | 15 |
| Physical Functioning, Cycle 11 Day 1, Improved | 25 | 35 |
| Physical Functioning, Cycle 11 Day 1, Stable | 59 | 44 |
| Physical Functioning, Cycle 11 Day 1, Worsened | 13 | 16 |
| Physical Functioning, Cycle 13 Day 1, Improved | 24 | 29 |
| Physical Functioning, Cycle 13 Day 1, Stable | 53 | 42 |
| Physical Functioning, Cycle 13 Day 1, Worsened | 11 | 10 |
| Physical Functioning, Cycle 15 Day 1, Improved | 18 | 32 |
| Physical Functioning, Cycle 15 Day 1, Stable | 50 | 37 |
| Physical Functioning, Cycle 15 Day 1, Worsened | 11 | 9 |
| Physical Functioning, Cycle 17 Day 1, Improved | 19 | 26 |
| Physical Functioning, Cycle 17 Day 1, Stable | 34 | 34 |
| Physical Functioning, Cycle 17 Day 1, Worsened | 15 | 12 |
| Physical Functioning, Cycle 19 Day 1, Improved | 20 | 23 |
| Physical Functioning, Cycle 19 Day 1, Stable | 38 | 35 |
| Physical Functioning, Cycle 19 Day 1, Worsened | 9 | 7 |
| Physical Functioning, Cycle 21 Day 1, Improved | 19 | 21 |
| Physical Functioning, Cycle 21 Day 1, Stable | 37 | 35 |
| Physical Functioning, Cycle 21 Day 1, Worsened | 7 | 10 |
| Physical Functioning, Cycle 23 Day 1, Improved | 14 | 20 |
| Physical Functioning, Cycle 23 Day 1, Stable | 35 | 36 |
| Physical Functioning, Cycle 23 Day 1, Worsened | 6 | 6 |
| Physical Functioning, Cycle 25 Day 1, Improved | 17 | 25 |
| Physical Functioning, Cycle 25 Day 1, Stable | 32 | 22 |
| Physical Functioning, Cycle 25 Day 1, Worsened | 4 | 9 |
| Physical Functioning, Cycle 27 Day 1, Improved | 17 | 19 |
| Physical Functioning, Cycle 27 Day 1, Stable | 25 | 30 |
| Physical Functioning, Cycle 27 Day 1, Worsened | 6 | 5 |
| Physical Functioning, Cycle 29 Day 1, Improved | 14 | 19 |
| Physical Functioning, Cycle 29 Day 1, Stable | 27 | 21 |
| Physical Functioning, Cycle 29 Day 1, Worsened | 5 | 8 |
| Physical Functioning, Cycle 31 Day 1, Improved | 14 | 15 |
| Physical Functioning, Cycle 31 Day 1, Stable | 18 | 18 |
| Physical Functioning, Cycle 31 Day 1, Worsened | 7 | 6 |
| Physical Functioning, Cycle 33 Day 1, Improved | 9 | 12 |
| Physical Functioning, Cycle 33 Day 1, Stable | 19 | 22 |
| Physical Functioning, Cycle 33 Day 1, Worsened | 3 | 5 |
| Physical Functioning, Cycle 35 Day 1, Improved | 10 | 11 |
| Physical Functioning, Cycle 35 Day 1, Stable | 17 | 20 |
| Physical Functioning, Cycle 35 Day 1, Worsened | 3 | 3 |
| Physical Functioning, Cycle 37 Day 1, Improved | 7 | 10 |
| Physical Functioning, Cycle 37 Day 1, Stable | 16 | 18 |
| Physical Functioning, Cycle 37 Day 1, Worsened | 2 | 5 |
| Physical Functioning, Cycle 39 Day 1, Improved | 7 | 11 |
| Physical Functioning, Cycle 39 Day 1, Stable | 15 | 14 |
| Physical Functioning, Cycle 39 Day1, Worsened | 3 | 8 |
| Physical Functioning, Cycle 41 Day 1, Improved | 6 | 10 |
| Physical Functioning, Cycle 41 Day 1, Stable | 12 | 17 |
| Physical Functioning, Cycle 41 Day 1, Worsened | 2 | 3 |
| Physical Functioning, Cycle 43 Day 1, Improved | 6 | 8 |
| Physical Functioning, Cycle 43 Day 1, Stable | 14 | 15 |
| Physical Functioning, Cycle 43 Day 1, Worsened | 0 | 5 |
| Physical Functioning, Cycle 45 Day 1, Improved | 4 | 8 |
| Physical Functioning, Cycle 45 Day 1, Stable | 12 | 12 |
| Physical Functioning, Cycle 45 Day 1, Worsened | 0 | 3 |
| Physical Functioning, Cycle 47 Day 1, Improved | 2 | 9 |
| Physical Functioning, Cycle 47 Day 1, Stable | 8 | 9 |
| Physical Functioning, Cycle 47 Day 1, Worsened | 1 | 1 |
| Physical Functioning, Cycle 49 Day 1, Improved | 3 | 4 |
| Physical Functioning, Cycle 49 Day 1, Stable | 7 | 10 |
| Physical Functioning, Cycle 49 Day 1, Worsened | 1 | 1 |
| Physical Functioning, Cycle 51 Day 1, Improved | 3 | 4 |
| Physical Functioning, Cycle 51 Day 1, Stable | 3 | 7 |
| Physical Functioning, Cycle 51 Day 1, Worsened | 0 | 2 |
| Physical Functioning, Cycle 53 Day 1, Improved | 2 | 4 |
| Physical Functioning, Cycle 53 Day 1, Stable | 2 | 3 |
| Physical Functioning, Cycle 53 Day 1, Worsened | 1 | 0 |
| Physical Functioning, Cycle 55 Day 1, Improved | 3 | 2 |
| Physical Functioning, Cycle 55 Day 1, Stable | 2 | 4 |
| Physical Functioning, Cycle 55 Day 1, Worsened | 0 | 0 |
| Physical Functioning, Cycle 57 Day 1, Improved | 3 | 1 |
| Physical Functioning, Cycle 57 Day 1, Stable | 2 | 2 |
| Physical Functioning, Cycle 57 Day 1, Worsened | 0 | 1 |
| Physical Functioning, Cycle 59 Day 1, Improved | 0 | 0 |
| Physical Functioning, Cycle 59 Day 1, Stable | 4 | 3 |
| Physical Functioning, Cycle 59 Day 1, Worsened | 0 | 1 |
| Physical Functioning, Cycle 61 Day 1, Improved | 1 | 1 |
| Physical Functioning, Cycle 61 Day 1, Stable | 2 | 2 |
| Physical Functioning, Cycle 61 Day 1, Worsened | 0 | 1 |
| Physical Functioning, Cycle 63 Day 1, Improved | 2 | 1 |
| Physical Functioning, Cycle 63 Day 1, Stable | 0 | 0 |
| Physical Functioning, Cycle 63 Day 1, Worsened | 0 | 0 |
| Physical Functioning, Cycle 65 Day 1, Improved | 0 | — |
| Physical Functioning, Cycle 65 Day 1, Stable | 1 | — |
| Physical Functioning, Cycle 65 Day 1, Worsened | 0 | — |
| Physical Functioning, Cycle 67 Day 1, Improved | 0 | — |
| Physical Functioning, Cycle 67 Day 1, Stable | 1 | — |
| Physical Functioning, Cycle 67 Day 1, Worsened | 0 | — |
| Physical Functioning, End of Treatment, Improved | 33 | 44 |
| Physical Functioning, End of Treatment, Stable | 85 | 73 |
| Physical Functioning, End of Treatment, Worsened | 53 | 42 |
| Physical Functioning, Safety Follow-up 1, Improved | 20 | 31 |
| Physical Functioning, Safety Follow-up 1, Stable | 44 | 43 |
| Physical Functioning, Safety Follow-up 1, Worsened | 32 | 25 |
| Physical Functioning, Safety Follow-up 2, Improved | 22 | 24 |
| Physical Functioning, Safety Follow-up 2, Stable | 37 | 45 |
| Physical Functioning, Safety Follow-up 2, Worsened | 28 | 24 |
| Role Functioning, Cycle 2 Day 1, Improved | 68 | 72 |
| Role Functioning, Cycle 2 Day 1, Stable | 101 | 111 |
| Role Functioning, Cycle 2 Day 1, Worsened | 41 | 36 |
| Role Functioning, Cycle 3 Day 1, Improved | 65 | 53 |
| Role Functioning, Cycle 3 Day 1, Stable | 100 | 109 |
| Role Functioning, Cycle 3 Day 1, Worsened | 28 | 34 |
| Role Functioning, Cycle 4 Day 1, Improved | 59 | 48 |
| Role Functioning, Cycle 4 Day 1, Stable | 79 | 92 |
| Role Functioning, Cycle 4 Day 1, Worsened | 28 | 25 |
| Role Functioning, Cycle 5 Day 1, Improved | 54 | 52 |
| Role Functioning, Cycle 5 Day 1, Stable | 70 | 70 |
| Role Functioning, Cycle 5 Day 1, Worsened | 35 | 31 |
| Role Functioning, Cycle 7 Day 1, Improved | 40 | 47 |
| Role Functioning, Cycle 7 Day 1, Stable | 68 | 61 |
| Role Functioning, Cycle 7 Day 1, Worsened | 25 | 20 |
| Role Functioning, Cycle 9 Day 1, Improved | 32 | 42 |
| Role Functioning, Cycle 9 Day 1, Stable | 58 | 51 |
| Role Functioning, Cycle 9 Day 1, Worsened | 28 | 19 |
| Role Functioning, Cycle 11 Day 1, Improved | 31 | 38 |
| Role Functioning, Cycle 11 Day 1, Stable | 42 | 43 |
| Role Functioning, Cycle 11 Day 1, Worsened | 25 | 15 |
| Role Functioning, Cycle 13 Day 1, Improved | 24 | 29 |
| Role Functioning, Cycle 13 Day 1, Stable | 45 | 42 |
| Role Functioning, Cycle 13 Day 1, Worsened | 18 | 9 |
| Role Functioning, Cycle 15 Day 1, Improved | 30 | 31 |
| Role Functioning, Cycle 15 Day 1, Stable | 34 | 39 |
| Role Functioning, Cycle 15 Day 1, Worsened | 16 | 8 |
| Role Functioning, Cycle 17 Day 1, Improved | 18 | 29 |
| Role Functioning, Cycle 17 Day 1, Stable | 36 | 32 |
| Role Functioning, Cycle 17 Day 1, Worsened | 13 | 10 |
| Role Functioning, Cycle 19 Day 1, Improved | 22 | 25 |
| Role Functioning, Cycle 19 Day 1, Stable | 37 | 32 |
| Role Functioning, Cycle 19 Day 1, Worsened | 10 | 8 |
| Role Functioning, Cycle 21 Day 1, Improved | 22 | 24 |
| Role Functioning, Cycle 21 Day 1, Stable | 32 | 33 |
| Role Functioning, Cycle 21 Day 1, Worsened | 9 | 9 |
| Role Functioning, Cycle 23 Day 1, Improved | 22 | 25 |
| Role Functioning, Cycle 23 Day 1, Stable | 25 | 29 |
| Role Functioning, Cycle 23 Day 1, Worsened | 9 | 8 |
| Role Functioning, Cycle 25 Day 1, Improved | 19 | 21 |
| Role Functioning, Cycle 25 Day 1, Stable | 27 | 29 |
| Role Functioning, Cycle 25 Day 1, Worsened | 8 | 6 |
| Role Functioning, Cycle 27 Day 1, Improved | 15 | 20 |
| Role Functioning, Cycle 27 Day 1, Stable | 27 | 28 |
| Role Functioning, Cycle 27 Day 1, Worsened | 7 | 6 |
| Role Functioning, Cycle 29 Day 1, Improved | 20 | 18 |
| Role Functioning, Cycle 29 Day 1, Stable | 21 | 19 |
| Role Functioning, Cycle 29 Day 1, Worsened | 6 | 11 |
| Role Functioning, Cycle 31 Day 1, Improved | 17 | 13 |
| Role Functioning, Cycle 31 Day 1, Stable | 17 | 19 |
| Role Functioning, Cycle 31 Day 1, Worsened | 6 | 7 |
| Role Functioning, Cycle 33 Day 1, Improved | 11 | 13 |
| Role Functioning, Cycle 33 Day 1, Stable | 18 | 19 |
| Role Functioning, Cycle 33 Day 1, Worsened | 3 | 8 |
| Role Functioning, Cycle 35 Day 1, Improved | 12 | 10 |
| Role Functioning, Cycle 35 Day 1, Stable | 13 | 18 |
| Role Functioning, Cycle 35 Day 1, Worsened | 6 | 5 |
| Role Functioning, Cycle 37 Day 1, Improved | 10 | 10 |
| Role Functioning, Cycle 37 Day 1, Stable | 14 | 17 |
| Role Functioning, Cycle 37 Day 1, Worsened | 2 | 6 |
| Role Functioning, Cycle 39 Day 1, Improved | 9 | 12 |
| Role Functioning, Cycle 39 Day 1, Stable | 11 | 13 |
| Role Functioning, Cycle 39 Day 1, Worsened | 5 | 8 |
| Role Functioning, Cycle 41 Day 1, Improved | 8 | 12 |
| Role Functioning, Cycle 41 Day 1, Stable | 10 | 13 |
| Role Functioning, Cycle 41 Day 1, Worsened | 3 | 4 |
| Role Functioning, Cycle 43 Day 1, Improved | 7 | 10 |
| Role Functioning, Cycle 43 Day 1, Stable | 10 | 11 |
| Role Functioning, Cycle 43 Day 1, Worsened | 3 | 7 |
| Role Functioning, Cycle 45 Day 1, Improved | 4 | 10 |
| Role Functioning, Cycle 45 Day 1, Stable | 8 | 10 |
| Role Functioning, Cycle 45 Day 1, Worsened | 4 | 3 |
| Role Functioning, Cycle 47 Day 1, Improved | 3 | 8 |
| Role Functioning, Cycle 47 Day 1, Stable | 6 | 9 |
| Role Functioning, Cycle 47 Day 1, Worsened | 2 | 2 |
| Role Functioning, Cycle 49 Day 1, Improved | 5 | 8 |
| Role Functioning, Cycle 49 Day 1, Stable | 5 | 7 |
| Role Functioning, Cycle 49 Day 1, Worsened | 1 | 0 |
| Role Functioning, Cycle 51 Day 1, Improved | 3 | 7 |
| Role Functioning, Cycle 51 Day 1, Stable | 3 | 3 |
| Role Functioning, Cycle 51 Day 1, Worsened | 0 | 3 |
| Role Functioning, Cycle 53 Day 1, Improved | 3 | 4 |
| Role Functioning, Cycle 53 Day 1, Stable | 2 | 3 |
| Role Functioning, Cycle 53 Day 1, Worsened | 0 | 0 |
| Role Functioning, Cycle 55 Day 1, Improved | 4 | 3 |
| Role Functioning, Cycle 55 Day 1, Stable | 1 | 3 |
| Role Functioning, Cycle 55 Day 1, Worsened | 0 | 0 |
| Role Functioning, C57 D1, Improved | 4 | 2 |
| Role Functioning, Cycle 57 Day 1, Stable | 1 | 2 |
| Role Functioning, Cycle 57 Day 1, Worsened | 0 | 0 |
| Role Functioning, Cycle 59 Day 1, Improved | 2 | 2 |
| Role Functioning, Cycle 59 Day 1, Stable | 1 | 1 |
| Role Functioning, Cycle 59 Day 1, Worsened | 1 | 1 |
| Role Functioning, Cycle 61 Day 1, Improved | 3 | 3 |
| Role Functioning, Cycle 61 Day 1, Stable | 0 | 1 |
| Role Functioning, Cycle 61 Day 1, Worsened | 0 | 0 |
| Role Functioning, Cycle 63 Day 1, Improved | 2 | 0 |
| Role Functioning, Cycle 63 Day 1, Stable | 0 | 1 |
| Role Functioning, Cycle 63 Day 1, Worsened | 0 | 0 |
| Role Functioning, Cycle 65 Day 1, Improved | 1 | — |
| Role Functioning, Cycle 65 Day 1, Stable | 0 | — |
| Role Functioning, Cycle 65 Day 1, Worsened | 0 | — |
| Role Functioning, Cycle 67 Day 1, Improved | 1 | — |
| Role Functioning, Cycle 67 Day 1, Stable | 0 | — |
| Role Functioning, Cycle 67 Day 1, Worsened | 0 | — |
| Role Functioning, End of Treatment, Improved | 46 | 46 |
| Role Functioning, End of Treatment, Stable | 82 | 63 |
| Role Functioning, End of Treatment, Worsened | 46 | 48 |
| Role Functioning, Safety Follow-up 1, Improved | 23 | 28 |
| Role Functioning, Safety Follow-up 1, Stable | 36 | 35 |
| Role Functioning, Safety Follow-up 1, Worsened | 39 | 36 |
| Role Functioning, Safety Follow-up 2, Improved | 17 | 25 |
| Role Functioning, Safety Follow-up 2, Stable | 35 | 37 |
| Role Functioning, Safety Follow-up 2, Worsened | 36 | 31 |
| Emotional Functioning, Cycle 2 Day 1, Improved | 59 | 44 |
| Emotional Functioning, Cycle 2 Day 1, Stable | 124 | 145 |
| Emotional Functioning, Cycle 2 Day 1, Worsened | 26 | 32 |
| Emotional Functioning, Cycle 3 Day 1, Improved | 57 | 39 |
| Emotional Functioning, Cycle 3 Day 1, Stable | 114 | 131 |
| Emotional Functioning, Cycle 3 Day 1, Worsened | 24 | 26 |
| Emotional Functioning, Cycle 4 Day 1, Improved | 51 | 37 |
| Emotional Functioning, Cycle 4 Day 1, Stable | 94 | 104 |
| Emotional Functioning, Cycle 4 Day 1, Worsened | 19 | 24 |
| Emotional Functioning, Cycle 5 Day 1, Improved | 49 | 36 |
| Emotional Functioning, Cycle 5 Day 1, Stable | 85 | 94 |
| Emotional Functioning, Cycle 5 Day 1, Worsened | 24 | 25 |
| Emotional Functioning, Cycle 7 Day 1, Improved | 45 | 34 |
| Emotional Functioning, Cycle 7 Day 1, Stable | 70 | 72 |
| Emotional Functioning, Cycle 7 Day 1, Worsened | 18 | 22 |
| Emotional Functioning, Cycle 9 Day 1, Improved | 34 | 31 |
| Emotional Functioning, Cycle 9 Day 1, Stable | 62 | 68 |
| Emotional Functioning, Cycle 9 Day 1, Worsened | 21 | 13 |
| Emotional Functioning, Cycle 11 Day 1, Improved | 31 | 32 |
| Emotional Functioning, Cycle 11 Day 1, Stable | 44 | 49 |
| Emotional Functioning, Cycle 11 Day 1, Worsened | 22 | 15 |
| Emotional Functioning, Cycle 13 Day 1, Improved | 25 | 19 |
| Emotional Functioning, Cycle 13 Day 1, Stable | 50 | 54 |
| Emotional Functioning, Cycle 13 Day 1, Worsened | 13 | 8 |
| Emotional Functioning, Cycle 15 Day 1, Improved | 27 | 28 |
| Emotional Functioning, Cycle 15 Day 1, Stable | 40 | 44 |
| Emotional Functioning, Cycle 15 Day 1, Worsened | 12 | 6 |
| Emotional Functioning, Cycle 17 Day 1, Improved | 22 | 21 |
| Emotional Functioning, Cycle 17 Day 1, Stable | 33 | 42 |
| Emotional Functioning, Cycle 17 Day 1, Worsened | 14 | 9 |
| Emotional Functioning, Cycle 19 Day 1, Improved | 25 | 16 |
| Emotional Functioning, Cycle 19 Day 1, Stable | 34 | 44 |
| Emotional Functioning, Cycle 19 Day 1, Worsened | 9 | 5 |
| Emotional Functioning, Cycle 21 Day 1, Improved | 24 | 18 |
| Emotional Functioning, Cycle 21 Day 1, Stable | 30 | 36 |
| Emotional Functioning, Cycle 21 Day 1, Worsened | 9 | 12 |
| Emotional Functioning, Cycle 23 Day 1, Improved | 24 | 17 |
| Emotional Functioning, Cycle 23 Day 1, Stable | 27 | 35 |
| Emotional Functioning, Cycle 23 Day 1, Worsened | 4 | 10 |
| Emotional Functioning, Cycle 25 Day 1, Improved | 19 | 18 |
| Emotional Functioning, Cycle 25 Day 1, Stable | 26 | 34 |
| Emotional Functioning, Cycle 25 Day 1, Worsened | 8 | 4 |
| Emotional Functioning, Cycle 27 Day 1, Improved | 15 | 9 |
| Emotional Functioning, Cycle 27 Day 1, Stable | 25 | 40 |
| Emotional Functioning, Cycle 27 Day 1, Worsened | 8 | 5 |
| Emotional Functioning, Cycle 29 Day 1, Improved | 22 | 8 |
| Emotional Functioning, Cycle 29 Day 1, Stable | 19 | 36 |
| Emotional Functioning, Cycle 29 Day 1, Worsened | 5 | 4 |
| Emotional Functioning, Cycle 31 Day 1, Improved | 18 | 8 |
| Emotional Functioning, Cycle 31 Day 1, Stable | 14 | 29 |
| Emotional Functioning, Cycle 31 Day 1, Worsened | 7 | 2 |
| Emotional Functioning, Cycle 33 Day 1, Improved | 12 | 8 |
| Emotional Functioning, Cycle 33 Day 1, Stable | 17 | 26 |
| Emotional Functioning, Cycle 33 Day 1, Worsened | 2 | 6 |
| Emotional Functioning, Cycle 35 Day 1, Improved | 9 | 9 |
| Emotional Functioning, Cycle 35 Day 1, Stable | 19 | 18 |
| Emotional Functioning, Cycle 35 Day 1, Worsened | 2 | 7 |
| Emotional Functioning, Cycle 37 Day 1, Improved | 9 | 5 |
| Emotional Functioning, Cycle 37 Day 1, Stable | 13 | 22 |
| Emotional Functioning, Cycle 37 Day 1, Worsened | 3 | 6 |
| Emotional Functioning, Cycle 39 Day 1, Improved | 9 | 9 |
| Emotional Functioning, Cycle 39 Day 1, Stable | 14 | 20 |
| Emotional Functioning, Cycle 39 Day 1, Worsened | 2 | 4 |
| Emotional Functioning, Cycle 41 Day 1, Improved | 7 | 8 |
| Emotional Functioning, Cycle 41 Day 1, Stable | 13 | 18 |
| Emotional Functioning, Cycle 41 Day 1, Worsened | 1 | 4 |
| Emotional Functioning, Cycle 43 Day 1, Improved | 10 | 7 |
| Emotional Functioning, Cycle 43 Day 1, Stable | 7 | 17 |
| Emotional Functioning, Cycle 43 Day 1, Worsened | 3 | 4 |
| Emotional Functioning, Cycle 45 Day 1, Improved | 5 | 5 |
| Emotional Functioning, Cycle 45 Day 1, Stable | 10 | 14 |
| Emotional Functioning, Cycle 45 Day 1, Worsened | 1 | 4 |
| Emotional Functioning, Cycle 47 Day 1, Improved | 3 | 7 |
| Emotional Functioning, Cycle 47 Day 1, Stable | 8 | 10 |
| Emotional Functioning, Cycle 47 Day 1, Worsened | 0 | 2 |
| Emotional Functioning, Cycle 49 Day 1, Improved | 5 | 3 |
| Emotional Functioning, Cycle 49 Day 1, Stable | 6 | 9 |
| Emotional Functioning, Cycle 49 Day 1, Worsened | 0 | 3 |
| Emotional Functioning, Cycle 51 Day 1, Improved | 2 | 4 |
| Emotional Functioning, Cycle 51 Day 1, Stable | 4 | 6 |
| Emotional Functioning, Cycle 51 Day 1, Worsened | 1 | 3 |
| Emotional Functioning, Cycle 53 Day 1, Improved | 3 | 3 |
| Emotional Functioning, Cycle 53 Day 1, Stable | 0 | 4 |
| Emotional Functioning, Cycle 53 Day 1, Worsened | 2 | 0 |
| Emotional Functioning, Cycle 55 Day 1, Improved | 3 | 3 |
| Emotional Functioning, Cycle 55 Day 1, Stable | 2 | 3 |
| Emotional Functioning, Cycle 55 Day 1, Worsened | 0 | 0 |
| Emotional Functioning, Cycle 57 Day 1, Improved | 3 | 2 |
| Emotional Functioning, Cycle 57 Day 1, Stable | 2 | 0 |
| Emotional Functioning, Cycle 57 Day 1, Worsened | 0 | 2 |
| Emotional Functioning, Cycle 59 Day 1, Improved | 1 | 2 |
| Emotional Functioning, Cycle 59 Day 1, Stable | 1 | 1 |
| Emotional Functioning, Cycle 59 Day 1, Worsened | 2 | 1 |
| Emotional Functioning, Cycle 61 Day 1, Improved | 2 | 3 |
| Emotional Functioning, Cycle 61 Day 1, Stable | 0 | 1 |
| Emotional Functioning, Cycle 61 Day 1, Worsened | 1 | 0 |
| Emotional Functioning, Cycle 63 Day 1, Improved | 1 | 1 |
| Emotional Functioning, Cycle 63 Day 1, Stable | 1 | 0 |
| Emotional Functioning, Cycle 63 Day 1, Worsened | 0 | 0 |
| Emotional Functioning, Cycle 65 Day 1, Improved | 1 | — |
| Emotional Functioning, Cycle 65 Day 1, Stable | 0 | — |
| Emotional Functioning, Cycle 65 Day 1, Worsened | 0 | — |
| Emotional Functioning, Cycle 67 Day 1, Improved | 1 | — |
| Emotional Functioning, Cycle 67 Day 1, Stable | 0 | — |
| Emotional Functioning, Cycle 67 Day 1, Worsened | 0 | — |
| Emotional Functioning, End of Treatment, Improved | 47 | 36 |
| Emotional Functioning, End of Treatment, Stable | 83 | 81 |
| Emotional Functioning, End of Treatment, Worsened | 43 | 42 |
| Emotional Functioning, Safety Follow-up 1, Improved | 24 | 24 |
| Emotional Functioning, Safety Follow-up 1, Stable | 48 | 47 |
| Emotional Functioning, Safety Follow-up 1, Worsened | 25 | 28 |
| Emotional Functioning, Safety Follow-up 2, Improved | 20 | 23 |
| Emotional Functioning, Safety Follow-up 2, Stable | 49 | 49 |
| Emotional Functioning, Safety Follow-up 2, Worsened | 18 | 21 |
| Cognitive Functioning, Cycle 2 Day 1, Improved | 60 | 48 |
| Cognitive Functioning, Cycle 2 Day 1, Stable | 120 | 142 |
| Cognitive Functioning, Cycle 2 Day 1, Worsened | 30 | 32 |
| Cognitive Functioning, Cycle 3 Day 1, Improved | 61 | 43 |
| Cognitive Functioning, Cycle 3 Day 1, Stable | 104 | 118 |
| Cognitive Functioning, Cycle 3 Day 1, Worsened | 31 | 35 |
| Cognitive Functioning, Cycle 4 Day 1, Improved | 53 | 31 |
| Cognitive Functioning, Cycle 4 Day 1, Stable | 89 | 105 |
| Cognitive Functioning, Cycle 4 Day 1, Worsened | 24 | 30 |
| Cognitive Functioning, Cycle 5 Day 1, Improved | 48 | 31 |
| Cognitive Functioning, Cycle 5 Day 1, Stable | 84 | 96 |
| Cognitive Functioning, Cycle 5 Day 1, Worsened | 27 | 28 |
| Cognitive Functioning, Cycle 7 Day 1, Improved | 32 | 25 |
| Cognitive Functioning, Cycle 7 Day 1, Stable | 80 | 75 |
| Cognitive Functioning, Cycle 7 Day 1, Worsened | 21 | 28 |
| Cognitive Functioning, Cycle 9 Day 1, Improved | 34 | 25 |
| Cognitive Functioning, Cycle 9 Day 1, Stable | 62 | 60 |
| Cognitive Functioning, Cycle 9 Day 1, Worsened | 21 | 27 |
| Cognitive Functioning, Cycle 11 Day 1, Improved | 26 | 26 |
| Cognitive Functioning, Cycle 11 Day 1, Stable | 51 | 52 |
| Cognitive Functioning, Cycle 11 Day 1, Worsened | 21 | 18 |
| Cognitive Functioning, Cycle 13 Day 1, Improved | 28 | 20 |
| Cognitive Functioning, Cycle 13 Day 1, Stable | 51 | 46 |
| Cognitive Functioning, Cycle 13 Day 1, Worsened | 11 | 15 |
| Cognitive Functioning, Cycle 15 Day 1, Improved | 29 | 21 |
| Cognitive Functioning, Cycle 15 Day 1, Stable | 42 | 47 |
| Cognitive Functioning, Cycle 15 Day 1, Worsened | 10 | 10 |
| Cognitive Functioning, Cycle 17 Day 1, Improved | 22 | 15 |
| Cognitive Functioning, Cycle 17 Day 1, Stable | 35 | 40 |
| Cognitive Functioning, Cycle 17 Day 1, Worsened | 13 | 17 |
| Cognitive Functioning, Cycle 19 Day 1, Improved | 22 | 14 |
| Cognitive Functioning, Cycle 19 Day 1, Stable | 35 | 38 |
| Cognitive Functioning, Cycle 19 Day 1, Worsened | 12 | 13 |
| Cognitive Functioning, Cycle 21 Day 1, Improved | 19 | 14 |
| Cognitive Functioning, Cycle 21 Day 1, Stable | 28 | 30 |
| Cognitive Functioning, Cycle 21 Day 1, Worsened | 16 | 22 |
| Cognitive Functioning, Cycle 23 Day 1, Improved | 16 | 8 |
| Cognitive Functioning, Cycle 23 Day 1, Stable | 28 | 38 |
| Cognitive Functioning, Cycle 23 Day 1, Worsened | 12 | 16 |
| Cognitive Functioning, Cycle 25 Day 1, Improved | 17 | 9 |
| Cognitive Functioning, Cycle 25 Day 1, Stable | 22 | 34 |
| Cognitive Functioning, Cycle 25 Day 1, Worsened | 15 | 13 |
| Cognitive Functioning, Cycle 27 Day 1, Improved | 15 | 13 |
| Cognitive Functioning, Cycle 27 Day 1, Stable | 24 | 27 |
| Cognitive Functioning, Cycle 27 Day 1, Worsened | 10 | 14 |
| Cognitive Functioning, Cycle 29 Day 1, Improved | 14 | 12 |
| Cognitive Functioning, Cycle 29 Day 1, Stable | 22 | 22 |
| Cognitive Functioning, Cycle 29 Day 1, Worsened | 11 | 14 |
| Cognitive Functioning, Cycle 31 Day 1, Improved | 16 | 7 |
| Cognitive Functioning, Cycle 31 Day 1, Stable | 18 | 23 |
| Cognitive Functioning, Cycle 31 Day 1, Worsened | 6 | 9 |
| Cognitive Functioning, Cycle 33 Day 1, Improved | 11 | 7 |
| Cognitive Functioning, Cycle 33 Day 1, Stable | 15 | 23 |
| Cognitive Functioning, Cycle 33 Day 1, Worsened | 6 | 10 |
| Cognitive Functioning, Cycle 35 Day 1, Improved | 7 | 7 |
| Cognitive Functioning, Cycle 35 Day 1, Stable | 23 | 18 |
| Cognitive Functioning, Cycle 35 Day 1, Worsened | 1 | 9 |
| Cognitive Functioning, Cycle 37 Day 1, Improved | 8 | 5 |
| Cognitive Functioning, Cycle 37 Day 1, Stable | 16 | 20 |
| Cognitive Functioning, Cycle 37 Day 1, Worsened | 2 | 8 |
| Cognitive Functioning, Cycle 39 Day 1, Improved | 9 | 8 |
| Cognitive Functioning, Cycle 39 Day 1, Stable | 13 | 16 |
| Cognitive Functioning, Cycle 39 Day 1, Worsened | 3 | 9 |
| Cognitive Functioning, Cycle 41 Day 1, Improved | 9 | 8 |
| Cognitive Functioning, Cycle 41 Day 1, Stable | 10 | 14 |
| Cognitive Functioning, Cycle 41 Day 1, Worsened | 2 | 8 |
| Cognitive Functioning, Cycle 43 Day 1, Improved | 6 | 5 |
| Cognitive Functioning, Cycle 43 Day 1, Stable | 11 | 13 |
| Cognitive Functioning, Cycle 43 Day 1, Worsened | 3 | 10 |
| Cognitive Functioning, Cycle 45 Day 1, Improved | 5 | 3 |
| Cognitive Functioning, Cycle 45 Day 1, Stable | 9 | 14 |
| Cognitive Functioning, Cycle 45 Day 1, Worsened | 2 | 6 |
| Cognitive Functioning, Cycle 47 Day 1, Improved | 3 | 8 |
| Cognitive Functioning, Cycle 47 Day 1, Stable | 5 | 7 |
| Cognitive Functioning, Cycle 47 Day 1, Worsened | 3 | 4 |
| Cognitive Functioning, Cycle 49 Day 1, Improved | 2 | 5 |
| Cognitive Functioning, Cycle 49 Day 1, Stable | 9 | 8 |
| Cognitive Functioning, Cycle 49 Day 1, Worsened | 0 | 2 |
| Cognitive Functioning, Cycle 51 Day 1, Improved | 3 | 4 |
| Cognitive Functioning, Cycle 51 Day 1, Stable | 4 | 5 |
| Cognitive Functioning, Cycle 51 Day 1, Worsened | 0 | 4 |
| Cognitive Functioning, Cycle 53 Day 1, Improved | 3 | 3 |
| Cognitive Functioning, Cycle 53 Day 1, Stable | 2 | 3 |
| Cognitive Functioning, Cycle 53 Day 1, Worsened | 0 | 1 |
| Cognitive Functioning, Cycle 55 Day 1, Improved | 3 | 2 |
| Cognitive Functioning, Cycle 55 Day 1, Stable | 1 | 4 |
| Cognitive Functioning, Cycle 55 Day 1, Worsened | 1 | 0 |
| Cognitive Functioning, Cycle 57 Day 1, Improved | 2 | 1 |
| Cognitive Functioning, Cycle 57 Day 1, Stable | 2 | 2 |
| Cognitive Functioning, Cycle 57 Day 1, Worsened | 1 | 1 |
| Cognitive Functioning, Cycle 59 Day 1, Improved | 0 | 1 |
| Cognitive Functioning, Cycle 59 Day 1, Stable | 4 | 2 |
| Cognitive Functioning, Cycle 59 Day 1, Worsened | 0 | 1 |
| Cognitive Functioning, Cycle 61 Day 1, Improved | 3 | 1 |
| Cognitive Functioning, Cycle 61 Day 1, Stable | 0 | 3 |
| Cognitive Functioning, Cycle 61 Day 1, Worsened | 0 | 0 |
| Cognitive Functioning, Cycle 63 Day 1, Improved | 1 | 1 |
| Cognitive Functioning, Cycle 63 Dy 1, Stable | 1 | 0 |
| Cognitive Functioning, Cycle 63 Day 1, Worsened | 0 | 0 |
| Cognitive Functioning, Cycle 65 Day 1, Improved | 0 | — |
| Cognitive Functioning, Cycle 65 Day 1, Stable | 1 | — |
| Cognitive Functioning, Cycle 65 Day 1, Worsened | 0 | — |
| Cognitive Functioning, Cycle 67 Day 1, Improved | 0 | — |
| Cognitive Functioning, Cycle 67 Day 1, Stable | 1 | — |
| Cognitive Functioning, Cycle 67 Day 1, Worsened | 0 | — |
| Cognitive Functioning, End of Treatment, Improved | 40 | 31 |
| Cognitive Functioning, End of Treatment, Stable | 97 | 85 |
| Cognitive Functioning, End of Treatment, Worsened | 37 | 43 |
| Cognitive Functioning, Safety Follow-up 1, Improved | 24 | 14 |
| Cognitive Functioning, Safety Follow-up 1, Stable | 49 | 59 |
| Cognitive Functioning, Safety Follow-up 1, Worsened | 25 | 26 |
| Cognitive Functioning, Safety Follow-up 2, Improved | 29 | 17 |
| Cognitive Functioning, Safety Follow-up 2, Stable | 40 | 48 |
| Cognitive Functioning, Safety Follow-up 2, Worsened | 19 | 28 |
| Social Functioning, Cycle 2 Day 1, Improved | 65 | 65 |
| Social Functioning, Cycle 2 Day 1, Stable | 109 | 121 |
| Social Functioning, Cycle 2 Day 1, Worsened | 36 | 36 |
| Social Functioning, Cycle 3 Day 1, Improved | 68 | 52 |
| Social Functioning, Cycle 3 Day 1, Stable | 92 | 101 |
| Social Functioning, Cycle 3 Day 1, Worsened | 34 | 41 |
| Social Functioning, Cycle 4 Day 1, Improved | 56 | 47 |
| Social Functioning, Cycle 4 Day 1, Stable | 81 | 99 |
| Social Functioning, Cycle 4 Day 1, Worsened | 28 | 19 |
| Social Functioning, Cycle 5 Day 1, Improved | 55 | 53 |
| Social Functioning, Cycle 5 Day 1, Stable | 76 | 75 |
| Social Functioning, Cycle 5 Day 1, Worsened | 27 | 28 |
| Social Functioning, Cycle 7 Day 1, Improved | 51 | 46 |
| Social Functioning, Cycle 7 Day 1, Stable | 58 | 58 |
| Social Functioning, Cycle 7 Day 1, Worsened | 24 | 23 |
| Social Functioning, Cycle 9 Day 1, Improved | 42 | 33 |
| Social Functioning, Cycle 9 Day 1, Stable | 53 | 59 |
| Social Functioning, Cycle 9 Day 1, Worsened | 21 | 18 |
| Social Functioning, Cycle 11 Day 1, Improved | 33 | 30 |
| Social Functioning, Cycle 11 Day 1, Stable | 42 | 49 |
| Social Functioning, Cycle 11 Day 1, Worsened | 23 | 17 |
| Social Functioning, Cycle 13 Day 1, Improved | 32 | 24 |
| Social Functioning, Cycle 13 Day 1, Stable | 43 | 44 |
| Social Functioning, Cycle 13 Day 1, Worsened | 15 | 11 |
| Social Functioning, Cycle 15 Day 1, Improved | 32 | 27 |
| Social Functioning, Cycle 15 Day 1, Stable | 39 | 42 |
| Social Functioning, Cycle 15 Day 1, Worsened | 10 | 9 |
| Social Functioning, Cycle 17 Day 1, Improved | 24 | 23 |
| Social Functioning, Cycle 17 Day 1, Stable | 33 | 44 |
| Social Functioning, Cycle 17 Day 1, Worsened | 12 | 5 |
| Social Functioning, Cycle 19 Day 1, Improved | 28 | 19 |
| Social Functioning, Cycle 19 Day 1, Stable | 33 | 35 |
| Social Functioning, Cycle 19 Day 1, Worsened | 8 | 11 |
| Social Functioning, Cycle 21 Day 1, Improved | 28 | 19 |
| Social Functioning, Cycle 21 Day 1, Stable | 24 | 33 |
| Social Functioning, Cycle 21 Day 1, Worsened | 10 | 14 |
| Social Functioning, Cycle 23 Day 1, Improved | 23 | 18 |
| Social Functioning, Cycle 23 Day 1, Stable | 24 | 38 |
| Social Functioning, Cycle 23 Day 1, Worsened | 8 | 6 |
| Social Functioning, Cycle 25 Day 1, Improved | 20 | 17 |
| Social Functioning, Cycle 25 Day 1, Stable | 27 | 33 |
| Social Functioning, Cycle 25 Day 1, Worsened | 7 | 6 |
| Social Functioning, Cycle 27 Day 1, Improved | 20 | 17 |
| Social Functioning, Cycle 27 Day 1, Stable | 21 | 29 |
| Social Functioning, Cycle 27 Day 1, Worsened | 8 | 8 |
| Social Functioning, Cycle 29 Day 1, Improved | 23 | 10 |
| Social Functioning, Cycle 29 Day 1, Stable | 17 | 25 |
| Social Functioning, Cycle 29 Day 1, Worsened | 7 | 12 |
| Social Functioning, Cycle 31 Day 1, Improved | 23 | 7 |
| Social Functioning, Cycle 31 Day 1, Stable | 12 | 23 |
| Social Functioning, Cycle 31 Day 1, Worsened | 5 | 9 |
| Social Functioning, Cycle 33 Day 1, Improved | 17 | 8 |
| Social Functioning, Cycle 33 Day 1, Stable | 13 | 25 |
| Social Functioning, Cycle 33 Day 1, Worsened | 2 | 7 |
| Social Functioning, Cycle 35 Day 1, Improved | 15 | 8 |
| Social Functioning, Cycle 35 Day 1, Stable | 13 | 19 |
| Social Functioning, Cycle 35 Day 1, Worsened | 3 | 6 |
| Social Functioning, Cycle 37 Day 1, Improved | 14 | 9 |
| Social Functioning, Cycle 37 Day 1, Stable | 11 | 17 |
| Social Functioning, Cycle 37 Day 1, Worsened | 1 | 7 |
| Social Functioning, Cycle 39 Day 1, Improved | 12 | 12 |
| Social Functioning, Cycle 39 Day 1, Stable | 9 | 15 |
| Social Functioning, Cycle 39 Day 1, Worsened | 4 | 6 |
| Social Functioning, Cycle 41 Day 1, Improved | 11 | 9 |
| Social Functioning, Cycle 41 Day 1, Stable | 8 | 17 |
| Social Functioning, Cycle 41 Day 1, Worsened | 2 | 4 |
| Social Functioning, Cycle 43 Day 1, Improved | 12 | 7 |
| Social Functioning, Cycle 43 Day 1, Stable | 6 | 14 |
| Social Functioning, Cycle 43 Day 1, Worsened | 2 | 7 |
| Social Functioning, Cycle 45 Day 1, Improved | 10 | 7 |
| Social Functioning, Cycle 45 Day 1, Stable | 4 | 12 |
| Social Functioning, Cycle 45 Day 1, Worsened | 2 | 3 |
| Social Functioning, Cycle 47 Day 1, Improved | 7 | 8 |
| Social Functioning, Cycle 47 Day 1, Stable | 4 | 7 |
| Social Functioning, Cycle 47 Day 1, Worsened | 0 | 4 |
| Social Functioning, Cycle 49 Day 1, Improved | 7 | 6 |
| Social Functioning, Cycle 49 Day 1, Stable | 3 | 7 |
| Social Functioning, Cycle 49 Day 1, Worsened | 1 | 2 |
| Social Functioning, Cycle 51 Day 1, Improved | 5 | 4 |
| Social Functioning, Cycle 51 Day 1, Stable | 1 | 6 |
| Social Functioning, Cycle 51 Day 1, Worsened | 1 | 3 |
| Social Functioning, Cycle 53 Day 1, Improved | 4 | 2 |
| Social Functioning, Cycle 53 Day 1, Stable | 1 | 5 |
| Social Functioning, Cycle 53 Day 1, Worsened | 0 | 0 |
| Social Functioning, Cycle 55 Day 1, Improved | 3 | 2 |
| Social Functioning, Cycle 55 Day 1, Stable | 2 | 3 |
| Social Functioning, Cycle 55 Day 1, Worsened | 0 | 1 |
| Social Functioning, Cycle 57 Day 1, Improved | 3 | 1 |
| Social Functioning, Cycle 57 Day 1, Stable | 2 | 1 |
| Social Functioning, Cycle 57 Day 1, Worsened | 0 | 2 |
| Social Functioning, Cycle 59 Day 1, Improved | 2 | 1 |
| Social Functioning, Cycle 59 Day 1, Stable | 1 | 3 |
| Social Functioning, Cycle 59 Day 1, Worsened | 1 | 0 |
| Social Functioning, Cycle 61 Day 1, Improved | 2 | 2 |
| Social Functioning, Cycle 61 Day 1, Stable | 1 | 1 |
| Social Functioning, Cycle 61 Day 1, Worsened | 0 | 1 |
| Social Functioning, Cycle 63 Day 1, Improved | 1 | 0 |
| Social Functioning, Cycle 63 Day 1, Stable | 0 | 1 |
| Social Functioning, Cycle 63 Day 1, Worsened | 1 | 0 |
| Social Functioning, Cycle 65 Day 1, Improved | 1 | — |
| Social Functioning, Cycle 65 Day 1, Stable | 0 | — |
| Social Functioning, Cycle 65 Day 1, Worsened | 0 | — |
| Social Functioning, Cycle 67 Day 1, Improved | 1 | — |
| Social Functioning, Cycle 67 Day 1, Stable | 0 | — |
| Social Functioning, Cycle 67 Day 1, Worsened | 0 | — |
| Social Functioning, End of Treatment, Improved | 56 | 44 |
| Social Functioning, End of Treatment, Stable | 67 | 68 |
| Social Functioning, End of Treatment, Worsened | 49 | 47 |
| Social Functioning, Safety Follow-up 1, Improved | 26 | 25 |
| Social Functioning, Safety Follow-up 1, Stable | 39 | 49 |
| Social Functioning, Safety Follow-up 1, Worsened | 33 | 25 |
| Social Functioning, Safety Follow-up 2, Improved | 29 | 22 |
| Social Functioning, Safety Follow-up 2, Stable | 31 | 40 |
| Social Functioning, Safety Follow-up 2, Worsened | 28 | 31 |
| Fatigue Symptom, Cycle 2 Day 1, Improved | 77 | 84 |
| Fatigue Symptom, Cycle 2 Day 1, Stable | 72 | 73 |
| Fatigue Symptom, Cycle 2 Day 1, Worsened | 56 | 63 |
| Fatigue Symptom, Cycle 3 Day 1, Improved | 75 | 80 |
| Fatigue Symptom, Cycle 3 Day 1, Stable | 61 | 58 |
| Fatigue Symptom, Cycle 3 Day 1, Worsened | 53 | 57 |
| Fatigue Symptom, Cycle 4 Day 1, Improved | 64 | 64 |
| Fatigue Symptom, Cycle 4 Day 1, Stable | 51 | 51 |
| Fatigue Symptom, Cycle 4 Day 1, Worsened | 46 | 47 |
| Fatigue Symptom, Cycle 5 Day 1, Improved | 60 | 63 |
| Fatigue Symptom, Cycle 5 Day 1, Stable | 49 | 44 |
| Fatigue Symptom, Cycle 5 Day 1, Worsened | 45 | 46 |
| Fatigue Symptom, Cycle 7 Day 1, Improved | 47 | 55 |
| Fatigue Symptom, Cycle 7 Day 1, Stable | 44 | 41 |
| Fatigue Symptom, Cycle 7 Day 1, Worsened | 39 | 30 |
| Fatigue Symptom, Cycle 9 Day 1, Improved | 44 | 52 |
| Fatigue Symptom, Cycle 9 Day 1, Stable | 36 | 24 |
| Fatigue Symptom, Cycle 9 Day 1, Worsened | 33 | 33 |
| Fatigue Symptom, Cycle 11 Day 1, Improved | 42 | 44 |
| Fatigue Symptom, Cycle 11 Day 1, Stable | 22 | 25 |
| Fatigue Symptom, Cycle 11 Day 1, Worsened | 31 | 26 |
| Fatigue Symptom, Cycle 13 Day 1, Improved | 33 | 39 |
| Fatigue Symptom, Cycle 13 Day 1, Stable | 31 | 19 |
| Fatigue Symptom, Cycle 13 Day 1, Worsened | 23 | 22 |
| Fatigue Symptom, Cycle 15 Day 1, Improved | 31 | 38 |
| Fatigue Symptom, Cycle 15 Day 1, Stable | 26 | 24 |
| Fatigue Symptom, Cycle 15 Day 1, Worsened | 21 | 15 |
| Fatigue Symptom, Cycle 17 Day 1, Improved | 32 | 33 |
| Fatigue Symptom, Cycle 17 Day 1, Stable | 19 | 25 |
| Fatigue Symptom, Cycle 17 Day 1, Worsened | 18 | 13 |
| Fatigue Symptom, Cycle 19 Day 1, Improved | 29 | 26 |
| Fatigue Symptom, Cycle 19 Day 1, Stable | 21 | 21 |
| Fatigue Symptom, Cycle 19 Day 1, Worsened | 17 | 15 |
| Fatigue Symptom, Cycle 21 Day 1, Improved | 27 | 27 |
| Fatigue Symptom, Cycle 21 Day 1, Stable | 21 | 22 |
| Fatigue Symptom, Cycle 21 Day 1, Worsened | 15 | 17 |
| Fatigue Symptom, Cycle 23 Day 1, Improved | 25 | 31 |
| Fatigue Symptom, Cycle 23 Day 1, Stable | 15 | 22 |
| Fatigue Symptom, Cycle 23 Day 1, Worsened | 15 | 9 |
| Fatigue Symptom, Cycle 25 Day 1, Improved | 23 | 27 |
| Fatigue Symptom, Cycle 25 Day 1, Stable | 18 | 20 |
| Fatigue Symptom, Cycle 25 Day 1, Worsened | 12 | 9 |
| Fatigue Symptom, Cycle 27 Day 1, Improved | 21 | 25 |
| Fatigue Symptom, Cycle 27 Day 1, Stable | 16 | 22 |
| Fatigue Symptom, Cycle 27 Day 1, Worsened | 11 | 7 |
| Fatigue Symptom, Cycle 29 Day 1, Improved | 22 | 21 |
| Fatigue Symptom, Cycle 29 Day 1, Stable | 13 | 15 |
| Fatigue Symptom, Cycle 29 Day 1, Worsened | 10 | 11 |
| Fatigue Symptom, Cycle 31 Day 1, Improved | 19 | 13 |
| Fatigue Symptom, Cycle 31 Day 1, Stable | 10 | 15 |
| Fatigue Symptom, Cycle 31 Day 1, Worsened | 10 | 11 |
| Fatigue Symptom, Cycle 33 Day 1, Improved | 16 | 17 |
| Fatigue Symptom, Cycle 33 Day 1, Stable | 11 | 6 |
| Fatigue Symptom, Cycle 33 Day 1, Worsened | 3 | 15 |
| Fatigue Symptom, Cycle 35 Day 1, Improved | 12 | 12 |
| Fatigue Symptom, Cycle 35 Day 1, Stable | 10 | 14 |
| Fatigue Symptom, Cycle 35 Day 1, Worsened | 7 | 8 |
| Fatigue Symptom, Cycle 37 Day 1, Improved | 13 | 9 |
| Fatigue Symptom, Cycle 37 Day 1, Stable | 6 | 15 |
| Fatigue Symptom, Cycle 37 Day 1, Worsened | 6 | 9 |
| Fatigue Symptom, Cycle 39 Day 1, Improved | 14 | 12 |
| Fatigue Symptom, Cycle 39 Day 1, Stable | 7 | 9 |
| Fatigue Symptom, Cycle 39 Day 1, Worsened | 4 | 12 |
| Fatigue Symptom, Cycle 41 Day 1, Improved | 11 | 12 |
| Fatigue Symptom, Cycle 41 Day 1, Stable | 6 | 11 |
| Fatigue Symptom, Cycle 41 Day 1, Worsened | 4 | 7 |
| Fatigue Symptom, Cycle 43 Day 1, Improved | 11 | 9 |
| Fatigue Symptom, Cycle 43 Day 1, Stable | 6 | 10 |
| Fatigue Symptom, Cycle 43 Day 1, Worsened | 3 | 9 |
| Fatigue Symptom, Cycle 45 Day 1, Improved | 8 | 9 |
| Fatigue Symptom, Cycle 45 Day 1, Stable | 5 | 5 |
| Fatigue Symptom, Cycle 45 Day 1, Worsened | 3 | 8 |
| Fatigue Symptom, Cycle 47 Day 1, Improved | 6 | 9 |
| Fatigue Symptom, Cycle 47 Day 1, Stable | 4 | 6 |
| Fatigue Symptom, Cycle 47 Day 1, Worsened | 1 | 4 |
| Fatigue Symptom, Cycle 49 Day 1, Improved | 8 | 7 |
| Fatigue Symptom, Cycle 49 Day 1, Stable | 2 | 5 |
| Fatigue Symptom, Cycle 49 Day 1, Worsened | 1 | 3 |
| Fatigue Symptom, Cycle 51 Day 1, Improved | 3 | 8 |
| Fatigue Symptom, Cycle 51 Day 1, Stable | 3 | 2 |
| Fatigue Symptom, Cycle 51 Day 1, Worsened | 0 | 3 |
| Fatigue Symptom, Cycle 53 Day 1, Improved | 2 | 6 |
| Fatigue Symptom, Cycle 53 Day 1, Stable | 3 | 1 |
| Fatigue Symptom, Cycle 53 Day 1, Worsened | 0 | 0 |
| Fatigue Symptom, Cycle 55 Day 1, Improved | 4 | 3 |
| Fatigue Symptom, Cycle 55 Day 1, Stable | 1 | 2 |
| Fatigue Symptom, Cycle 55 Day 1, Worsened | 0 | 1 |
| Fatigue Symptom, Cycle 57 Day 1, Improved | 4 | 2 |
| Fatigue Symptom, Cycle 57 Day 1, Stable | 0 | 1 |
| Fatigue Symptom, Cycle 57 Day 1, Worsened | 1 | 1 |
| Fatigue Symptom, Cycle 59 Day 1, Improved | 2 | 2 |
| Fatigue Symptom, Cycle 59 Day 1, Stable | 1 | 1 |
| Fatigue Symptom, Cycle 59 Day 1, Worsened | 1 | 1 |
| Fatigue Symptom, Cycle 61 Day 1, Improved | 2 | 4 |
| Fatigue Symptom, Cycle 61 Day 1, Stable | 1 | 0 |
| Fatigue Symptom, Cycle 61 Day 1, Worsened | 0 | 0 |
| Fatigue Symptom, Cycle 63 Day 1, Improved | 2 | 1 |
| Fatigue Symptom, Cycle 63 Day 1, Stable | 0 | 0 |
| Fatigue Symptom, Cycle 63 Day 1, Worsened | 0 | 0 |
| Fatigue Symptom, Cycle 65 Day 1, Improved | 1 | — |
| Fatigue Symptom, Cycle 65 Day 1, Stable | 0 | — |
| Fatigue Symptom, Cycle 65 Day 1, Worsened | 0 | — |
| Fatigue Symptom, Cycle 67 Day 1, Improved | 1 | — |
| Fatigue Symptom, Cycle 67 Day 1, Stable | 0 | — |
| Fatigue Symptom, Cycle 67 Day 1, Worsened | 0 | — |
| Fatigue Symptom, End of Treatment, Improved | 55 | 59 |
| Fatigue Symptom, End of Treatment, Stable | 46 | 37 |
| Fatigue Symptom, End of Treatment, Worsened | 66 | 62 |
| Fatigue Symptom, Safety Follow-up 1, Improved | 32 | 42 |
| Fatigue Symptom, Safety Follow-up 1, Stable | 21 | 16 |
| Fatigue Symptom, Safety Follow-up 1, Worsened | 43 | 39 |
| Fatigue Symptom, Safety Follow-up 2, Improved | 27 | 31 |
| Fatigue Symptom, Safety Follow-up 2, Stable | 16 | 22 |
| Fatigue Symptom, Safety Follow-up 2, Worsened | 40 | 38 |
| Nausea and Vomiting Symptom, Cycle 2 Day 1, Improved | 42 | 36 |
| Nausea and Vomiting Symptom, Cycle 2 Day 1, Stable | 121 | 161 |
| Nausea and Vomiting Symptom, Cycle 2 Day 1, Worsened | 45 | 18 |
| Nausea and Vomiting Symptom, Cycle 3 Day 1, Improved | 34 | 32 |
| Nausea and Vomiting Symptom, Cycle 3 Day 1, Stable | 111 | 147 |
| Nausea and Vomiting Symptom, Cycle 3 Day 1, Worsened | 46 | 15 |
| Nausea and Vomiting Symptom, Cycle 4 Day 1, Improved | 32 | 30 |
| Nausea and Vomiting Symptom, Cycle 4 Day 1, Stable | 102 | 114 |
| Nausea and Vomiting Symptom, Cycle 4 Day 1, Worsened | 29 | 16 |
| Nausea and Vomiting Symptom, Cycle 5 Day 1, Improved | 27 | 31 |
| Nausea and Vomiting Symptom, Cycle 5 Day 1, Stable | 106 | 107 |
| Nausea and Vomiting Symptom, Cycle 5 Day 1, Worsened | 25 | 14 |
| Nausea and Vomiting Symptom, Cycle 7 Day 1, Improved | 24 | 27 |
| Nausea and Vomiting Symptom, Cycle 7 Day 1, Stable | 88 | 88 |
| Nausea and Vomiting Symptom, Cycle 7 Day 1, Worsened | 21 | 10 |
| Nausea and Vomiting Symptom, Cycle 9 Day 1, Improved | 27 | 23 |
| Nausea and Vomiting Symptom, Cycle 9 Day 1, Stable | 72 | 75 |
| Nausea and Vomiting Symptom, Cycle 9 Day 1, Worsened | 16 | 11 |
| Nausea and Vomiting Symptom, Cycle 11 Day 1, Improved | 15 | 20 |
| Nausea and Vomiting Symptom, Cycle 11 Day 1, Stable | 68 | 62 |
| Nausea and Vomiting Symptom, Cycle 11 Day 1, Worsened | 14 | 10 |
| Nausea and Vomiting Symptom, Cycle 13 Day 1, Improved | 16 | 14 |
| Nausea and Vomiting Symptom, Cycle 13 Day 1, Stable | 57 | 56 |
| Nausea and Vomiting Symptom, Cycle 13 Day 1, Worsened | 13 | 8 |
| Nausea and Vomiting Symptom, Cycle 15 Day 1, Improved | 14 | 16 |
| Nausea and Vomiting Symptom, Cycle 15 Day 1, Stable | 55 | 56 |
| Nausea and Vomiting Symptom, Cycle 15 Day 1, Worsened | 10 | 5 |
| Nausea and Vomiting Symptom, Cycle 17 Day 1, Improved | 16 | 13 |
| Nausea and Vomiting Symptom, Cycle 17 Day 1, Stable | 37 | 49 |
| Nausea and Vomiting Symptom, Cycle 17 Day 1, Worsened | 14 | 9 |
| Nausea and Vomiting Symptom, Cycle 19 Day 1, Improved | 13 | 13 |
| Nausea and Vomiting Symptom, Cycle 19 Day 1, Stable | 47 | 47 |
| Nausea and Vomiting Symptom, Cycle 19 Day 1, Worsened | 8 | 4 |
| Nausea and Vomiting Symptom, Cycle 21 Day 1, Improved | 14 | 12 |
| Nausea and Vomiting Symptom, Cycle 21 Day 1, Stable | 42 | 44 |
| Nausea and Vomiting Symptom, Cycle 21 Day 1, Worsened | 7 | 9 |
| Nausea and Vomiting Symptom, Cycle 23 Day 1, Improved | 9 | 11 |
| Nausea and Vomiting Symptom, Cycle 23 Day 1, Stable | 39 | 43 |
| Nausea and Vomiting Symptom, Cycle 23 Day 1, Worsened | 7 | 5 |
| Nausea and Vomiting Symptom, Cycle 25 Day 1, Improved | 12 | 9 |
| Nausea and Vomiting Symptom, Cycle 25 Day 1, Stable | 32 | 40 |
| Nausea and Vomiting Symptom, Cycle 25 Day 1, Worsened | 8 | 5 |
| Nausea and Vomiting Symptom, Cycle 27 Day 1, Improved | 10 | 10 |
| Nausea and Vomiting Symptom, Cycle 27 Day 1, Stable | 30 | 38 |
| Nausea and Vomiting Symptom, Cycle 27 Day 1, Worsened | 7 | 5 |
| Nausea and Vomiting Symptom, Cycle 29 Day 1, Improved | 8 | 7 |
| Nausea and Vomiting Symptom, Cycle 29 Day 1, Stable | 32 | 37 |
| Nausea and Vomiting Symptom, Cycle 29 Day 1, Worsened | 6 | 3 |
| Nausea and Vomiting Symptom, Cycle 31 Day 1, Improved | 9 | 6 |
| Nausea and Vomiting Symptom, Cycle 31 Day 1, Stable | 26 | 27 |
| Nausea and Vomiting Symptom, Cycle 31 Day 1, Worsened | 4 | 6 |
| Nausea and Vomiting Symptom, Cycle 33 Day 1, Improved | 5 | 6 |
| Nausea and Vomiting Symptom, Cycle 33 Day 1, Stable | 22 | 26 |
| Nausea and Vomiting Symptom, Cycle 33 Day 1, Worsened | 4 | 7 |
| Nausea and Vomiting Symptom, Cycle 35 Day 1, Improved | 5 | 6 |
| Nausea and Vomiting Symptom, Cycle 35 Day 1, Stable | 22 | 23 |
| Nausea and Vomiting Symptom, Cycle 35 Day 1, Worsened | 3 | 4 |
| Nausea and Vomiting Symptom, Cycle 37 Day 1, Improved | 4 | 7 |
| Nausea and Vomiting Symptom, Cycle 37 Day 1, Stable | 20 | 23 |
| Nausea and Vomiting Symptom, Cycle 37 Day 1, Worsened | 1 | 3 |
| Nausea and Vomiting Symptom, Cycle 39 Day 1, Improved | 5 | 7 |
| Nausea and Vomiting Symptom, Cycle 39 Day 1, Stable | 18 | 23 |
| Nausea and Vomiting Symptom, Cycle 39 Day 1, Worsened | 2 | 3 |
| Nausea and Vomiting Symptom, Cycle 41 Day 1, Improved | 5 | 5 |
| Nausea and Vomiting Symptom, Cycle 41 Day 1, Stable | 15 | 24 |
| Nausea and Vomiting Symptom, Cycle 41 Day 1, Worsened | 1 | 1 |
| Nausea and Vomiting Symptom, Cycle 43 Day 1, Improved | 6 | 5 |
| Nausea and Vomiting Symptom, Cycle 43 Day 1, Stable | 13 | 19 |
| Nausea and Vomiting Symptom, Cycle 43 Day 1, Worsened | 1 | 4 |
| Nausea and Vomiting Symptom, Cycle 45 Day 1, Improved | 5 | 6 |
| Nausea and Vomiting Symptom, Cycle 45 Day 1, Stable | 11 | 13 |
| Nausea and Vomiting Symptom, Cycle 45 Day 1, Worsened | 0 | 3 |
| Nausea and Vomiting Symptom, Cycle 47 Day 1, Improved | 3 | 6 |
| Nausea and Vomiting Symptom, Cycle 47 Day 1, Stable | 8 | 11 |
| Nausea and Vomiting Symptom, Cycle 47 Day 1, Worsened | 0 | 2 |
| Nausea and Vomiting Symptom, Cycle 49 Day 1, Improved | 4 | 4 |
| Nausea and Vomiting Symptom, Cycle 49 Day 1, Stable | 6 | 10 |
| Nausea and Vomiting Symptom, Cycle 49 Day 1, Worsened | 1 | 1 |
| Nausea and Vomiting Symptom, Cycle 51 Day 1, Improved | 3 | 4 |
| Nausea and Vomiting Symptom, Cycle 51 Day 1, Stable | 3 | 9 |
| Nausea and Vomiting Symptom, Cycle 51 Day 1, Worsened | 0 | 0 |
| Nausea and Vomiting Symptom, Cycle 53 Day 1, Improved | 2 | 2 |
| Nausea and Vomiting Symptom, Cycle 53 Day 1, Stable | 2 | 5 |
| Nausea and Vomiting Symptom, Cycle 53 Day 1, Worsened | 0 | 0 |
| Nausea and Vomiting Symptom, Cycle 55 Day 1, Improved | 2 | 1 |
| Nausea and Vomiting Symptom, Cycle 55 Day 1, Stable | 3 | 5 |
| Nausea and Vomiting Symptom, Cycle 55 Day 1, Worsened | 0 | 0 |
| Nausea and Vomiting Symptom, Cycle 57 Day 1, Improved | 1 | 0 |
| Nausea and Vomiting Symptom, Cycle 57 Day 1, Stable | 4 | 4 |
| Nausea and Vomiting Symptom, Cycle 57 Day 1, Worsened | 0 | 0 |
| Nausea and Vomiting Symptom, Cycle 59 Day 1, Improved | 0 | 0 |
| Nausea and Vomiting Symptom, Cycle 59 Day 1, Stable | 3 | 4 |
| Nausea and Vomiting Symptom, Cycle 59 Day 1, Worsened | 1 | 0 |
| Nausea and Vomiting Symptom, Cycle 61 Day 1, Improved | 2 | 1 |
| Nausea and Vomiting Symptom, Cycle 61 Day 1, Stable | 1 | 3 |
| Nausea and Vomiting Symptom, Cycle 61 Day 1, Worsened | 0 | 0 |
| Nausea and Vomiting Symptom, Cycle 63 Day 1, Improved | 2 | 0 |
| Nausea and Vomiting Symptom, Cycle 63 Day 1, Stable | 0 | 1 |
| Nausea and Vomiting Symptom, Cycle 63 Day 1, Worsened | 0 | 0 |
| Nausea and Vomiting Symptom, Cycle 65 Day 1, Improved | 0 | — |
| Nausea and Vomiting Symptom, Cycle 65 Day 1, Stable | 1 | — |
| Nausea and Vomiting Symptom, Cycle 65 Day 1, Worsened | 0 | — |
| Nausea and Vomiting Symptom, Cycle 67 Day 1, Improved | 0 | — |
| Nausea and Vomiting Symptom, Cycle 67 Day 1, Stable | 0 | — |
| Nausea and Vomiting Symptom, Cycle 67 Day 1, Worsened | 1 | — |
| Nausea and Vomiting Symptom, End of Treatment, Improved | 33 | 21 |
| Nausea and Vomiting Symptom, End of Treatment, Stable | 87 | 111 |
| Nausea and Vomiting Symptom, End of Treatment, Worsened | 51 | 22 |
| Nausea and Vomiting Symptom, Safety Follow-up 1, Improved | 24 | 15 |
| Nausea and Vomiting Symptom, Safety Follow-up 1, Stable | 51 | 65 |
| Nausea and Vomiting Symptom, Safety Follow-up 1, Worsened | 20 | 16 |
| Nausea and Vomiting Symptom, Safety Follow-up 2, Improved | 19 | 14 |
| Nausea and Vomiting Symptom, Safety Follow-up 2, Stable | 52 | 60 |
| Nausea and Vomiting Symptom, Safety Follow-up 2, Worsened | 15 | 17 |
| Pain Symptom, Cycle 2 Day 1, Improved | 55 | 52 |
| Pain Symptom, Cycle 2 Day 1, Stable | 110 | 131 |
| Pain Symptom, Cycle 2 Day 1, Worsened | 45 | 39 |
| Pain Symptom, Cycle 3 Day 1, Improved | 50 | 49 |
| Pain Symptom, Cycle 3 Day 1, Stable | 98 | 101 |
| Pain Symptom, Cycle 3 Day 1, Worsened | 48 | 46 |
| Pain Symptom, Cycle 4 Day 1, Improved | 48 | 41 |
| Pain Symptom, Cycle 4 Day 1, Stable | 87 | 78 |
| Pain Symptom, Cycle 4 Day 1, Worsened | 31 | 46 |
| Pain Symptom, Cycle 5 Day 1, Improved | 48 | 41 |
| Pain Symptom, Cycle 5 Day 1, Stable | 78 | 74 |
| Pain Symptom, Cycle 5 Day 1, Worsened | 33 | 39 |
| Pain Symptom, Cycle 7 Day 1, Improved | 28 | 38 |
| Pain Symptom, Cycle 7 Day 1, Stable | 72 | 62 |
| Pain Symptom, Cycle 7 Day 1, Worsened | 33 | 28 |
| Pain Symptom, Cycle 9 Day 1, Improved | 32 | 33 |
| Pain Symptom, Cycle 9 Day 1, Stable | 57 | 60 |
| Pain Symptom, Cycle 9 Day 1, Worsened | 28 | 19 |
| Pain Symptom, Cycle 11 Day 1, Improved | 26 | 33 |
| Pain Symptom, Cycle 11 Day 1, Stable | 42 | 42 |
| Pain Symptom, Cycle 11 Day 1, Worsened | 30 | 21 |
| Pain Symptom, Cycle 13 Day 1, Improved | 28 | 22 |
| Pain Symptom, Cycle 13 Day 1, Stable | 50 | 45 |
| Pain Symptom, Cycle 13 Day 1, Worsened | 12 | 14 |
| Pain Symptom, Cycle 15 Day 1, Improved | 23 | 29 |
| Pain Symptom, Cycle 15 Day 1, Stable | 43 | 38 |
| Pain Symptom, Cycle 15 Day 1, Worsened | 15 | 11 |
| Pain Symptom, Cycle 17 Day 1, Improved | 19 | 24 |
| Pain Symptom, Cycle 17 Day 1, Stable | 37 | 37 |
| Pain Symptom, Cycle 17 Day 1, Worsened | 14 | 11 |
| Pain Symptom, Cycle 19 Day 1, Improved | 17 | 22 |
| Pain Symptom, Cycle 19 Day 1, Stable | 39 | 33 |
| Pain Symptom, Cycle 19 Day 1, Worsened | 13 | 10 |
| Pain Symptom, Cycle 21 Day 1, Improved | 18 | 26 |
| Pain Symptom, Cycle 21 Day 1, Stable | 37 | 30 |
| Pain Symptom, Cycle 21 Day 1, Worsened | 7 | 10 |
| Pain Symptom, Cycle 23 Day 1, Improved | 15 | 23 |
| Pain Symptom, Cycle 23 Day 1, Stable | 31 | 28 |
| Pain Symptom, Cycle 23 Day 1, Worsened | 10 | 11 |
| Pain Symptom, Cycle 25 Day 1, Improved | 14 | 21 |
| Pain Symptom, Cycle 25 Day 1, Stable | 33 | 26 |
| Pain Symptom, Cycle 25 Day 1, Worsened | 7 | 9 |
| Pain Symptom, Cycle 27 Day 1, Improved | 12 | 20 |
| Pain Symptom, Cycle 27 Day 1, Stable | 26 | 28 |
| Pain Symptom, Cycle 27 Day 1, Worsened | 11 | 6 |
| Pain Symptom, Cycle 29 Day 1, Improved | 14 | 15 |
| Pain Symptom, Cycle 29 Day 1, Stable | 25 | 25 |
| Pain Symptom, Cycle 29 Day 1, Worsened | 8 | 7 |
| Pain Symptom, Cycle 31 Day 1, Improved | 13 | 10 |
| Pain Symptom, Cycle 31 Day 1, Stable | 17 | 23 |
| Pain Symptom, Cycle 31 Day 1, Worsened | 10 | 6 |
| Pain Symptom, Cycle 33 Day 1, Improved | 6 | 10 |
| Pain Symptom, Cycle 33 Day 1, Stable | 22 | 21 |
| Pain Symptom, Cycle 33 Day 1, Worsened | 4 | 9 |
| Pain Symptom, Cycle 35 Day 1, Improved | 10 | 11 |
| Pain Symptom, Cycle 35 Day 1, Stable | 17 | 16 |
| Pain Symptom, Cycle 35 Day 1, Worsened | 4 | 7 |
| Pain Symptom, Cycle 37 Day 1, Improved | 6 | 11 |
| Pain Symptom, Cycle 37 Day 1, Stable | 12 | 16 |
| Pain Symptom, Cycle 37 Day 1, Worsened | 7 | 6 |
| Pain Symptom, Cycle 39 Day 1, Improved | 8 | 11 |
| Pain Symptom, Cycle 39 Day 1, Stable | 14 | 14 |
| Pain Symptom, Cycle 39 Day 1, Worsened | 3 | 8 |
| Pain Symptom, Cycle 41 Day 1, Improved | 7 | 12 |
| Pain Symptom, Cycle 41 Day 1, Stable | 9 | 13 |
| Pain Symptom, Cycle 41 Day 1, Worsened | 5 | 5 |
| Pain Symptom, Cycle 43 Day 1, Improved | 9 | 8 |
| Pain Symptom, Cycle 43 Day 1, Stable | 8 | 12 |
| Pain Symptom, Cycle 43 Day 1, Worsened | 3 | 8 |
| Pain Symptom, Cycle 45 Day 1, Improved | 5 | 5 |
| Pain Symptom, Cycle 45 Day 1, Stable | 7 | 12 |
| Pain Symptom, Cycle 45 Day 1, Worsened | 4 | 6 |
| Pain Symptom, Cycle 47 Day 1, Improved | 5 | 8 |
| Pain Symptom, Cycle 47 Day 1, Stable | 4 | 8 |
| Pain Symptom, Cycle 47 Day 1, Worsened | 2 | 3 |
| Pain Symptom, Cycle 49 Day 1, Improved | 4 | 3 |
| Pain Symptom, Cycle 49 Day 1, Stable | 6 | 9 |
| Pain Symptom, Cycle 49 Day 1, Worsened | 1 | 3 |
| Pain Symptom, Cycle 51 Day 1, Improved | 5 | 3 |
| Pain Symptom, Cycle 51 Day 1, Stable | 2 | 6 |
| Pain Symptom, Cycle 51 Day 1, Worsened | 0 | 4 |
| Pain Symptom, Cycle 53 Day 1, Improved | 3 | 1 |
| Pain Symptom, Cycle 53 Day 1, Stable | 2 | 5 |
| Pain Symptom, Cycle 53 Day 1, Worsened | 0 | 1 |
| Pain Symptom, Cycle 55 Day 1, Improved | 3 | 1 |
| Pain Symptom, Cycle 55 Day 1, Stable | 2 | 3 |
| Pain Symptom, Cycle 55 Day 1, Worsened | 0 | 2 |
| Pain Symptom, Cycle 57 Day 1, Improved | 3 | 0 |
| Pain Symptom, Cycle 57 Day 1, Stable | 2 | 4 |
| Pain Symptom, Cycle 57 Day 1, Worsened | 0 | 0 |
| Pain Symptom, Cycle 59 Day 1, Improved | 1 | 1 |
| Pain Symptom, Cycle 59 Day 1, Stable | 2 | 3 |
| Pain Symptom, Cycle 59 Day 1, Worsened | 1 | 0 |
| Pain Symptom, Cycle 61 Day 1, Improved | 2 | 2 |
| Pain Symptom, Cycle 61 Day 1, Stable | 1 | 1 |
| Pain Symptom, Cycle 61 Day 1, Worsened | 0 | 1 |
| Pain Symptom, Cycle 63 Day 1, Improved | 2 | 1 |
| Pain Symptom, Cycle 63 Day 1, Stable | 0 | 0 |
| Pain Symptom, Cycle 63 Day 1, Worsened | 0 | 0 |
| Pain Symptom, Cycle 65 Day 1, Improved | 0 | — |
| Pain Symptom, Cycle 65 Day 1, Stable | 1 | — |
| Pain Symptom, Cycle 65 Day 1, Worsened | 0 | — |
| Pain Symptom, Cycle 67 Day 1, Improved | 0 | — |
| Pain Symptom, Cycle 67 Day 1, Stable | 1 | — |
| Pain Symptom, Cycle 67 Day 1, Worsened | 0 | — |
| Pain Symptom, End of Treatment, Improved | 34 | 35 |
| Pain Symptom, End of Treatment, Stable | 79 | 64 |
| Pain Symptom, End of Treatment, Worsened | 61 | 60 |
| Pain Symptom, Safety Follow-up 1, Improved | 22 | 17 |
| Pain Symptom, Safety Follow-up 1, Stable | 38 | 42 |
| Pain Symptom, Safety Follow-up 1, Worsened | 38 | 40 |
| Pain Symptom, Safety Follow-up 2, Improved | 23 | 22 |
| Pain Symptom, Safety Follow-up 2, Stable | 43 | 40 |
| Pain Symptom, Safety Follow-up 2, Worsened | 22 | 31 |
| Dyspnea Symptom, Cycle 2 Day 1, Improved | 47 | 53 |
| Dyspnea Symptom, Cycle 2 Day 1, Stable | 127 | 134 |
| Dyspnea Symptom, Cycle 2 Day 1, Worsened | 35 | 30 |
| Dyspnea Symptom, Cycle 3 Day 1, Improved | 46 | 47 |
| Dyspnea Symptom, Cycle 3 Day 1, Stable | 119 | 117 |
| Dyspnea Symptom, Cycle 3 Day 1, Worsened | 26 | 30 |
| Dyspnea Symptom, Cycle 4 Day 1, Improved | 46 | 43 |
| Dyspnea Symptom, Cycle 4 Day 1, Stable | 93 | 96 |
| Dyspnea Symptom, Cycle 4 Day 1, Worsened | 25 | 24 |
| Dyspnea Symptom, Cycle 5 Day 1, Improved | 38 | 43 |
| Dyspnea Symptom, Cycle 5 Day 1, Stable | 95 | 86 |
| Dyspnea Symptom, Cycle 5 Day 1, Worsened | 25 | 24 |
| Dyspnea Symptom, Cycle 7 Day 1, Improved | 36 | 36 |
| Dyspnea Symptom, Cycle 7 Day 1, Stable | 80 | 76 |
| Dyspnea Symptom, Cycle 7 Day 1, Worsened | 17 | 15 |
| Dyspnea Symptom, Cycle 9 Day 1, Improved | 26 | 30 |
| Dyspnea Symptom, Cycle 9 Day 1, Stable | 76 | 65 |
| Dyspnea Symptom, Cycle 9 Day 1, Worsened | 12 | 16 |
| Dyspnea Symptom, Cycle 11 Day 1, Improved | 25 | 32 |
| Dyspnea Symptom, Cycle 11 Day 1, Stable | 59 | 51 |
| Dyspnea Symptom, Cycle 11 Day 1, Worsened | 13 | 12 |
| Dyspnea Symptom, Cycle 13 Day 1, Improved | 27 | 24 |
| Dyspnea Symptom, Cycle 13 Day 1, Stable | 47 | 48 |
| Dyspnea Symptom, Cycle 13 Day 1, Worsened | 11 | 8 |
| Dyspnea Symptom, Cycle 15 Day 1, Improved | 22 | 22 |
| Dyspnea Symptom, Cycle 15 Day 1, Stable | 41 | 48 |
| Dyspnea Symptom, Cycle 15 Day 1, Worsened | 15 | 7 |
| Dyspnea Symptom, Cycle 17 Day 1, Improved | 18 | 20 |
| Dyspnea Symptom, Cycle 17 Day 1, Stable | 33 | 40 |
| Dyspnea Symptom, Cycle 17 Day 1, Worsened | 15 | 11 |
| Dyspnea Symptom, Cycle 19 Day 1, Improved | 21 | 19 |
| Dyspnea Symptom, Cycle 19 Day 1, Stable | 34 | 39 |
| Dyspnea Symptom, Cycle 19 Day 1, Worsened | 13 | 7 |
| Dyspnea Symptom, Cycle 21 Day 1, Improved | 22 | 18 |
| Dyspnea Symptom, Cycle 21 Day 1, Stable | 34 | 35 |
| Dyspnea Symptom, Cycle 21 Day 1, Worsened | 7 | 13 |
| Dyspnea Symptom, Cycle 23 Day 1, Improved | 19 | 14 |
| Dyspnea Symptom, Cycle 23 Day 1, Stable | 29 | 37 |
| Dyspnea Symptom, Cycle 23 Day 1, Worsened | 7 | 11 |
| Dyspnea Symptom, Cycle 25 Day 1, Improved | 15 | 18 |
| Dyspnea Symptom, Cycle 25 Day 1, Stable | 33 | 33 |
| Dyspnea Symptom, Cycle 25 Day 1, Worsened | 5 | 5 |
| Dyspnea Symptom, Cycle 27 Day 1, Improved | 15 | 13 |
| Dyspnea Symptom, Cycle 27 Day 1, Stable | 27 | 36 |
| Dyspnea Symptom, Cycle 27 Day 1, Worsened | 6 | 5 |
| Dyspnea Symptom, Cycle 29 Day 1, Improved | 13 | 9 |
| Dyspnea Symptom, Cycle 29 Day 1, Stable | 26 | 33 |
| Dyspnea Symptom, Cycle 29 Day 1, Worsened | 7 | 6 |
| Dyspnea Symptom, Cycle 31 Day 1, Improved | 10 | 10 |
| Dyspnea Symptom, Cycle 31 Day 1, Stable | 25 | 22 |
| Dyspnea Symptom, Cycle 31 Day 1, Worsened | 4 | 7 |
| Dyspnea Symptom, Cycle 33 Day 1, Improved | 10 | 9 |
| Dyspnea Symptom, Cycle 33 Day 1, Stable | 16 | 24 |
| Dyspnea Symptom, Cycle 33 Day 1, Worsened | 5 | 6 |
| Dyspnea Symptom, Cycle 35 Day 1, Improved | 9 | 11 |
| Dyspnea Symptom, Cycle 35 Day 1, Stable | 17 | 18 |
| Dyspnea Symptom, Cycle 35 Day 1, Worsened | 4 | 4 |
| Dyspnea Symptom, Cycle 37 Day 1, Improved | 8 | 8 |
| Dyspnea Symptom, Cycle 37 Day 1, Stable | 15 | 18 |
| Dyspnea Symptom, Cycle 37 Day 1, Worsened | 2 | 7 |
| Dyspnea Symptom, Cycle 39 Day 1, Improved | 8 | 8 |
| Dyspnea Symptom, Cycle 39 Day 1, Stable | 16 | 20 |
| Dyspnea Symptom, Cycle 39 Day 1, Worsened | 1 | 5 |
| Dyspnea Symptom, Cycle 41 Day 1, Improved | 7 | 10 |
| Dyspnea Symptom, Cycle 41 Day 1, Stable | 11 | 17 |
| Dyspnea Symptom, Cycle 41 Day 1, Worsened | 2 | 2 |
| Dyspnea Symptom, Cycle 43 Day 1, Improved | 6 | 7 |
| Dyspnea Symptom, Cycle 43 Day 1, Stable | 10 | 19 |
| Dyspnea Symptom, Cycle 43 Day 1, Worsened | 4 | 2 |
| Dyspnea Symptom, Cycle 45 Day 1, Improved | 4 | 4 |
| Dyspnea Symptom, Cycle 45 Day 1, Stable | 10 | 16 |
| Dyspnea Symptom, Cycle 45 Day 1, Worsened | 2 | 3 |
| Dyspnea Symptom, Cycle 47 Day 1, Improved | 2 | 4 |
| Dyspnea Symptom, Cycle 47 Day 1, Stable | 8 | 15 |
| Dyspnea Symptom, Cycle 47 Day 1, Worsened | 1 | 0 |
| Dyspnea Symptom, Cycle 49 Day 1, Improved | 4 | 3 |
| Dyspnea Symptom, Cycle 49 Day 1, Stable | 6 | 11 |
| Dyspnea Symptom, Cycle 49 Day 1, Worsened | 1 | 1 |
| Dyspnea Symptom, Cycle 51 Day 1, Improved | 2 | 6 |
| Dyspnea Symptom, Cycle 51 Day 1, Stable | 3 | 5 |
| Dyspnea Symptom, Cycle 51 Day 1, Worsened | 0 | 2 |
| Dyspnea Symptom, Cycle 53 Day 1, Improved | 2 | 2 |
| Dyspnea Symptom, Cycle 53 Day 1, Stable | 3 | 5 |
| Dyspnea Symptom, Cycle 53 Day 1, Worsened | 0 | 0 |
| Dyspnea Symptom, Cycle 55 Day 1, Improved | 3 | 1 |
| Dyspnea Symptom, Cycle 55 Day 1, Stable | 2 | 5 |
| Dyspnea Symptom, Cycle 55 Day 1, Worsened | 0 | 0 |
| Dyspnea Symptom, Cycle 57 Day 1, Improved | 2 | 1 |
| Dyspnea Symptom, Cycle 57 Day 1, Stable | 3 | 3 |
| Dyspnea Symptom, Cycle 57 Day 1, Worsened | 0 | 0 |
| Dyspnea Symptom, Cycle 59 Day 1, Improved | 0 | 1 |
| Dyspnea Symptom, Cycle 59 Day 1, Stable | 3 | 3 |
| Dyspnea Symptom, Cycle 59 Day 1, Worsened | 1 | 0 |
| Dyspnea Symptom, Cycle 61 Day 1, Improved | 2 | 2 |
| Dyspnea Symptom, Cycle 61 Day 1, Stable | 1 | 1 |
| Dyspnea Symptom, Cycle 61 Day 1, Worsened | 0 | 1 |
| Dyspnea Symptom, Cycle 63 Day 1, Improved | 1 | 0 |
| Dyspnea Symptom, Cycle 63 Day 1, Stable | 1 | 1 |
| Dyspnea Symptom, Cycle 63 Day 1, Worsened | 0 | 0 |
| Dyspnea Symptom, Cycle 65 Day 1, Improved | 0 | — |
| Dyspnea Symptom, Cycle 65 Day 1, Stable | 1 | — |
| Dyspnea Symptom, Cycle 65 Day 1, Worsened | 0 | — |
| Dyspnea Symptom, Cycle 67 Day 1, Improved | 0 | — |
| Dyspnea Symptom, Cycle 67 Day 1, Stable | 1 | — |
| Dyspnea Symptom, Cycle 67 Day 1, Worsened | 0 | — |
| Dyspnea Symptom, End of Treatment, Improved | 39 | 39 |
| Dyspnea Symptom, End of Treatment, Stable | 92 | 80 |
| Dyspnea Symptom, End of Treatment, Worsened | 42 | 36 |
| Dyspnea Symptom, Safety Follow-up 1, Improved | 27 | 23 |
| Dyspnea Symptom, Safety Follow-up 1, Stable | 43 | 60 |
| Dyspnea Symptom, Safety Follow-up 1, Worsened | 27 | 16 |
| Dyspnea Symptom, Safety Follow-up 2, Improved | 20 | 18 |
| Dyspnea Symptom, Safety Follow-up 2, Stable | 40 | 50 |
| Dyspnea Symptom, Safety Follow-up 2, Worsened | 27 | 25 |
| Insomnia Symptom, Cycle 2 Day 1, Improved | 46 | 45 |
| Insomnia Symptom, Cycle 2 Day 1, Stable | 120 | 141 |
| Insomnia Symptom, Cycle 2 Day 1, Worsened | 39 | 33 |
| Insomnia Symptom, Cycle 3 Day 1, Improved | 53 | 33 |
| Insomnia Symptom, Cycle 3 Day 1, Stable | 98 | 132 |
| Insomnia Symptom, Cycle 3 Day 1, Worsened | 37 | 29 |
| Insomnia Symptom, Cycle 4 Day 1, Improved | 40 | 38 |
| Insomnia Symptom, Cycle 4 Day 1, Stable | 92 | 90 |
| Insomnia Symptom, Cycle 4 Day 1, Worsened | 29 | 34 |
| Insomnia Symptom, Cycle 5 Day 1, Improved | 39 | 34 |
| Insomnia Symptom, Cycle 5 Day 1, Stable | 86 | 93 |
| Insomnia Symptom, Cycle 5 Day 1, Worsened | 29 | 26 |
| Insomnia Symptom, Cycle 7 Day 1, Improved | 42 | 34 |
| Insomnia Symptom, Cycle 7 Day 1, Stable | 60 | 64 |
| Insomnia Symptom, Cycle 7 Day 1, Worsened | 27 | 27 |
| Insomnia Symptom, Cycle 9 Day 1, Improved | 32 | 26 |
| Insomnia Symptom, Cycle 9 Day 1, Stable | 57 | 63 |
| Insomnia Symptom, Cycle 9 Day 1, Worsened | 24 | 19 |
| Insomnia Symptom, Cycle 11 Day 1, Improved | 19 | 27 |
| Insomnia Symptom, Cycle 11 Day 1, Stable | 59 | 50 |
| Insomnia Symptom, Cycle 11 Day 1, Worsened | 16 | 18 |
| Insomnia Symptom, Cycle 13 Day 1, Improved | 24 | 22 |
| Insomnia Symptom, Cycle 13 Day 1, Stable | 49 | 45 |
| Insomnia Symptom, Cycle 13 Day 1, Worsened | 14 | 13 |
| Insomnia Symptom, Cycle 15 Day 1, Improved | 20 | 23 |
| Insomnia Symptom, Cycle 15 Day 1, Stable | 41 | 45 |
| Insomnia Symptom, Cycle 15 Day 1, Worsened | 16 | 9 |
| Insomnia Symptom, Cycle 17 Day 1, Improved | 19 | 20 |
| Insomnia Symptom, Cycle 17 Day 1, Stable | 37 | 41 |
| Insomnia Symptom, Cycle 17 Day 1, Worsened | 13 | 10 |
| Insomnia Symptom, Cycle 19 Day 1, Improved | 17 | 15 |
| Insomnia Symptom, Cycle 19 Day 1, Stable | 39 | 36 |
| Insomnia Symptom, Cycle 19 Day 1, Worsened | 11 | 11 |
| Insomnia Symptom, Cycle 21 Day 1, Improved | 18 | 18 |
| Insomnia Symptom, Cycle 21 Day 1, Stable | 34 | 38 |
| Insomnia Symptom, Cycle 21 Day 1, Worsened | 11 | 10 |
| Insomnia Symptom, Cycle 23 Day 1, Improved | 20 | 16 |
| Insomnia Symptom, Cycle 23 Day 1, Stable | 28 | 33 |
| Insomnia Symptom, Cycle 23 Day 1, Worsened | 7 | 13 |
| Insomnia Symptom, Cycle 25 Day 1, Improved | 15 | 16 |
| Insomnia Symptom, Cycle 25 Day 1, Stable | 26 | 35 |
| Insomnia Symptom, Cycle 25 Day 1, Worsened | 12 | 5 |
| Insomnia Symptom, Cycle 27 Day 1, Improved | 13 | 16 |
| Insomnia Symptom, Cycle 27 Day 1, Stable | 25 | 31 |
| Insomnia Symptom, Cycle 27 Day 1, Worsened | 10 | 7 |
| Insomnia Symptom, Cycle 29 Day 1, Improved | 15 | 14 |
| Insomnia Symptom, Cycle 29 Day 1, Stable | 23 | 28 |
| Insomnia Symptom, Cycle 29 Day 1, Worsened | 7 | 5 |
| Insomnia Symptom, Cycle 31 Day 1, Improved | 12 | 8 |
| Insomnia Symptom, Cycle 31 Day 1, Stable | 18 | 25 |
| Insomnia Symptom, Cycle 31 Day 1, Worsened | 9 | 6 |
| Insomnia Symptom, Cycle 33 Day 1, Improved | 8 | 12 |
| Insomnia Symptom, Cycle 33 Day 1, Stable | 17 | 21 |
| Insomnia Symptom, Cycle 33 Day 1, Worsened | 5 | 5 |
| Insomnia Symptom, Cycle 35 Day 1, Improved | 8 | 7 |
| Insomnia Symptom, Cycle 35 Day 1, Stable | 14 | 21 |
| Insomnia Symptom, Cycle 35 Day 1, Worsened | 7 | 6 |
| Insomnia Symptom, Cycle 37 Day 1, Improved | 8 | 9 |
| Insomnia Symptom, Cycle 37 Day 1, Stable | 12 | 19 |
| Insomnia Symptom, Cycle 37 Day 1, Worsened | 5 | 5 |
| Insomnia Symptom, Cycle 39 Day 1, Improved | 10 | 11 |
| Insomnia Symptom, Cycle 39 Day 1, Stable | 11 | 16 |
| Insomnia Symptom, Cycle 39 Day 1, Worsened | 4 | 6 |
| Insomnia Symptom, Cycle 41 Day 1, Improved | 8 | 8 |
| Insomnia Symptom, Cycle 41 Day 1, Stable | 9 | 17 |
| Insomnia Symptom, Cycle 41 Day 1, Worsened | 4 | 5 |
| Insomnia Symptom, Cycle 43 Day 1, Improved | 8 | 7 |
| Insomnia Symptom, Cycle 43 Day 1, Stable | 10 | 16 |
| Insomnia Symptom, Cycle 43 Day 1, Worsened | 2 | 5 |
| Insomnia Symptom, Cycle 45 Day 1, Improved | 4 | 6 |
| Insomnia Symptom, Cycle 45 Day 1, Stable | 10 | 11 |
| Insomnia Symptom, Cycle 45 Day 1, Worsened | 2 | 5 |
| Insomnia Symptom, Cycle 47 Day 1, Improved | 3 | 8 |
| Insomnia Symptom, Cycle 47 Day 1, Stable | 5 | 9 |
| Insomnia Symptom, Cycle 47 Day 1, Worsened | 3 | 2 |
| Insomnia Symptom, Cycle 49 Day 1, Improved | 3 | 6 |
| Insomnia Symptom, Cycle 49 Day 1, Stable | 7 | 7 |
| Insomnia Symptom, Cycle 49 Day 1, Worsened | 1 | 2 |
| Insomnia Symptom, Cycle 51 Day 1, Improved | 2 | 4 |
| Insomnia Symptom, Cycle 51 Day 1, Stable | 3 | 6 |
| Insomnia Symptom, Cycle 51 Day 1, Worsened | 1 | 3 |
| Insomnia Symptom, Cycle 53 Day 1, Improved | 1 | 3 |
| Insomnia Symptom, Cycle 53 Day 1, Stable | 3 | 3 |
| Insomnia Symptom, Cycle 53 Day 1, Worsened | 1 | 1 |
| Insomnia Symptom, Cycle 55 Day 1, Improved | 3 | 2 |
| Insomnia Symptom, Cycle 55 Day 1, Stable | 1 | 3 |
| Insomnia Symptom, Cycle 55 Day 1, Worsened | 1 | 1 |
| Insomnia Symptom, Cycle 57 Day 1, Improved | 2 | 1 |
| Insomnia Symptom, Cycle 57 Day 1, Stable | 2 | 1 |
| Insomnia Symptom, Cycle 57 Day 1, Worsened | 1 | 2 |
| Insomnia Symptom, Cycle 59 Day 1, Improved | 1 | 1 |
| Insomnia Symptom, Cycle 59 Day 1, Stable | 2 | 1 |
| Insomnia Symptom, Cycle 59 Day 1, Worsened | 1 | 2 |
| Insomnia Symptom, Cycle 61 Day 1, Improved | 1 | 2 |
| Insomnia Symptom, Cycle 61 Day 1, Stable | 1 | 2 |
| Insomnia Symptom, Cycle 61 Day 1, Worsened | 1 | 0 |
| Insomnia Symptom, Cycle 63 Day 1, Improved | 1 | 0 |
| Insomnia Symptom, Cycle 63 Day 1, Stable | 0 | 1 |
| Insomnia Symptom, Cycle 63 Day 1, Worsened | 1 | 0 |
| Insomnia Symptom, Cycle 65 Day 1, Improved | 1 | — |
| Insomnia Symptom, Cycle 65 Day 1, Stable | 0 | — |
| Insomnia Symptom, Cycle 65 Day 1, Worsened | 0 | — |
| Insomnia Symptom, Cycle 67 Day 1, Improved | 0 | — |
| Insomnia Symptom, Cycle 67 Day 1, Stable | 1 | — |
| Insomnia Symptom, Cycle 67 Day 1, Worsened | 0 | — |
| Insomnia Symptom, End of Treatment, Improved | 38 | 31 |
| Insomnia Symptom, End of Treatment, Stable | 76 | 81 |
| Insomnia Symptom, End of Treatment, Worsened | 53 | 44 |
| Insomnia Symptom, Safety Follow-up 1, Improved | 20 | 18 |
| Insomnia Symptom, Safety Follow-up 1, Stable | 48 | 57 |
| Insomnia Symptom, Safety Follow-up 1, Worsened | 28 | 22 |
| Insomnia Symptom, Safety Follow-up 2, Improved | 19 | 19 |
| Insomnia Symptom, Safety Follow-up 2, Stable | 43 | 50 |
| Insomnia Symptom, Safety Follow-up 2, Worsened | 21 | 22 |
| Appetite Loss Symptom, Cycle 2 Day 1, Improved | 28 | 37 |
| Appetite Loss Symptom, Cycle 2 Day 1, Stable | 130 | 155 |
| Appetite Loss Symptom, Cycle 2 Day 1, Worsened | 48 | 24 |
| Appetite Loss Symptom, Cycle 3 Day 1, Improved | 29 | 35 |
| Appetite Loss Symptom, Cycle 3 Day 1, Stable | 129 | 133 |
| Appetite Loss Symptom, Cycle 3 Day 1, Worsened | 34 | 26 |
| Appetite Loss Symptom, Cycle 4 Day 1, Improved | 28 | 33 |
| Appetite Loss Symptom, Cycle 4 Day 1, Stable | 102 | 109 |
| Appetite Loss Symptom, Cycle 4 Day 1, Worsened | 35 | 19 |
| Appetite Loss Symptom, Cycle 5 Day 1, Improved | 24 | 34 |
| Appetite Loss Symptom, Cycle 5 Day 1, Stable | 104 | 104 |
| Appetite Loss Symptom, Cycle 5 Day 1, Worsened | 30 | 15 |
| Appetite Loss Symptom, Cycle 7 Day 1, Improved | 19 | 28 |
| Appetite Loss Symptom, Cycle 7 Day 1, Stable | 91 | 85 |
| Appetite Loss Symptom, Cycle 7 Day 1, Worsened | 23 | 12 |
| Appetite Loss Symptom, Cycle 9 Day 1, Improved | 20 | 22 |
| Appetite Loss Symptom, Cycle 9 Day 1, Stable | 85 | 77 |
| Appetite Loss Symptom, Cycle 9 Day 1, Worsened | 12 | 10 |
| Appetite Loss Symptom, Cycle 11 Day 1, Improved | 19 | 21 |
| Appetite Loss Symptom, Cycle 11 Day 1, Stable | 63 | 66 |
| Appetite Loss Symptom, Cycle 11 Day 1, Worsened | 16 | 5 |
| Appetite Loss Symptom, Cycle 13 Day 1, Improved | 19 | 19 |
| Appetite Loss Symptom, Cycle 13 Day 1, Stable | 57 | 55 |
| Appetite Loss Symptom, Cycle 13 Day 1, Worsened | 12 | 4 |
| Appetite Loss Symptom, Cycle 15 Day 1, Improved | 19 | 17 |
| Appetite Loss Symptom, Cycle 15 Day 1, Stable | 56 | 55 |
| Appetite Loss Symptom, Cycle 15 Day 1, Worsened | 6 | 5 |
| Appetite Loss Symptom, Cycle 17 Day 1, Improved | 15 | 15 |
| Appetite Loss Symptom, Cycle 17 Day 1, Stable | 44 | 52 |
| Appetite Loss Symptom, Cycle 17 Day 1, Worsened | 9 | 4 |
| Appetite Loss Symptom, Cycle 19 Day 1, Improved | 12 | 13 |
| Appetite Loss Symptom, Cycle 19 Day 1, Stable | 53 | 50 |
| Appetite Loss Symptom, Cycle 19 Day 1, Worsened | 4 | 1 |
| Appetite Loss Symptom, Cycle 21 Day 1, Improved | 15 | 12 |
| Appetite Loss Symptom, Cycle 21 Day 1, Stable | 42 | 49 |
| Appetite Loss Symptom, Cycle 21 Day 1, Worsened | 6 | 4 |
| Appetite Loss Symptom, Cycle 23 Day 1, Improved | 14 | 11 |
| Appetite Loss Symptom, Cycle 23 Day 1, Stable | 38 | 47 |
| Appetite Loss Symptom, Cycle 23 Day 1, Worsened | 4 | 1 |
| Appetite Loss Symptom, Cycle 25 Day 1, Improved | 12 | 11 |
| Appetite Loss Symptom, Cycle 25 Day 1, Stable | 36 | 42 |
| Appetite Loss Symptom, Cycle 25 Day 1, Worsened | 5 | 1 |
| Appetite Loss Symptom, Cycle 27 Day 1, Improved | 11 | 9 |
| Appetite Loss Symptom, Cycle 27 Day 1, Stable | 31 | 41 |
| Appetite Loss Symptom, Cycle 27 Day 1, Worsened | 6 | 3 |
| Appetite Loss Symptom, Cycle 29 Day 1, Improved | 7 | 9 |
| Appetite Loss Symptom, Cycle 29 Day 1, Stable | 37 | 36 |
| Appetite Loss Symptom, Cycle 29 Day 1, Worsened | 3 | 2 |
| Appetite Loss Symptom, Cycle 31 Day 1, Improved | 10 | 5 |
| Appetite Loss Symptom, Cycle 31 Day 1, Stable | 26 | 30 |
| Appetite Loss Symptom, Cycle 31 Day 1, Worsened | 4 | 4 |
| Appetite Loss Symptom, Cycle 33 Day 1, Improved | 8 | 7 |
| Appetite Loss Symptom, Cycle 33 Day 1, Stable | 23 | 32 |
| Appetite Loss Symptom, Cycle 33 Day 1, Worsened | 1 | 1 |
| Appetite Loss Symptom, Cycle 35 Day 1, Improved | 8 | 6 |
| Appetite Loss Symptom, Cycle 35 Day 1, Stable | 21 | 25 |
| Appetite Loss Symptom, Cycle 35 Day 1, Worsened | 2 | 2 |
| Appetite Loss Symptom, Cycle 37 Day 1, Improved | 7 | 4 |
| Appetite Loss Symptom, Cycle 37 Day 1, Stable | 17 | 28 |
| Appetite Loss Symptom, Cycle 37 Day 1, Worsened | 2 | 1 |
| Appetite Loss Symptom, Cycle 39 Day 1, Improved | 6 | 5 |
| Appetite Loss Symptom, Cycle 39 Day 1, Stable | 17 | 25 |
| Appetite Loss Symptom, Cycle 39 Day 1, Worsened | 2 | 3 |
| Appetite Loss Symptom, Cycle 41 Day 1, Improved | 6 | 6 |
| Appetite Loss Symptom, Cycle 41 Day 1, Stable | 14 | 23 |
| Appetite Loss Symptom, Cycle 41 Day 1, Worsened | 1 | 1 |
| Appetite Loss Symptom, Cycle 43 Day 1, Improved | 6 | 3 |
| Appetite Loss Symptom, Cycle 43 Day 1, Stable | 12 | 22 |
| Appetite Loss Symptom, Cycle 43 Day 1, Worsened | 2 | 3 |
| Appetite Loss Symptom, Cycle 45 Day 1, Improved | 9 | 4 |
| Appetite Loss Symptom, Cycle 45 Day 1, Stable | 7 | 17 |
| Appetite Loss Symptom, Cycle 45 Day 1, Worsened | 0 | 1 |
| Appetite Loss Symptom, Cycle 47 Day 1, Improved | 5 | 4 |
| Appetite Loss Symptom, Cycle 47 Day 1, Stable | 5 | 15 |
| Appetite Loss Symptom, Cycle 47 Day 1, Worsened | 1 | 0 |
| Appetite Loss Symptom, Cycle 49 Day 1, Improved | 5 | 3 |
| Appetite Loss Symptom, Cycle 49 Day 1, Stable | 5 | 11 |
| Appetite Loss Symptom, Cycle 49 Day 1, Worsened | 1 | 1 |
| Appetite Loss Symptom, Cycle 51 Day 1, Improved | 3 | 2 |
| Appetite Loss Symptom, Cycle 51 Day 1, Stable | 4 | 10 |
| Appetite Loss Symptom, Cycle 51 Day 1, Worsened | 0 | 1 |
| Appetite Loss Symptom, Cycle 53 Day 1, Improved | 2 | 2 |
| Appetite Loss Symptom, Cycle 53 Day 1, Stable | 2 | 5 |
| Appetite Loss Symptom, Cycle 53 Day 1, Worsened | 0 | 0 |
| Appetite Loss Symptom, Cycle 55 Day 1, Improved | 2 | 2 |
| Appetite Loss Symptom, Cycle 55 Day 1, Stable | 2 | 4 |
| Appetite Loss Symptom, Cycle 55 Day 1, Worsened | 1 | 0 |
| Appetite Loss Symptom, Cycle 57 Day 1, Improved | 2 | 0 |
| Appetite Loss Symptom, Cycle 57 Day 1, Stable | 3 | 3 |
| Appetite Loss Symptom, Cycle 57 Day 1, Worsened | 0 | 1 |
| Appetite Loss Symptom, Cycle 59 Day 1, Improved | 1 | 0 |
| Appetite Loss Symptom, Cycle 59 Day 1, Stable | 2 | 3 |
| Appetite Loss Symptom, Cycle 59 Day 1, Worsened | 1 | 1 |
| Appetite Loss Symptom, Cycle 61 Day 1, Improved | 1 | 0 |
| Appetite Loss Symptom, Cycle 61 Day 1, Stable | 2 | 4 |
| Appetite Loss Symptom, Cycle 61 Day 1, Worsened | 0 | 0 |
| Appetite Loss Symptom, Cycle 63 Day 1, Improved | 2 | 0 |
| Appetite Loss Symptom, Cycle 63 Day 1, Stable | 0 | 1 |
| Appetite Loss Symptom, Cycle 63 Day 1, Worsened | 0 | 0 |
| Appetite Loss Symptom, Cycle 65 Day 1, Improved | 0 | — |
| Appetite Loss Symptom, Cycle 65 Day 1, Stable | 1 | — |
| Appetite Loss Symptom, Cycle 65 Day 1, Worsened | 0 | — |
| Appetite Loss Symptom, Cycle 67 Day 1, Improved | 0 | — |
| Appetite Loss Symptom, Cycle 67 Day 1, Stable | 1 | — |
| Appetite Loss Symptom, Cycle 67 Day 1, Worsened | 0 | — |
| Appetite Loss Symptom, End of Treatment, Improved | 24 | 24 |
| Appetite Loss Symptom, End of Treatment, Stable | 90 | 97 |
| Appetite Loss Symptom, End of Treatment, Worsened | 56 | 33 |
| Appetite Loss Symptom, Safety Follow-up 1, Improved | 15 | 14 |
| Appetite Loss Symptom, Safety Follow-up 1, Stable | 46 | 62 |
| Appetite Loss Symptom, Safety Follow-up 1, Worsened | 35 | 20 |
| Appetite Loss Symptom, Safety Follow-up 2, Improved | 12 | 21 |
| Appetite Loss Symptom, Safety Follow-up 2, Stable | 52 | 48 |
| Appetite Loss Symptom, Safety Follow-up 2, Worsened | 23 | 22 |
| Constipation Symptom, Cycle 2 Day 1, Improved | 31 | 57 |
| Constipation Symptom, Cycle 2 Day 1, Stable | 133 | 140 |
| Constipation Symptom, Cycle 2 Day 1, Worsened | 44 | 18 |
| Constipation Symptom, Cycle 3 Day 1, Improved | 30 | 59 |
| Constipation Symptom, Cycle 3 Day 1, Stable | 122 | 116 |
| Constipation Symptom, Cycle 3 Day 1, Worsened | 39 | 19 |
| Constipation Symptom, Cycle 4 Day 1, Improved | 26 | 46 |
| Constipation Symptom, Cycle 4 Day 1, Stable | 103 | 105 |
| Constipation Symptom, Cycle 4 Day 1, Worsened | 34 | 9 |
| Constipation Symptom, Cycle 5 Day 1, Improved | 26 | 40 |
| Constipation Symptom, Cycle 5 Day 1, Stable | 98 | 102 |
| Constipation Symptom, Cycle 5 Day 1, Worsened | 34 | 9 |
| Constipation Symptom, Cycle 7 Day 1, Improved | 24 | 37 |
| Constipation Symptom, Cycle 7 Day 1, Stable | 80 | 80 |
| Constipation Symptom, Cycle 7 Day 1, Worsened | 28 | 8 |
| Constipation Symptom, Cycle 9 Day 1, Improved | 23 | 27 |
| Constipation Symptom, Cycle 9 Day 1, Stable | 72 | 74 |
| Constipation Symptom, Cycle 9 Day 1, Worsened | 20 | 8 |
| Constipation Symptom, Cycle 11 Day 1, Improved | 17 | 27 |
| Constipation Symptom, Cycle 11 Day 1, Stable | 60 | 59 |
| Constipation Symptom, Cycle 11 Day 1, Worsened | 20 | 6 |
| Constipation Symptom, Cycle 13 Day 1, Improved | 15 | 24 |
| Constipation Symptom, Cycle 13 Day 1, Stable | 62 | 49 |
| Constipation Symptom, Cycle 13 Day 1, Worsened | 9 | 5 |
| Constipation Symptom, Cycle 15 Day 1, Improved | 18 | 23 |
| Constipation Symptom, Cycle 15 Day 1, Stable | 52 | 52 |
| Constipation Symptom, Cycle 15 Day 1, Worsened | 9 | 2 |
| Constipation Symptom, Cycle 17 Day 1, Improved | 17 | 20 |
| Constipation Symptom, Cycle 17 Day 1, Stable | 41 | 48 |
| Constipation Symptom, Cycle 17 Day 1, Worsened | 9 | 3 |
| Constipation Symptom, Cycle 19 Day 1, Improved | 17 | 21 |
| Constipation Symptom, Cycle 19 Day 1, Stable | 44 | 37 |
| Constipation Symptom, Cycle 19 Day 1, Worsened | 7 | 6 |
| Constipation Symptom, Cycle 21 Day 1, Improved | 16 | 21 |
| Constipation Symptom, Cycle 21 Day 1, Stable | 40 | 41 |
| Constipation Symptom, Cycle 21 Day 1, Worsened | 7 | 3 |
| Constipation Symptom, Cycle 23 Day 1, Improved | 13 | 18 |
| Constipation Symptom, Cycle 23 Day 1, Stable | 36 | 39 |
| Constipation Symptom, Cycle 23 Day 1, Worsened | 6 | 2 |
| Constipation Symptom, Cycle 25 Day 1, Improved | 15 | 13 |
| Constipation Symptom, Cycle 25 Day 1, Stable | 31 | 38 |
| Constipation Symptom, Cycle 25 Day 1, Worsened | 6 | 3 |
| Constipation Symptom, Cycle 27 Day 1, Improved | 13 | 13 |
| Constipation Symptom, Cycle 27 Day 1, Stable | 29 | 39 |
| Constipation Symptom, Cycle 27 Day 1, Worsened | 5 | 1 |
| Constipation Symptom, Cycle 29 Day 1, Improved | 13 | 10 |
| Constipation Symptom, Cycle 29 Day 1, Stable | 30 | 35 |
| Constipation Symptom, Cycle 29 Day 1, Worsened | 3 | 2 |
| Constipation Symptom, Cycle 31 Day 1, Improved | 10 | 6 |
| Constipation Symptom, Cycle 31 Day 1, Stable | 25 | 32 |
| Constipation Symptom, Cycle 31 Day 1, Worsened | 4 | 1 |
| Constipation Symptom, Cycle 33 Day 1, Improved | 9 | 5 |
| Constipation Symptom, Cycle 33 Day 1, Stable | 18 | 31 |
| Constipation Symptom, Cycle 33 Day 1, Worsened | 4 | 3 |
| Constipation Symptom, Cycle 35 Day 1, Improved | 10 | 7 |
| Constipation Symptom, Cycle 35 Day 1, Stable | 19 | 21 |
| Constipation Symptom, Cycle 35 Day 1, Worsened | 1 | 5 |
| Constipation Symptom, Cycle 37 Day 1, Improved | 6 | 8 |
| Constipation Symptom, Cycle 37 Day 1, Stable | 16 | 22 |
| Constipation Symptom, Cycle 37 Day 1, Worsened | 3 | 3 |
| Constipation Symptom, Cycle 39 Day 1, Improved | 9 | 7 |
| Constipation Symptom, Cycle 39 Day 1, Stable | 15 | 21 |
| Constipation Symptom, Cycle 39 Day 1, Worsened | 1 | 5 |
| Constipation Symptom, Cycle 41 Day 1, Improved | 5 | 7 |
| Constipation Symptom, Cycle 41 Day 1, Stable | 13 | 19 |
| Constipation Symptom, Cycle 41 Day 1, Worsened | 3 | 4 |
| Constipation Symptom, Cycle 43 Day 1, Improved | 6 | 4 |
| Constipation Symptom, Cycle 43 Day 1, Stable | 12 | 21 |
| Constipation Symptom, Cycle 43 Day 1, Worsened | 2 | 3 |
| Constipation Symptom, Cycle 45 Day 1, Improved | 5 | 4 |
| Constipation Symptom, Cycle 45 Day 1, Stable | 10 | 15 |
| Constipation Symptom, Cycle 45 Day 1, Worsened | 1 | 3 |
| Constipation Symptom, Cycle 47 Day 1, Improved | 3 | 5 |
| Constipation Symptom, Cycle 47 Day 1, Stable | 8 | 11 |
| Constipation Symptom, Cycle 47 Day 1, Worsened | 0 | 3 |
| Constipation Symptom, Cycle 49 Day 1, Improved | 3 | 4 |
| Constipation Symptom, Cycle 49 Day 1, Stable | 5 | 7 |
| Constipation Symptom, Cycle 49 Day 1, Worsened | 3 | 4 |
| Constipation Symptom, Cycle 51 Day 1, Improved | 2 | 1 |
| Constipation Symptom, Cycle 51 Day 1, Stable | 3 | 10 |
| Constipation Symptom, Cycle 51 Day 1, Worsened | 1 | 2 |
| Constipation Symptom, Cycle 53 Day 1, Improved | 1 | 0 |
| Constipation Symptom, Cycle 53 Day 1, Stable | 2 | 7 |
| Constipation Symptom, Cycle 53 Day 1, Worsened | 1 | 0 |
| Constipation Symptom, Cycle 55 Day 1, Improved | 2 | 0 |
| Constipation Symptom, Cycle 55 Day 1, Stable | 2 | 4 |
| Constipation Symptom, Cycle 55 Day 1, Worsened | 1 | 2 |
| Constipation Symptom, Cycle 57 Day 1, Improved | 1 | 0 |
| Constipation Symptom, Cycle 57 Day 1, Stable | 3 | 3 |
| Constipation Symptom, Cycle 57 Day 1, Worsened | 1 | 1 |
| Constipation Symptom, Cycle 59 Day 1, Improved | 1 | 0 |
| Constipation Symptom, Cycle 59 Day 1, Stable | 2 | 3 |
| Constipation Symptom, Cycle 59 Day 1, Worsened | 1 | 1 |
| Constipation Symptom, Cycle 61 Day 1, Improved | 1 | 0 |
| Constipation Symptom, Cycle 61 Day 1, Stable | 2 | 3 |
| Constipation Symptom, Cycle 61 Day 1, Worsened | 0 | 1 |
| Constipation Symptom, Cycle 63 Day 1, Improved | 1 | 0 |
| Constipation Symptom, Cycle 63 Day 1, Stable | 1 | 1 |
| Constipation Symptom, Cycle 63 Day 1, Worsened | 0 | 0 |
| Constipation Symptom, Cycle 65 Day 1, Improved | 0 | — |
| Constipation Symptom, Cycle 65 Day 1, Stable | 1 | — |
| Constipation Symptom, Cycle 65 Day 1, Worsened | 0 | — |
| Constipation Symptom, Cycle 67 Day 1, Improved | 0 | — |
| Constipation Symptom, Cycle 67 Day 1, Stable | 1 | — |
| Constipation Symptom, Cycle 67 Day 1, Worsened | 0 | — |
| Constipation Symptom, End of Treatment, Improved | 32 | 41 |
| Constipation Symptom, End of Treatment, Stable | 98 | 99 |
| Constipation Symptom, End of Treatment, Worsened | 41 | 14 |
| Constipation Symptom, Safety Follow-up 1, Improved | 16 | 32 |
| Constipation Symptom, Safety Follow-up 1, Stable | 61 | 54 |
| Constipation Symptom, Safety Follow-up 1, Worsened | 18 | 10 |
| Constipation Symptom, Safety Follow-up 2, Improved | 22 | 31 |
| Constipation Symptom, Safety Follow-up 2, Stable | 53 | 50 |
| Constipation Symptom, Safety Follow-up 2, Worsened | 11 | 10 |
| Diarrhea Symptom, Cycle 2 Day 1, Improved | 32 | 34 |
| Diarrhea Symptom, Cycle 2 Day 1, Stable | 166 | 167 |
| Diarrhea Symptom, Cycle 2 Day 1, Worsened | 11 | 21 |
| Diarrhea Symptom, Cycle 3 Day 1, Improved | 35 | 28 |
| Diarrhea Symptom, Cycle 3 Day 1, Stable | 145 | 147 |
| Diarrhea Symptom, Cycle 3 Day 1, Worsened | 15 | 20 |
| Diarrhea Symptom, Cycle 4 Day 1, Improved | 25 | 27 |
| Diarrhea Symptom, Cycle 4 Day 1, Stable | 132 | 130 |
| Diarrhea Symptom, Cycle 4 Day 1, Worsened | 7 | 8 |
| Diarrhea Symptom, Cycle 5 Day 1, Improved | 28 | 26 |
| Diarrhea Symptom, Cycle 5 Day 1, Stable | 118 | 115 |
| Diarrhea Symptom, Cycle 5 Day 1, Worsened | 11 | 11 |
| Diarrhea Symptom, Cycle 7 Day 1, Improved | 20 | 21 |
| Diarrhea Symptom, Cycle 7 Day 1, Stable | 99 | 94 |
| Diarrhea Symptom, Cycle 7 Day 1, Worsened | 12 | 13 |
| Diarrhea Symptom, Cycle 9 Day 1, Improved | 21 | 19 |
| Diarrhea Symptom, Cycle 9 Day 1, Stable | 85 | 82 |
| Diarrhea Symptom, Cycle 9 Day 1, Worsened | 9 | 11 |
| Diarrhea Symptom, Cycle 11 Day 1, Improved | 13 | 16 |
| Diarrhea Symptom, Cycle 11 Day 1, Stable | 78 | 73 |
| Diarrhea Symptom, Cycle 11 Day 1, Worsened | 6 | 7 |
| Diarrhea Symptom, Cycle 13 Day 1, Improved | 12 | 18 |
| Diarrhea Symptom, Cycle 13 Day 1, Stable | 73 | 61 |
| Diarrhea Symptom, Cycle 13 Day 1, Worsened | 4 | 2 |
| Diarrhea Symptom, Cycle 15 Day 1, Improved | 12 | 18 |
| Diarrhea Symptom, Cycle 15 Day 1, Stable | 63 | 57 |
| Diarrhea Symptom, Cycle 15 Day 1, Worsened | 5 | 3 |
| Diarrhea Symptom, Cycle 17 Day 1, Improved | 12 | 13 |
| Diarrhea Symptom, Cycle 17 Day 1, Stable | 53 | 53 |
| Diarrhea Symptom, Cycle 17 Day 1, Worsened | 4 | 6 |
| Diarrhea Symptom, Cycle 19 Day 1, Improved | 13 | 16 |
| Diarrhea Symptom, Cycle 19 Day 1, Stable | 48 | 43 |
| Diarrhea Symptom, Cycle 19 Day 1, Worsened | 7 | 5 |
| Diarrhea Symptom, Cycle 21 Day 1, Improved | 12 | 16 |
| Diarrhea Symptom, Cycle 21 Day 1, Stable | 45 | 45 |
| Diarrhea Symptom, Cycle 21 Day 1, Worsened | 4 | 5 |
| Diarrhea Symptom, Cycle 23 Day 1, Improved | 13 | 15 |
| Diarrhea Symptom, Cycle 23 Day 1, Stable | 41 | 41 |
| Diarrhea Symptom, Cycle 23 Day 1, Worsened | 2 | 6 |
| Diarrhea Symptom, Cycle 25 Day 1, Improved | 10 | 13 |
| Diarrhea Symptom, Cycle 25 Day 1, Stable | 42 | 41 |
| Diarrhea Symptom, Cycle 25 Day 1, Worsened | 2 | 2 |
| Diarrhea Symptom, Cycle 27 Day 1, Improved | 9 | 12 |
| Diarrhea Symptom, Cycle 27 Day 1, Stable | 37 | 38 |
| Diarrhea Symptom, Cycle 27 Day 1, Worsened | 3 | 3 |
| Diarrhea Symptom, Cycle 29 Day 1, Improved | 11 | 9 |
| Diarrhea Symptom, Cycle 29 Day 1, Stable | 33 | 35 |
| Diarrhea Symptom, Cycle 29 Day 1, Worsened | 3 | 3 |
| Diarrhea Symptom, Cycle 31 Day 1, Improved | 11 | 11 |
| Diarrhea Symptom, Cycle 31 Day 1, Stable | 25 | 25 |
| Diarrhea Symptom, Cycle 31 Day 1, Worsened | 4 | 3 |
| Diarrhea Symptom, Cycle 33 Day 1, Improved | 7 | 11 |
| Diarrhea Symptom, Cycle 33 Day 1, Stable | 24 | 24 |
| Diarrhea Symptom, Cycle 33 Day 1, Worsened | 1 | 4 |
| Diarrhea Symptom, Cycle 35 Day 1, Improved | 4 | 10 |
| Diarrhea Symptom, Cycle 35 Day 1, Stable | 23 | 20 |
| Diarrhea Symptom, Cycle 35 Day 1, Worsened | 4 | 4 |
| Diarrhea Symptom, Cycle 37 Day 1, Improved | 1 | 10 |
| Diarrhea Symptom, Cycle 37 Day 1, Stable | 20 | 20 |
| Diarrhea Symptom, Cycle 37 Day 1, Worsened | 5 | 3 |
| Diarrhea Symptom, Cycle 39 Day 1, Improved | 5 | 11 |
| Diarrhea Symptom, Cycle 39 Day 1, Stable | 17 | 19 |
| Diarrhea Symptom, Cycle 39 Day 1, Worsened | 3 | 3 |
| Diarrhea Symptom, Cycle 41 Day 1, Improved | 5 | 11 |
| Diarrhea Symptom, Cycle 41 Day 1, Stable | 13 | 15 |
| Diarrhea Symptom, Cycle 41 Day 1, Worsened | 3 | 3 |
| Diarrhea Symptom, Cycle 43 Day 1, Improved | 5 | 9 |
| Diarrhea Symptom, Cycle 43 Day 1, Stable | 11 | 17 |
| Diarrhea Symptom, Cycle 43 Day 1, Worsened | 4 | 2 |
| Diarrhea Symptom, Cycle 45 Day 1, Improved | 4 | 8 |
| Diarrhea Symptom, Cycle 45 Day 1, Stable | 10 | 14 |
| Diarrhea Symptom, Cycle 45 Day 1, Worsened | 2 | 1 |
| Diarrhea Symptom, Cycle 47 Day 1, Improved | 1 | 6 |
| Diarrhea Symptom, Cycle 47 Day 1, Stable | 8 | 11 |
| Diarrhea Symptom, Cycle 47 Day 1, Worsened | 1 | 2 |
| Diarrhea Symptom, Cycle 49 Day 1, Improved | 2 | 7 |
| Diarrhea Symptom, Cycle 49 Day 1, Stable | 7 | 7 |
| Diarrhea Symptom, Cycle 49 Day 1, Worsened | 2 | 1 |
| Diarrhea Symptom, Cycle 51 Day 1, Improved | 2 | 7 |
| Diarrhea Symptom, Cycle 51 Day 1, Stable | 4 | 5 |
| Diarrhea Symptom, Cycle 51 Day 1, Worsened | 1 | 1 |
| Diarrhea Symptom, Cycle 53 Day 1, Improved | 2 | 4 |
| Diarrhea Symptom, Cycle 53 Day 1, Stable | 3 | 3 |
| Diarrhea Symptom, Cycle 53 Day 1, Worsened | 0 | 0 |
| Diarrhea Symptom, Cycle 55 Day 1, Improved | 1 | 2 |
| Diarrhea Symptom, Cycle 55 Day 1, Stable | 3 | 4 |
| Diarrhea Symptom, Cycle 55 Day 1, Worsened | 1 | 0 |
| Diarrhea Symptom, Cycle 57 Day 1, Improved | 0 | 2 |
| Diarrhea Symptom, Cycle 57 Day 1, Stable | 4 | 2 |
| Diarrhea Symptom, Cycle 57 Day 1, Worsened | 1 | 0 |
| Diarrhea Symptom, Cycle 59 Day 1, Improved | 0 | 2 |
| Diarrhea Symptom, Cycle 59 Day 1, Stable | 4 | 2 |
| Diarrhea Symptom, Cycle 59 Day 1, Worsened | 0 | 0 |
| Diarrhea Symptom, Cycle 61 Day 1, Improved | 1 | 3 |
| Diarrhea Symptom, Cycle 61 Day 1, Stable | 2 | 1 |
| Diarrhea Symptom, Cycle 61 Day 1, Worsened | 0 | 0 |
| Diarrhea Symptom, Cycle 63 Day 1, Improved | 0 | 1 |
| Diarrhea Symptom, Cycle 63 Day 1, Stable | 1 | 0 |
| Diarrhea Symptom, Cycle 63 Day 1, Worsened | 1 | 0 |
| Diarrhea Symptom, Cycle 65 Day 1, Improved | 0 | — |
| Diarrhea Symptom, Cycle 65 Day 1, Stable | 1 | — |
| Diarrhea Symptom, Cycle 65 Day 1, Worsened | 0 | — |
| Diarrhea Symptom, Cycle 67 Day 1, Improved | 0 | — |
| Diarrhea Symptom, Cycle 67 Day 1, Stable | 1 | — |
| Diarrhea Symptom, Cycle 67 Day 1, Worsened | 0 | — |
| Diarrhea Symptom, End of Treatment, Improved | 24 | 20 |
| Diarrhea Symptom, End of Treatment, Stable | 135 | 122 |
| Diarrhea Symptom, End of Treatment, Worsened | 13 | 16 |
| Diarrhea Symptom, Safety Follow-up 1, Improved | 16 | 10 |
| Diarrhea Symptom, Safety Follow-up 1, Stable | 67 | 74 |
| Diarrhea Symptom, Safety Follow-up 1, Worsened | 14 | 14 |
| Diarrhea Symptom, Safety Follow-up 2, Improved | 14 | 9 |
| Diarrhea Symptom, Safety Follow-up 2, Stable | 60 | 72 |
| Diarrhea Symptom, Safety Follow-up 2, Worsened | 14 | 11 |
| Financial Difficulties Symptom, Cycle 2 Day 1, Improved | 46 | 40 |
| Financial Difficulties Symptom, Cycle 2 Day 1, Stable | 143 | 154 |
| Financial Difficulties Symptom, Cycle 2 Day 1, Worsened | 20 | 27 |
| Financial Difficulties Symptom, Cycle 3 Day 1, Improved | 49 | 33 |
| Financial Difficulties Symptom, Cycle 3 Day 1, Stable | 124 | 138 |
| Financial Difficulties Symptom, Cycle 3 Day 1, Worsened | 20 | 23 |
| Financial Difficulties Symptom, Cycle 4 Day 1, Improved | 35 | 26 |
| Financial Difficulties Symptom, Cycle 4 Day 1, Stable | 110 | 121 |
| Financial Difficulties Symptom, Cycle 4 Day 1, Worsened | 18 | 17 |
| Financial Difficulties Symptom, Cycle 5 Day 1, Improved | 41 | 28 |
| Financial Difficulties Symptom, Cycle 5 Day 1, Stable | 103 | 104 |
| Financial Difficulties Symptom, Cycle 5 Day 1, Worsened | 13 | 22 |
| Financial Difficulties Symptom, Cycle 7 Day 1, Improved | 37 | 24 |
| Financial Difficulties Symptom, Cycle 7 Day 1, Stable | 78 | 88 |
| Financial Difficulties Symptom, Cycle 7 Day 1, Worsened | 18 | 15 |
| Financial Difficulties Symptom, Cycle 9 Day 1, Improved | 32 | 25 |
| Financial Difficulties Symptom, Cycle 9 Day 1, Stable | 66 | 74 |
| Financial Difficulties Symptom, Cycle 9 Day 1, Worsened | 18 | 11 |
| Financial Difficulties Symptom, Cycle 11 Day 1, Improved | 19 | 22 |
| Financial Difficulties Symptom, Cycle 11 Day 1, Stable | 68 | 65 |
| Financial Difficulties Symptom, Cycle 11 Day 1, Worsened | 10 | 9 |
| Financial Difficulties Symptom, Cycle 13 Day 1, Improved | 21 | 19 |
| Financial Difficulties Symptom, Cycle 13 Day 1, Stable | 57 | 52 |
| Financial Difficulties Symptom, Cycle 13 Day 1, Worsened | 10 | 8 |
| Financial Difficulties Symptom, Cycle 15 Day 1, Improved | 23 | 24 |
| Financial Difficulties Symptom, Cycle 15 Day 1, Stable | 50 | 48 |
| Financial Difficulties Symptom, Cycle 15 Day 1, Worsened | 6 | 6 |
| Financial Difficulties Symptom, Cycle 17 Day 1, Improved | 17 | 15 |
| Financial Difficulties Symptom, Cycle 17 Day 1, Stable | 39 | 48 |
| Financial Difficulties Symptom, Cycle 17 Day 1, Worsened | 12 | 9 |
| Financial Difficulties Symptom, Cycle 19 Day 1, Improved | 17 | 11 |
| Financial Difficulties Symptom, Cycle 19 Day 1, Stable | 43 | 45 |
| Financial Difficulties Symptom, Cycle 19 Day 1, Worsened | 8 | 9 |
| Financial Difficulties Symptom, Cycle 21 Day 1, Improved | 16 | 14 |
| Financial Difficulties Symptom, Cycle 21 Day 1, Stable | 32 | 39 |
| Financial Difficulties Symptom, Cycle 21 Day 1, Worsened | 14 | 13 |
| Financial Difficulties Symptom, Cycle 23 Day 1, Improved | 17 | 15 |
| Financial Difficulties Symptom, Cycle 23 Day 1, Stable | 29 | 39 |
| Financial Difficulties Symptom, Cycle 23 Day 1, Worsened | 8 | 8 |
| Financial Difficulties Symptom, Cycle 25 Day 1, Improved | 10 | 10 |
| Financial Difficulties Symptom, Cycle 25 Day 1, Stable | 34 | 39 |
| Financial Difficulties Symptom, Cycle 25 Day 1, Worsened | 9 | 7 |
| Financial Difficulties Symptom, Cycle 27 Day 1, Improved | 11 | 12 |
| Financial Difficulties Symptom, Cycle 27 Day 1, Stable | 29 | 37 |
| Financial Difficulties Symptom, Cycle 27 Day 1, Worsened | 8 | 5 |
| Financial Difficulties Symptom, Cycle 29 Day 1, Improved | 13 | 8 |
| Financial Difficulties Symptom, Cycle 29 Day 1, Stable | 27 | 34 |
| Financial Difficulties Symptom, Cycle 29 Day 1, Worsened | 6 | 5 |
| Financial Difficulties Symptom, Cycle 31 Day 1, Improved | 10 | 7 |
| Financial Difficulties Symptom, Cycle 31 Day 1, Stable | 25 | 26 |
| Financial Difficulties Symptom, Cycle 31 Day 1, Worsened | 4 | 6 |
| Financial Difficulties Symptom, Cycle 33 Day 1, Improved | 5 | 10 |
| Financial Difficulties Symptom, Cycle 33 Day 1, Stable | 21 | 23 |
| Financial Difficulties Symptom, Cycle 33 Day 1, Worsened | 5 | 7 |
| Financial Difficulties Symptom, Cycle 35 Day 1, Improved | 7 | 5 |
| Financial Difficulties Symptom, Cycle 35 Day 1, Stable | 19 | 20 |
| Financial Difficulties Symptom, Cycle 35 Day 1, Worsened | 4 | 8 |
| Financial Difficulties Symptom, Cycle 37 Day 1, Improved | 6 | 6 |
| Financial Difficulties Symptom, Cycle 37 Day 1, Stable | 16 | 19 |
| Financial Difficulties Symptom, Cycle 37 Day 1, Worsened | 3 | 8 |
| Financial Difficulties Symptom, Cycle 39 Day 1, Improved | 7 | 9 |
| Financial Difficulties Symptom, Cycle 39 Day 1, Stable | 14 | 15 |
| Financial Difficulties Symptom, Cycle 39 Day 1, Worsened | 4 | 9 |
| Financial Difficulties Symptom, Cycle 41 Day 1, Improved | 5 | 8 |
| Financial Difficulties Symptom, Cycle 41 Day 1, Stable | 13 | 17 |
| Financial Difficulties Symptom, Cycle 41 Day 1, Worsened | 3 | 5 |
| Financial Difficulties Symptom, Cycle 43 Day 1, Improved | 5 | 5 |
| Financial Difficulties Symptom, Cycle 43 Day 1, Stable | 13 | 16 |
| Financial Difficulties Symptom, Cycle 43 Day 1, Worsened | 2 | 7 |
| Financial Difficulties Symptom, Cycle 45 Day 1, Improved | 3 | 6 |
| Financial Difficulties Symptom, Cycle 45 Day 1, Stable | 9 | 13 |
| Financial Difficulties Symptom, Cycle 45 Day 1, Worsened | 4 | 3 |
| Financial Difficulties Symptom, Cycle 47 Day 1, Improved | 1 | 6 |
| Financial Difficulties Symptom, Cycle 47 Day 1, Stable | 8 | 9 |
| Financial Difficulties Symptom, Cycle 47 Day 1, Worsened | 2 | 4 |
| Financial Difficulties Symptom, Cycle 49 Day 1, Improved | 0 | 4 |
| Financial Difficulties Symptom, Cycle 49 Day 1, Stable | 8 | 9 |
| Financial Difficulties Symptom, Cycle 49 Day 1, Worsened | 3 | 2 |
| Financial Difficulties Symptom, Cycle 51 Day 1, Improved | 1 | 4 |
| Financial Difficulties Symptom, Cycle 51 Day 1, Stable | 3 | 5 |
| Financial Difficulties Symptom, Cycle 51 Day 1, Worsened | 3 | 4 |
| Financial Difficulties Symptom, Cycle 53 Day 1, Improved | 1 | 2 |
| Financial Difficulties Symptom, Cycle 53 Day 1, Stable | 3 | 4 |
| Financial Difficulties Symptom, Cycle 53 Day 1, Worsened | 1 | 1 |
| Financial Difficulties Symptom, Cycle 55 Day 1, Improved | 2 | 1 |
| Financial Difficulties Symptom, Cycle 55 Day 1, Stable | 3 | 4 |
| Financial Difficulties Symptom, Cycle 55 Day 1, Worsened | 0 | 1 |
| Financial Difficulties Symptom, Cycle 57 Day 1, Improved | 2 | 0 |
| Financial Difficulties Symptom, Cycle 57 Day 1, Stable | 3 | 3 |
| Financial Difficulties Symptom, Cycle 57 Day 1, Worsened | 0 | 1 |
| Financial Difficulties Symptom, Cycle 59 Day 1, Improved | 2 | 0 |
| Financial Difficulties Symptom, Cycle 59 Day 1, Stable | 2 | 2 |
| Financial Difficulties Symptom, Cycle 59 Day 1, Worsened | 0 | 2 |
| Financial Difficulties Symptom, Cycle 61 Day 1, Improved | 2 | 0 |
| Financial Difficulties Symptom, Cycle 61 Day 1, Stable | 1 | 3 |
| Financial Difficulties Symptom, Cycle 61 Day 1, Worsened | 0 | 1 |
| Financial Difficulties Symptom, Cycle 63 Day 1, Improved | 0 | 0 |
| Financial Difficulties Symptom, Cycle 63 Day 1, Stable | 2 | 1 |
| Financial Difficulties Symptom, Cycle 63 Day 1, Worsened | 0 | 0 |
| Financial Difficulties Symptom, Cycle 65 Day 1, Improved | 1 | — |
| Financial Difficulties Symptom, Cycle 65 Day 1, Stable | 0 | — |
| Financial Difficulties Symptom, Cycle 65 Day 1, Worsened | 0 | — |
| Financial Difficulties Symptom, Cycle 67 Day 1, Improved | 1 | — |
| Financial Difficulties Symptom, Cycle 67 Day 1, Stable | 0 | — |
| Financial Difficulties Symptom, Cycle 67 Day 1, Worsened | 0 | — |
| Financial Difficulties Symptom, End of Treatment, Improved | 36 | 26 |
| Financial Difficulties Symptom, End of Treatment, Stable | 109 | 102 |
| Financial Difficulties Symptom, End of Treatment, Worsened | 26 | 30 |
| Financial Difficulties Symptom, Safety Follow-up 1, Improved | 24 | 9 |
| Financial Difficulties Symptom, Safety Follow-up 1, Stable | 51 | 70 |
| Financial Difficulties Symptom, Safety Follow-up 1, Worsened | 22 | 20 |
| Financial Difficulties Symptom, Safety Follow-up 2, Improved | 21 | 14 |
| Financial Difficulties Symptom, Safety Follow-up 2, Stable | 52 | 63 |
| Financial Difficulties Symptom, Safety Follow-up 2, Worsened | 14 | 16 |
EORTC QLQ-LC13 is a 13-items questionnaire used in clinical research to assess health-related quality of life in lung cancer patients. The QLQ-LC13 includes questions assessing lung cancer-associated symptoms (Coughing, hemoptysis, dyspnea and site specific pain), treatment-related side effects (sore mouth, dysphagia, peripheral neuropathy and alopecia) and pain medication. Scores are calculated and transformed to range from 0 to 100. For the disease symptoms and side-effects of treatment scales a higher score represents a higher level of symptoms/problems and a negative change from baseline value indicates reduction (i.e. improvement) in symptoms.
| Participants | Niraparib + Pembrolizumab | Placebo + Pembrolizumab |
|---|---|---|
| Dyspnea Symptom, CFB to Cycle 2 Day 1, Improved | 59 | 61 |
| Dyspnea Symptom, CFB to Cycle 2 Day 1, Stable | 86 | 94 |
| Dyspnea Symptom, CFB to Cycle 2 Day 1, Worsened | 50 | 58 |
| Dyspnea Symptom, CFB to Cycle 3 Day 1, Improved | 57 | 60 |
| Dyspnea Symptom, CFB to Cycle 3 Day 1, Stable | 75 | 80 |
| Dyspnea Symptom, CFB to Cycle 3 Day 1, Worsened | 48 | 47 |
| Dyspnea Symptom, Cycle 4 Day 1, Improved | 39 | 61 |
| Dyspnea Symptom, CFB to Cycle 4 Day 1, Stable | 70 | 54 |
| Dyspnea Symptom, CFB to Cycle 4 Day 1, Worsened | 39 | 41 |
| Dyspnea Symptom, CFB to 5 Day 1, Improved | 47 | 48 |
| Dyspnea Symptom, CFB to Cycle 5 Day 1, Stable | 54 | 60 |
| Dyspnea Symptom, CFB to Cycle 5 Day 1, Worsened | 46 | 37 |
| Dyspnea Symptom, CFB to Cycle 7 Day 1, Improved | 41 | 43 |
| Dyspnea Symptom, CFB to Cycle 7 Day 1, Stable | 54 | 51 |
| Dyspnea Symptom, CFB to Cycle 7 Day 1, Worsened | 31 | 27 |
| Dyspnea Symptom, CFB to Cycle 9 Day 1, Improved | 34 | 42 |
| Dyspnea Symptom, CFB to Cycle 9 Day 1, Stable | 51 | 41 |
| Dyspnea Symptom, CFB to Cycle 9 Day 1, Worsened | 25 | 23 |
| Dyspnea Symptom, CFB to Cycle 11 Day 1, Improved | 24 | 31 |
| Dyspnea Symptom, CFB to Cycle 11 Day 1, Stable | 48 | 30 |
| Dyspnea Symptom, CFB to Cycle 11 Day 1, Worsened | 20 | 29 |
| Dyspnea Symptom, CFB to Cycle 13 Day 1, Improved | 26 | 28 |
| Dyspnea Symptom, CFB to Cycle 13 Day 1, Stable | 34 | 33 |
| Dyspnea Symptom, CFB to Cycle 13 Day 1, Worsened | 24 | 17 |
| Dyspnea Symptom, CFB to Cycle 15 Day 1, Improved | 23 | 34 |
| Dyspnea Symptom, CFB to Cycle 15 Day 1, Stable | 38 | 27 |
| Dyspnea Symptom, CFB to Cycle 15 Day 1, Worsened | 15 | 15 |
| Dyspnea Symptom, CFB to Cycle 17 Day 1, Improved | 16 | 26 |
| Dyspnea Symptom, CFB to Cycle 17 Day 1, Stable | 31 | 26 |
| Dyspnea Symptom, CFB to Cycle 17 Day 1, Worsened | 18 | 18 |
| Dyspnea Symptom, CFB to Cycle 19 Day 1, Improved | 21 | 21 |
| Dyspnea Symptom, CFB to Cycle 19 Day 1, Stable | 27 | 28 |
| Dyspnea Symptom, CFB to Cycle 19 Day 1, Worsened | 16 | 13 |
| Dyspnea Symptom, CFB to Cycle 21 Day 1, Improved | 20 | 21 |
| Dyspnea Symptom, CFB to Cycle 21 Day 1, Stable | 28 | 24 |
| Dyspnea Symptom, CFB to Cycle 21 Day 1, Worsened | 10 | 18 |
| Dyspnea Symptom, CFB to Cycle 23 Day 1, Improved | 22 | 22 |
| Dyspnea Symptom, CFB to Cycle 23 Day 1, Stable | 19 | 20 |
| Dyspnea Symptom, CFB to Cycle 23 Day 1, Worsened | 11 | 17 |
| Dyspnea Symptom, CFB to Cycle 25 Day 1, Improved | 19 | 20 |
| Dyspnea Symptom, CFB to Cycle 25 Day 1, Stable | 20 | 18 |
| Dyspnea Symptom, CFB to Cycle 25 Day 1, Worsened | 9 | 15 |
| Dyspnea Symptom, CFB to Cycle 27 Day 1, Improved | 14 | 21 |
| Dyspnea Symptom, CFB to Cycle 27 Day 1, Stable | 19 | 23 |
| Dyspnea Symptom, CFB to Cycle 27 Day 1, Worsened | 10 | 9 |
| Dyspnea Symptom, CFB to Cycle 29 Day 1, Improved | 13 | 18 |
| Dyspnea Symptom, CFB to Cycle 29 Day 1, Stable | 21 | 22 |
| Dyspnea Symptom, CFB to Cycle 29 Day 1, Worsened | 9 | 6 |
| Dyspnea Symptom, CFB to Cycle 31 Day 1, Improved | 12 | 10 |
| Dyspnea Symptom, CFB to Cycle 31 Day 1, Stable | 14 | 14 |
| Dyspnea Symptom, CFB to Cycle 31 Day 1, Worsened | 11 | 14 |
| Dyspnea Symptom, CFB to Cycle 33 Day 1, Improved | 9 | 14 |
| Dyspnea Symptom, CFB to Cycle 33 Day 1, Stable | 15 | 13 |
| Dyspnea Symptom, CFB to Cycle 33 Day 1, Worsened | 5 | 12 |
| Dyspnea Symptom, CFB to Cycle 35 Day 1, Improved | 10 | 7 |
| Dyspnea Symptom, CFB to Cycle 35 Day 1, Stable | 10 | 16 |
| Dyspnea Symptom, CFB to Cycle 35 Day 1, Worsened | 8 | 9 |
| Dyspnea Symptom, CFB to Cycle 37 Day 1, Improved | 8 | 10 |
| Dyspnea Symptom, CFB to Cycle 37 Day 1, Stable | 8 | 13 |
| Dyspnea Symptom, Cycle 37 Day 1, Worsened | 8 | 9 |
| Dyspnea Symptom, CFB to Cycle 39 Day 1, Improved | 9 | 12 |
| Dyspnea Symptom, CFB to Cycle 39 Day 1, Stable | 9 | 12 |
| Dyspnea Symptom, CFB to Cycle 39 Day 1, Worsened | 6 | 8 |
| Dyspnea Symptom, CFB to Cycle 41 Day 1, Improved | 9 | 10 |
| Dyspnea Symptom, CFB to 41 Day 1, Stable | 6 | 11 |
| Dyspnea Symptom, CFB to Cycle 41 Day 1, Worsened | 5 | 8 |
| Dyspnea Symptom, CFB to Cycle 43 Day 1, Improved | 7 | 8 |
| Dyspnea Symptom, CFB to Cycle 43 Day 1, Stable | 6 | 10 |
| Dyspnea Symptom, CFB to Cycle 43 Day 1, Worsened | 5 | 10 |
| Dyspnea Symptom, CFB to Cycle 45 Day 1, Improved | 5 | 8 |
| Dyspnea Symptom, CFB to 45 Day 1, Stable | 6 | 9 |
| Dyspnea Symptom, CFB to Cycle 45 Day 1, Worsened | 4 | 6 |
| Dyspnea Symptom, CFB to Cycle 47 Day 1, Improved | 1 | 6 |
| Dyspnea Symptom, CFB to Cycle 47 Day 1, Stable | 6 | 6 |
| Dyspnea Symptom, CFB to Cycle 47 Day 1, Worsened | 3 | 6 |
| Dyspnea Symptom, CFB to Cycle 49 Day 1, Improved | 3 | 5 |
| Dyspnea Symptom, CFB to Cycle 49 Day 1, Stable | 6 | 6 |
| Dyspnea Symptom, CFB to Cycle 49 Day 1, Worsened | 1 | 4 |
| Dyspnea Symptom, CFB to Cycle 51 Day 1, Improved | 2 | 5 |
| Dyspnea Symptom, CFB to Cycle 51 Day 1, Stable | 1 | 5 |
| Dyspnea Symptom, CFB to Cycle 51 Day 1, Worsened | 3 | 3 |
| Dyspnea Symptom, CFB to Cycle 53 Day 1, Improved | 1 | 0 |
| Dyspnea Symptom, CFB to Cycle 53 Day 1, Stable | 1 | 5 |
| Dyspnea Symptom, CFB to Cycle 53 Day 1, Worsened | 3 | 1 |
| Dyspnea Symptom, CFB to Cycle 55 Day 1, Improved | 3 | 1 |
| Dyspnea Symptom, CFB to Cycle 55 Day 1, Stable | 1 | 3 |
| Dyspnea Symptom, CFB to Cycle 55 Day 1, Worsened | 1 | 2 |
| Dyspnea Symptom, CFB to Cycle 57 Day 1, Improved | 3 | 0 |
| Dyspnea Symptom, CFB to Cycle 57 Day 1, Stable | 2 | 1 |
| Dyspnea Symptom, CFB to Cycle 57 Day 1, Worsened | 0 | 3 |
| Dyspnea Symptom, CFB to Cycle 59 Day 1, Improved | 2 | 0 |
| Dyspnea Symptom, CFB to Cycle 59 Day 1, Stable | 1 | 0 |
| Dyspnea Symptom, CFB to Cycle 59 Day 1, Worsened | 1 | 4 |
| Dyspnea Symptom, CFB to Cycle 61 Day 1, Improved | 2 | 1 |
| Dyspnea Symptom, CFB to Cycle 61 Day 1, Stable | 0 | 2 |
| Dyspnea Symptom, CFB to Cycle 61 Day 1, Worsened | 1 | 1 |
| Dyspnea Symptom, CFB to Cycle 63 Day 1, Improved | 0 | 0 |
| Dyspnea Symptom, CFB to Cycle 63 Day 1, Stable | 1 | 1 |
| Dyspnea Symptom, CFB to Cycle 63 Day 1, Worsened | 1 | 0 |
| Dyspnea Symptom, CFB to Cycle 65 Day 1, Improved | 0 | — |
| Dyspnea Symptom, CFB to Cycle 65 Day 1, Stable | 1 | — |
| Dyspnea Symptom, CFB to Cycle 65 Day 1, Worsened | 0 | — |
| Dyspnea Symptom, CFB to End of Treatment, Improved | 48 | 57 |
| Dyspnea Symptom, CFB to End of Treatment, Stable | 48 | 45 |
| Dyspnea Symptom, CFB to End of Treatment, Worsened | 67 | 51 |
| Dyspnea Symptom, CFB to Safety Follow-up 1, Improved | 22 | 28 |
| Dyspnea Symptom, CFB to Safety Follow-up 1, Stable | 31 | 32 |
| Dyspnea Symptom, CFB to Safety Follow-up 1, Worsened | 37 | 36 |
| Dyspnea Symptom, CFB to Safety Follow-up 2, Improved | 19 | 24 |
| Dyspnea Symptom, CFB to Safety Follow-up 2, Stable | 26 | 32 |
| Dyspnea Symptom, CFB to Safety Follow-up 2, Worsened | 33 | 35 |
| Coughing Symptom, CFB to Cycle 2 Day 1, Improved | 35 | 54 |
| Coughing Symptom, CFB to Cycle 2 Day 1, Stable | 137 | 133 |
| Coughing Symptom, CFB to Cycle 2 Day 1, Worsened | 28 | 29 |
| Coughing Symptom, CFB to Cycle 3 Day 1, Improved | 40 | 47 |
| Coughing Symptom, CFB to Cycle 3 Day 1, Stable | 113 | 117 |
| Coughing Symptom, CFB to Cycle 3 Day 1, Worsened | 35 | 26 |
| Coughing Symptom, CFB to Cycle 4 Day 1, Improved | 32 | 45 |
| Coughing Symptom, CFB to Cycle 4 Day 1, Stable | 98 | 93 |
| Coughing Symptom, CFB to Cycle 4 Day 1, Worsened | 27 | 22 |
| Coughing Symptom, CFB to Cycle 5 Day 1, Improved | 35 | 40 |
| Coughing Symptom, CFB to Cycle 5 Day 1, Stable | 89 | 75 |
| Coughing Symptom, CFB to Cycle 5 Day 1, Worsened | 26 | 34 |
| Coughing Symptom, CFB to Cycle 7 Day 1, Improved | 28 | 39 |
| Coughing Symptom, CFB to Cycle 7 Day 1, Stable | 79 | 63 |
| Coughing Symptom, CFB to Cycle 7 Day 1, Worsened | 23 | 21 |
| Coughing Symptom, CFB to Cycle 9 Day 1, Improved | 27 | 33 |
| Coughing Symptom, CFB to Cycle 9 Day 1, Stable | 63 | 64 |
| Coughing Symptom, CFB to Cycle 9 Day 1, Worsened | 25 | 12 |
| Coughing Symptom, CFB to Cycle 11 Day 1, Improved | 23 | 30 |
| Coughing Symptom, CFB to Cycle 11 Day 1, Stable | 50 | 42 |
| Coughing Symptom, CFB to Cycle 11 Day 1, Worsened | 23 | 20 |
| Coughing Symptom, CFB to Cycle 13 Day 1, Improved | 15 | 19 |
| Coughing Symptom, CFB to Cycle 13 Day 1, Stable | 52 | 51 |
| Coughing Symptom, CFB to Cycle 13 Day 1, Worsened | 19 | 9 |
| Coughing Symptom, CFB to Cycle 15 Day 1, Improved | 13 | 21 |
| Coughing Symptom, CFB to Cycle 15 Day 1, Stable | 48 | 50 |
| Coughing Symptom, CFB to Cycle 15 Day 1, Worsened | 17 | 4 |
| Coughing Symptom, CFB to Cycle 17 Day 1, Improved | 19 | 21 |
| Coughing Symptom, CFB to Cycle 17 Day 1, Stable | 33 | 44 |
| Coughing Symptom, CFB to Cycle 17 Day 1, Worsened | 16 | 5 |
| Coughing Symptom, CFB to Cycle 19 Day 1, Improved | 12 | 20 |
| Coughing Symptom, CFB to Cycle 19 Day 1, Stable | 40 | 36 |
| Coughing Symptom, CFB to Cycle 19 Day 1, Worsened | 15 | 7 |
| Coughing Symptom, CFB to Cycle 21 Day 1, Improved | 13 | 18 |
| Coughing Symptom, CFB to Cycle 21 Day 1, Stable | 41 | 36 |
| Coughing Symptom, CFB to Cycle 21 Day 1, Worsened | 7 | 9 |
| Coughing Symptom, CFB to Cycle 23 Day 1, Improved | 11 | 16 |
| Coughing Symptom, CFB to Cycle 23 Day 1, Stable | 37 | 36 |
| Coughing Symptom, CFB to Cycle 23 Day 1, Worsened | 5 | 8 |
| Coughing Symptom, CFB to Cycle 25 Day 1, Improved | 12 | 18 |
| Coughing Symptom, CFB to Cycle 25 Day 1, Stable | 35 | 33 |
| Coughing Symptom, CFB to Cycle 25 Day 1, Worsened | 4 | 3 |
| Coughing Symptom, CFB to Cycle 27 Day 1, Improved | 8 | 16 |
| Coughing Symptom, CFB to Cycle 27 Day 1, Stable | 31 | 29 |
| Coughing Symptom, CFB to Cycle 27 Day 1, Worsened | 7 | 8 |
| Coughing Symptom, CFB to Cycle 29 Day 1, Improved | 11 | 13 |
| Coughing Symptom, CFB to Cycle 29 Day 1, Stable | 24 | 26 |
| Coughing Symptom, CFB to Cycle 29 Day 1, Worsened | 10 | 7 |
| Coughing Symptom, CFB to Cycle 31 Day 1, Improved | 6 | 10 |
| Coughing Symptom, CFB to Cycle 31 Day 1, Stable | 21 | 22 |
| Coughing Symptom, CFB to Cycle 31 Day 1, Worsened | 12 | 6 |
| Coughing Symptom, CFB to Cycle 33 Day 1, Improved | 5 | 10 |
| Coughing Symptom, CFB to Cycle 33 Day 1, Stable | 21 | 21 |
| Coughing Symptom, CFB to Cycle 33 Day 1, Worsened | 5 | 8 |
| Coughing Symptom, CFB to Cycle 35 Day 1, Improved | 7 | 9 |
| Coughing Symptom, CFB to Cycle 35 Day 1, Stable | 15 | 21 |
| Coughing Symptom, CFB to Cycle 35 Day 1, Worsened | 7 | 3 |
| Coughing Symptom, CFB to Cycle 37 Day 1, Improved | 4 | 10 |
| Coughing Symptom, CFB to Cycle 37 Day 1, Stable | 16 | 17 |
| Coughing Symptom, CFB to Cycle 37 Day 1, Worsened | 5 | 5 |
| Coughing Symptom, CFB to Cycle 39 Day 1, Improved | 4 | 11 |
| Coughing Symptom, CFB to Cycle 39 Day 1, Stable | 17 | 18 |
| Coughing Symptom, CFB to 39 Day 1, Worsened | 3 | 3 |
| Coughing Symptom, CFB to Cycle 41 Day 1, Improved | 2 | 13 |
| Coughing Symptom, CFB to Cycle 41 Day 1, Stable | 14 | 13 |
| Coughing Symptom, CFB to Cycle 41 Day 1, Worsened | 4 | 3 |
| Coughing Symptom, CFB to Cycle 43 Day 1, Improved | 4 | 10 |
| Coughing Symptom, CFB to Cycle 43 Day 1, Stable | 9 | 14 |
| Coughing Symptom, CFB to Cycle 43 Day 1, Worsened | 5 | 4 |
| Coughing Symptom, CFB to Cycle 45 Day 1, Improved | 2 | 7 |
| Coughing Symptom, CFB to Cycle 45 Day 1, Stable | 9 | 11 |
| Coughing Symptom, CFB to Cycle 45 Day 1, Worsened | 4 | 5 |
| Coughing Symptom, CFB to Cycle 47 Day 1, Improved | 0 | 9 |
| Coughing Symptom, CFB to Cycle 47 Day 1, Stable | 8 | 8 |
| Coughing Symptom, CFB to Cycle 47 Day 1, Worsened | 2 | 2 |
| Coughing Symptom, CFB to Cycle 49 Day 1, Improved | 2 | 3 |
| Coughing Symptom, CFB to Cycle 49 Day 1, Stable | 4 | 10 |
| Coughing Symptom, CFB to Cycle 49 Day 1, Worsened | 4 | 2 |
| Coughing Symptom, CFB to Cycle 51 Day 1, Improved | 1 | 6 |
| Coughing Symptom, CFB to Cycle 51 Day 1, Stable | 3 | 6 |
| Coughing Symptom, CFB to Cycle 51 Day 1, Worsened | 2 | 1 |
| Coughing Symptom, CFB to Cycle 53 Day 1, Improved | 0 | 2 |
| Coughing Symptom, CFB to Cycle 53 Day 1, Stable | 3 | 5 |
| Coughing Symptom, CFB to Cycle 53 Day 1, Worsened | 2 | 0 |
| Coughing Symptom, CFB to Cycle 55 Day 1, Improved | 0 | 2 |
| Coughing Symptom, CFB to Cycle 55 Day 1, Stable | 4 | 4 |
| Coughing Symptom, CFB to Cycle 55 Day 1, Worsened | 1 | 0 |
| Coughing Symptom, CFB to Cycle 57 Day 1, Improved | 0 | 2 |
| Coughing Symptom, CFB to Cycle 57 Day 1, Stable | 3 | 1 |
| Coughing Symptom, CFB to Cycle 57 Day 1, Worsened | 2 | 1 |
| Coughing Symptom, CFB to Cycle 59 Day 1, Improved | 0 | 2 |
| Coughing Symptom, CFB to Cycle 59 Day 1, Stable | 3 | 0 |
| Coughing Symptom, CFB to Cycle 59 Day 1, Worsened | 1 | 2 |
| Coughing Symptom, CFB to Cycle 61 Day 1, Improved | 0 | 3 |
| Coughing Symptom, CFB to Cycle 61 Day 1, Stable | 1 | 1 |
| Coughing Symptom, CFB to Cycle 61 Day 1, Worsened | 2 | 0 |
| Coughing Symptom, CFB to Cycle 63 Day 1, Improved | 0 | 1 |
| Coughing Symptom, CFB to Cycle 63 Day 1, Stable | 0 | 0 |
| Coughing Symptom, CFB to Cycle 63 Day 1, Worsened | 2 | 0 |
| Coughing Symptom, CFB to Cycle 65 Day 1, Improved | 0 | — |
| Coughing Symptom, CFB to Cycle 65 Day 1, Stable | 1 | — |
| Coughing Symptom, CFB to Cycle 65 Day 1, Worsened | 0 | — |
| Coughing Symptom, CFB to Cycle 67 Day 1, Improved | 0 | — |
| Coughing Symptom, CFB to Cycle 67 Day 1, Stable | 1 | — |
| Coughing Symptom, CFB to Cycle 67 Day 1, Worsened | 0 | — |
| Coughing Symptom, CFB to End of Treatment, Improved | 32 | 40 |
| Coughing Symptom, CFB to End of Treatment, Stable | 89 | 85 |
| Coughing Symptom, CFB to End of Treatment, Worsened | 47 | 32 |
| Coughing Symptom, CFB to Safety Follow-up 1, Improved | 20 | 29 |
| Coughing Symptom, CFB to Safety Follow-up 1, Stable | 46 | 48 |
| Coughing Symptom, CFB to Safety Follow-up 1, Worsened | 27 | 20 |
| Coughing Symptom, CFB to Safety Follow-up 2, Improved | 15 | 23 |
| Coughing Symptom, CFB to Safety Follow-up 2, Stable | 38 | 44 |
| Coughing Symptom, CFB to Safety Follow-up 2, Worsened | 30 | 25 |
| Hemoptysis Symptom, CFB to Cycle 2 Day 1, Improved | 8 | 7 |
| Hemoptysis Symptom, CFB to Cycle 2 Day 1, Stable | 186 | 198 |
| Hemoptysis Symptom, CFB to Cycle 2 Day 1, Worsened | 3 | 12 |
| Hemoptysis Symptom, CFB to Cycle 3 Day 1, Improved | 7 | 6 |
| Hemoptysis Symptom, CFB to Cycle 3 Day 1, Stable | 173 | 182 |
| Hemoptysis Symptom, CFB to Cycle 3 Day 1, Worsened | 6 | 2 |
| Hemoptysis Symptom, CFB to Cycle 4 Day 1, Improved | 7 | 4 |
| Hemoptysis Symptom, CFB to Cycle 4 Day 1, Stable | 141 | 152 |
| Hemoptysis Symptom, CFB to Cycle 4 Day 1, Worsened | 7 | 3 |
| Hemoptysis Symptom, CFB to Cycle 5 Day 1, Improved | 7 | 3 |
| Hemoptysis Symptom, CFB to Cycle 5 Day 1, Stable | 140 | 142 |
| Hemoptysis Symptom, CFB to Cycle 5 Day 1, Worsened | 1 | 4 |
| Hemoptysis Symptom, CFB to Cycle 7 Day 1, Improved | 8 | 2 |
| Hemoptysis Symptom, CFB to Cycle 7 Day 1, Stable | 119 | 119 |
| Hemoptysis Symptom, CFB to Cycle 7 Day 1, Worsened | 2 | 2 |
| Hemoptysis Symptom, CFB to Cycle 9 Day 1, Improved | 6 | 2 |
| Hemoptysis Symptom, CFB to Cycle 9 Day 1, Stable | 104 | 104 |
| Hemoptysis Symptom, CFB to Cycle 9 Day 1, Worsened | 3 | 3 |
| Hemoptysis Symptom, CFB to Cycle 11 Day 1, Improved | 3 | 2 |
| Hemoptysis Symptom, CFB to Cycle 11 Day 1, Stable | 90 | 85 |
| Hemoptysis Symptom, CFB to Cycle 11 Day 1, Worsened | 2 | 5 |
| Hemoptysis Symptom, CFB to Cycle 13 Day 1, Improved | 2 | 1 |
| Hemoptysis Symptom, CFB to Cycle 13 Day 1, Stable | 82 | 76 |
| Hemoptysis Symptom, CFB to Cycle 13 Day 1, Worsened | 0 | 2 |
| Hemoptysis Symptom, CFB to Cycle 15 Day 1, Improved | 2 | 2 |
| Hemoptysis Symptom, CFB to Cycle 15 Day 1, Stable | 72 | 72 |
| Hemoptysis Symptom, CFB to Cycle 15 Day 1, Worsened | 2 | 2 |
| Hemoptysis Symptom, CFB to Cycle 17 Day 1, Improved | 2 | 1 |
| Hemoptysis Symptom, CFB to Cycle 17 Day 1, Stable | 60 | 68 |
| Hemoptysis Symptom, CFB to Cycle 17 Day 1, Worsened | 4 | 1 |
| Hemoptysis Symptom, CFB to Cycle 19 Day 1, Improved | 2 | 2 |
| Hemoptysis Symptom, CFB to Cycle 19 Day 1, Stable | 63 | 59 |
| Hemoptysis Symptom, CFB to Cycle 19 Day 1, Worsened | 1 | 2 |
| Hemoptysis Symptom, CFB to Cycle 21 Day 1, Improved | 2 | 2 |
| Hemoptysis Symptom, CFB to Cycle 21 Day 1, Stable | 58 | 58 |
| Hemoptysis Symptom, CFB to Cycle 21 Day 1, Worsened | 1 | 3 |
| Hemoptysis Symptom, CFB to Cycle 23 Day 1, Improved | 1 | 1 |
| Hemoptysis Symptom, CFB to Cycle 23 Day 1, Stable | 51 | 55 |
| Hemoptysis Symptom, CFB to Cycle 23 Day 1, Worsened | 1 | 4 |
| Hemoptysis Symptom, CFB to Cycle 25 Day 1, Improved | 0 | 1 |
| Hemoptysis Symptom, CFB to Cycle 25 Day 1, Stable | 49 | 52 |
| Hemoptysis Symptom, CFB to Cycle 25 Day 1, Worsened | 1 | 0 |
| Hemoptysis Symptom, CFB to Cycle 27 Day 1, Improved | 0 | 1 |
| Hemoptysis Symptom, CFB to Cycle 27 Day 1, Stable | 43 | 52 |
| Hemoptysis Symptom, CFB to Cycle 27 Day 1, Worsened | 2 | 0 |
| Hemoptysis Symptom, CFB to Cycle 29 Day 1, Improved | 0 | 1 |
| Hemoptysis Symptom, CFB to Cycle 29 Day 1, Stable | 43 | 45 |
| Hemoptysis Symptom, CFB to 29 Day 1, Worsened | 1 | 0 |
| Hemoptysis Symptom, CFB to Cycle 31 Day 1, Improved | 0 | 1 |
| Hemoptysis Symptom, CFB to Cycle 31 Day 1, Stable | 36 | 37 |
| Hemoptysis Symptom, CFB to Cycle 31 Day 1, Worsened | 2 | 0 |
| Hemoptysis Symptom, CFB to Cycle 33 Day 1, Improved | 0 | 1 |
| Hemoptysis Symptom, CFB to Cycle 33 Day 1, Stable | 29 | 37 |
| Hemoptysis Symptom, CFB to 33 Day 1, Worsened | 1 | 1 |
| Hemoptysis Symptom, CFB to Cycle 35 Day 1, Improved | 0 | 1 |
| Hemoptysis Symptom, CFB to Cycle 35 Day 1, Stable | 28 | 31 |
| Hemoptysis Symptom, CFB to Cycle 35 Day 1, Worsened | 0 | 1 |
| Hemoptysis Symptom, CFB to Cycle 37 Day 1, Improved | 0 | 1 |
| Hemoptysis Symptom, CFB to Cycle 37 Day 1, Stable | 24 | 31 |
| Hemoptysis Symptom, CFB to Cycle 37 Day 1, Worsened | 0 | 0 |
| Hemoptysis Symptom, CFB to Cycle 39 Day 1, Improved | 0 | 1 |
| Hemoptysis Symptom, CFB to Cycle 39 Day 1, Stable | 24 | 30 |
| Hemoptysis Symptom, CFB to Cycle 39 Day 1, Worsened | 0 | 1 |
| Hemoptysis Symptom, CFB to Cycle 41 Day 1, Improved | 0 | 1 |
| Hemoptysis Symptom, CFB to Cycle 41 Day 1, Stable | 19 | 27 |
| Hemoptysis Symptom, CFB to Cycle 41 Day 1, Worsened | 1 | 1 |
| Hemoptysis Symptom, CFB to Cycle 43 Day 1, Improved | 0 | 1 |
| Hemoptysis Symptom, CFB to Cycle 43 Day 1, Stable | 16 | 25 |
| Hemoptysis Symptom, CFB to Cycle 43 Day 1, Worsened | 2 | 2 |
| Hemoptysis Symptom, CFB to Cycle 45 Day 1, Improved | 0 | 1 |
| Hemoptysis Symptom, CFB to Cycle 45 Day 1, Stable | 15 | 22 |
| Hemoptysis Symptom, CFB to Cycle 45 Day 1, Worsened | 0 | 0 |
| Hemoptysis Symptom, CFB to Cycle 47 Day 1, Improved | 0 | 0 |
| Hemoptysis Symptom, CFB to Cycle 47 Day 1, Stable | 10 | 18 |
| Hemoptysis Symptom, CFB to Cycle 47 Day 1, Worsened | 0 | 1 |
| Hemoptysis Symptom, CFB to Cycle 49 Day 1, Improved | 0 | 0 |
| Hemoptysis Symptom, CFB to Cycle 49 Day 1, Stable | 9 | 15 |
| Hemoptysis Symptom, CFB to Cycle 49 Day 1, Worsened | 1 | 0 |
| Hemoptysis Symptom, CFB to Cycle 51 Day 1, Improved | 0 | 0 |
| Hemoptysis Symptom, CFB to Cycle 51 Day 1, Stable | 6 | 13 |
| Hemoptysis Symptom, CFB to Cycle 51 Day 1, Worsened | 0 | 0 |
| Hemoptysis Symptom, CFB to Cycle 53 Day 1, Improved | 0 | 0 |
| Hemoptysis Symptom, CFB to Cycle 53 Day 1, Stable | 4 | 7 |
| Hemoptysis Symptom, CFB to Cycle 53 Day 1, Worsened | 0 | 0 |
| Hemoptysis Symptom, CFB to Cycle 55 Day 1, Improved | 0 | 0 |
| Hemoptysis Symptom, CFB to Cycle 55 Day 1, Stable | 5 | 6 |
| Hemoptysis Symptom, CFB to Cycle 55 Day 1, Worsened | 0 | 0 |
| Hemoptysis Symptom, CFB to 57 Day 1, Improved | 0 | 0 |
| Hemoptysis Symptom, CFB to Cycle 57 Day 1, Stable | 5 | 4 |
| Hemoptysis Symptom, CFB to Cycle 57 Day 1, Worsened | 0 | 0 |
| Hemoptysis Symptom, CFB to Cycle 59 Day 1, Improved | 0 | 0 |
| Hemoptysis Symptom, CFB to Cycle 59 Day 1, Stable | 4 | 4 |
| Hemoptysis Symptom, CFB to Cycle 59 Day 1, Worsened | 0 | 0 |
| Hemoptysis Symptom, CFB to Cycle 61 Day 1, Improved | 0 | 0 |
| Hemoptysis Symptom, CFB to Cycle 61 Day 1, Stable | 3 | 4 |
| Hemoptysis Symptom, CFB to Cycle 61 Day 1, Worsened | 0 | 0 |
| Hemoptysis Symptom, CFB to Cycle 63 Day 1, Improved | 0 | 0 |
| Hemoptysis Symptom, CFB to Cycle 63 Day 1, Stable | 2 | 1 |
| Hemoptysis Symptom, CFB to Cycle 63 Day 1, Worsened | 0 | 0 |
| Hemoptysis Symptom, CFB to Cycle 65 Day 1, Improved | 0 | — |
| Hemoptysis Symptom, CFB to Cycle 65 Day 1, Stable | 1 | — |
| Hemoptysis Symptom, CFB to Cycle 65 Day 1, Worsened | 0 | — |
| Hemoptysis Symptom, CFB to Cycle 67 Day 1, Improved | 0 | — |
| Hemoptysis Symptom, CFB to Cycle 67 Day 1, Stable | 1 | — |
| Hemoptysis Symptom, CFB to Cycle 67 Day 1, Worsened | 0 | — |
| Hemoptysis Symptom, CFB to End of Treatment, Improved | 4 | 7 |
| Hemoptysis Symptom, CFB to End of Treatment, Stable | 148 | 138 |
| Hemoptysis Symptom, CFB to End of Treatment, Worsened | 15 | 11 |
| Hemoptysis Symptom, CFB to Safety Follow-up 1, Improved | 2 | 3 |
| Hemoptysis Symptom, CFB to Safety Follow-up 1, Stable | 86 | 90 |
| Hemoptysis Symptom, CFB to Safety Follow-up 1, Worsened | 5 | 3 |
| Hemoptysis Symptom, CFB to Safety Follow-up 2, Improved | 1 | 4 |
| Hemoptysis Symptom, CFB to Safety Follow-up 2, Stable | 79 | 86 |
| Hemoptysis Symptom, CFB to Safety Follow-up 2, Worsened | 2 | 2 |
| Sore Mouth Symptom, CFB to Cycle 2 Day 1, Improved | 22 | 17 |
| Sore Mouth Symptom, CFB to Cycle 2 Day 1, Stable | 156 | 183 |
| Sore Mouth Symptom, CFB to Cycle 2 Day 1, Worsened | 19 | 15 |
| Sore Mouth Symptom, CFB to Cycle 3 Day 1, Improved | 23 | 16 |
| Sore Mouth Symptom, CFB to Cycle 3 Day 1, Stable | 134 | 158 |
| Sore Mouth Symptom, Cycle 3 Day 1, Worsened | 25 | 14 |
| Sore Mouth Symptom, CFB to Cycle 4 Day 1, Improved | 19 | 16 |
| Sore Mouth Symptom, CFB to Cycle 4 Day 1, Stable | 113 | 131 |
| Sore Mouth Symptom, CFB to Cycle 4 Day 1, Worsened | 20 | 10 |
| Sore Mouth Symptom, Cycle 5 Day 1, Improved | 20 | 15 |
| Sore Mouth Symptom, CFB to Cycle 5 Day 1, Stable | 115 | 126 |
| Sore Mouth Symptom, CFB to Cycle 5 Day 1, Worsened | 15 | 7 |
| Sore Mouth Symptom, CFB to Cycle 7 Day 1, Improved | 15 | 12 |
| Sore Mouth Symptom, CFB to Cycle 7 Day 1, Stable | 104 | 99 |
| Sore Mouth Symptom, CFB to Cycle 7 Day 1, Worsened | 8 | 13 |
| Sore Mouth Symptom, CFB to Cycle 9 Day 1, Improved | 13 | 10 |
| Sore Mouth Symptom, CFB to Cycle 9 Day 1, Stable | 90 | 91 |
| Sore Mouth Symptom, CFB to Cycle 9 Day 1, Worsened | 7 | 5 |
| Sore Mouth Symptom, CFB to Cycle 11 Day 1, Improved | 7 | 8 |
| Sore Mouth Symptom, CFB to Cycle 11 Day 1, Stable | 79 | 78 |
| Sore Mouth Symptom, CFB to Cycle 11 Day 1, Worsened | 6 | 6 |
| Sore Mouth Symptom, CFB to Cycle 13 Day 1, Improved | 7 | 6 |
| Sore Mouth Symptom, Cycle 13 Day 1, Stable | 71 | 64 |
| Sore Mouth Symptom, CFB to Cycle 13 Day 1, Worsened | 7 | 8 |
| Sore Mouth Symptom, CFB to Cycle 15 Day 1, Improved | 8 | 7 |
| Sore Mouth Symptom, CFB to Cycle 15 Day 1, Stable | 63 | 64 |
| Sore Mouth Symptom, CFB to Cycle 15 Day 1, Worsened | 6 | 4 |
| Sore Mouth Symptom, CFB to Cycle 17 Day 1, Improved | 7 | 6 |
| Sore Mouth Symptom, CFB to Cycle 17 Day 1, Stable | 56 | 60 |
| Sore Mouth Symptom, CFB to Cycle 17 Day 1, Worsened | 3 | 4 |
| Sore Mouth Symptom, CFB to Cycle 19 Day 1, Improved | 6 | 6 |
| Sore Mouth Symptom, CFB to Cycle 19 Day 1, Stable | 51 | 49 |
| Sore Mouth Symptom, CFB to Cycle 19 Day 1, Worsened | 7 | 8 |
| Sore Mouth Symptom, CFB to Cycle 21 Day 1, Improved | 6 | 7 |
| Sore Mouth Symptom, CFB to Cycle 21 Day 1, Stable | 48 | 50 |
| Sore Mouth Symptom, CFB to Cycle 21 Day 1, Worsened | 5 | 7 |
| Sore Mouth Symptom, CFB to Cycle 23 Day 1, Improved | 7 | 4 |
| Sore Mouth Symptom, CFB to Cycle 23 Day 1, Stable | 39 | 48 |
| Sore Mouth Symptom, CFB to Cycle 23 Day 1, Worsened | 6 | 7 |
| Sore Mouth Symptom, CFB to Cycle 25 Day 1, Improved | 5 | 5 |
| Sore Mouth Symptom, CFB to Cycle 25 Day 1, Stable | 38 | 42 |
| Sore Mouth Symptom, CFB to Cycle 25 Day 1, Worsened | 6 | 5 |
| Sore Mouth Symptom, CFB to Cycle 27 Day 1, Improved | 4 | 7 |
| Sore Mouth Symptom, CFB to Cycle 27 Day 1, Stable | 38 | 43 |
| Sore Mouth Symptom, CFB to Cycle 27 Day 1, Worsened | 4 | 3 |
| Sore Mouth Symptom, CFB to Cycle 29 Day 1, Improved | 4 | 6 |
| Sore Mouth Symptom, CFB to Cycle 29 Day 1, Stable | 35 | 38 |
| Sore Mouth Symptom, CFB to Cycle 29 Day 1, Worsened | 5 | 3 |
| Sore Mouth Symptom, CFB to Cycle 31 Day 1, Improved | 4 | 5 |
| Sore Mouth Symptom, CFB to Cycle 31 Day 1, Stable | 28 | 31 |
| Sore Mouth Symptom, CFB to Cycle 31 Day 1, Worsened | 5 | 2 |
| Sore Mouth Symptom, CFB to Cycle 33 Day 1, Improved | 3 | 5 |
| Sore Mouth Symptom, CFB to Cycle 33 Day 1, Stable | 22 | 29 |
| Sore Mouth Symptom, CFB to Cycle 33 Day 1, Worsened | 5 | 5 |
| Sore Mouth Symptom, CFB to Cycle 35 Day 1, Improved | 2 | 4 |
| Sore Mouth Symptom, CFB to Cycle 35 Day 1, Stable | 21 | 25 |
| Sore Mouth Symptom, CFB to Cycle 35 Day 1, Worsened | 5 | 3 |
| Sore Mouth Symptom, CFB to Cycle 37 Day 1, Improved | 2 | 5 |
| Sore Mouth Symptom, CFB to Cycle 37 Day 1, Stable | 19 | 26 |
| Sore Mouth Symptom, CFB to Cycle 37 Day 1, Worsened | 3 | 1 |
| Sore Mouth Symptom, CFB to Cycle 39 Day 1, Improved | 2 | 5 |
| Sore Mouth Symptom, CFB to Cycle 39 Day 1, Stable | 19 | 24 |
| Sore Mouth Symptom, CFB to Cycle 39 Day 1, Worsened | 3 | 3 |
| Sore Mouth Symptom, CFB to Cycle 41 Day 1, Improved | 3 | 6 |
| Sore Mouth Symptom, CFB to Cycle 41 Day 1, Stable | 12 | 20 |
| Sore Mouth Symptom, CFB to Cycle 41 Day 1, Worsened | 5 | 3 |
| Sore Mouth Symptom, CFB to Cycle 43 Day 1, Improved | 3 | 5 |
| Sore Mouth Symptom, CFB to Cycle 43 Day 1, Stable | 15 | 18 |
| Sore Mouth Symptom, CFB to Cycle 43 Day 1, Worsened | 1 | 5 |
| Sore Mouth Symptom, CFB to Cycle 45 Day 1, Improved | 2 | 5 |
| Sore Mouth Symptom, CFB to Cycle 45 Day 1, Stable | 10 | 16 |
| Sore Mouth Symptom, CFB to Cycle 45 Day 1, Worsened | 3 | 2 |
| Sore Mouth Symptom, CFB to Cycle 47 Day 1, Improved | 1 | 4 |
| Sore Mouth Symptom, CFB to Cycle 47 Day 1, Stable | 7 | 12 |
| Sore Mouth Symptom, CFB to Cycle 47 Day 1, Worsened | 2 | 2 |
| Sore Mouth Symptom, CFB to Cycle 49 Day 1, Improved | 0 | 4 |
| Sore Mouth Symptom, CFB to Cycle 49 Day 1, Stable | 8 | 10 |
| Sore Mouth Symptom, CFB to Cycle 49 Day 1, Worsened | 2 | 1 |
| Sore Mouth Symptom, CFB to Cycle 51 Day 1, Improved | 0 | 3 |
| Sore Mouth Symptom, CFB to Cycle 51 Day 1, Stable | 4 | 9 |
| Sore Mouth Symptom, CFB to Cycle 51 Day 1, Worsened | 2 | 1 |
| Sore Mouth Symptom, CFB to Cycle 53 Day 1, Improved | 0 | 1 |
| Sore Mouth Symptom, CFB to Cycle 53 Day 1, Stable | 3 | 4 |
| Sore Mouth Symptom, CFB to Cycle 53 Day 1, Worsened | 2 | 1 |
| Sore Mouth Symptom, CFB to Cycle 55 Day 1, Improved | 0 | 1 |
| Sore Mouth Symptom, CFB to Cycle 55 Day 1, Stable | 4 | 5 |
| Sore Mouth Symptom, CFB to Cycle 55 Day 1, Worsened | 1 | 0 |
| Sore Mouth Symptom, CFB to Cycle 57 Day 1, Improved | 0 | 0 |
| Sore Mouth Symptom, CFB to Cycle 57 Day 1, Stable | 3 | 4 |
| Sore Mouth Symptom, CFB to Cycle 57 Day 1, Worsened | 2 | 0 |
| Sore Mouth Symptom, CFB to Cycle 59 Day 1, Improved | 0 | 0 |
| Sore Mouth Symptom, CFB to Cycle 59 Day 1, Stable | 3 | 4 |
| Sore Mouth Symptom, CFB to Cycle 59 Day 1, Worsened | 1 | 0 |
| Sore Mouth Symptom, CFB to Cycle 61 Day 1, Improved | 0 | 0 |
| Sore Mouth Symptom, CFB to Cycle 61 Day 1, Stable | 2 | 3 |
| Sore Mouth Symptom, CFB to Cycle 61 Day 1, Worsened | 1 | 1 |
| Sore Mouth Symptom, CFB to Cycle 63 Day 1, Improved | 0 | 0 |
| Sore Mouth Symptom, CFB to Cycle 63 Day 1, Stable | 1 | 1 |
| Sore Mouth Symptom, CFB to Cycle 63 Day 1, Worsened | 1 | 0 |
| Sore Mouth Symptom, CFB to Cycle 65 Day 1, Improved | 0 | — |
| Sore Mouth Symptom, CFB to Cycle 65 Day 1, Stable | 1 | — |
| Sore Mouth Symptom, CFB to Cycle 65 Day 1, Worsened | 0 | — |
| Sore Mouth Symptom, CFB to Cycle 67 Day 1, Improved | 0 | — |
| Sore Mouth Symptom, CFB to Cycle 67 Day 1, Stable | 0 | — |
| Sore Mouth Symptom, CFB to Cycle 67 Day 1, Worsened | 1 | — |
| Sore Mouth Symptom, CFB to End of Treatment, Improved | 19 | 15 |
| Sore Mouth Symptom, CFB to End of Treatment, Stable | 126 | 128 |
| Sore Mouth Symptom, CFB to End of Treatment, Worsened | 21 | 12 |
| Sore Mouth Symptom, CFB to Safety Follow-up 1, Improved | 13 | 9 |
| Sore Mouth Symptom, CFB to Safety Follow-up 1, Stable | 67 | 74 |
| Sore Mouth Symptom, CFB to Safety Follow-up 1, Worsened | 11 | 14 |
| Sore Mouth Symptom, CFB to Safety Follow-up 2, Improved | 6 | 6 |
| Sore Mouth Symptom, CFB to Safety Follow-up 2, Stable | 59 | 72 |
| Sore Mouth Symptom, CFB to Safety Follow-up 2, Worsened | 15 | 13 |
| Dysphagia Symptom, CFB to Cycle 2 Day 1, Improved | 20 | 14 |
| Dysphagia Symptom, CFB to Cycle 2 Day 1, Stable | 158 | 184 |
| Dysphagia Symptom, CFB to Cycle 2 Day 1, Worsened | 21 | 12 |
| Dysphagia Symptom, CFB to Cycle 3 Day 1, Improved | 19 | 11 |
| Dysphagia Symptom, CFB to Cycle 3 Day 1, Stable | 148 | 164 |
| Dysphagia Symptom, CFB to Cycle 3 Day 1, Worsened | 21 | 10 |
| Dysphagia Symptom, CFB to Cycle 4 Day 1, Improved | 16 | 12 |
| Dysphagia Symptom, CFB to 4 Day 1, Stable | 124 | 131 |
| Dysphagia Symptom, CFB to Cycle 4 Day 1, Worsened | 19 | 15 |
| Dysphagia Symptom, CFB to Cycle 5 Day 1, Improved | 16 | 9 |
| Dysphagia Symptom, CFB to Cycle 5 Day 1, Stable | 120 | 123 |
| Dysphagia Symptom, CFB to Cycle 5 Day 1, Worsened | 15 | 13 |
| Dysphagia Symptom, CFB to Cycle 7 Day 1, Improved | 11 | 7 |
| Dysphagia Symptom, CFB to Cycle 7 Day 1, Stable | 109 | 99 |
| Dysphagia Symptom, CFB to Cycle 7 Day 1, Worsened | 10 | 13 |
| Dysphagia Symptom, CFB to Cycle 9 Day 1, Improved | 10 | 8 |
| Dysphagia Symptom, CFB to Cycle 9 Day 1, Stable | 96 | 88 |
| Dysphagia Symptom, CFB to Cycle 9 Day 1, Worsened | 8 | 9 |
| Dysphagia Symptom, CFB to Cycle 11 Day 1, Improved | 10 | 7 |
| Dysphagia Symptom, CFB to Cycle 11 Day 1, Stable | 73 | 73 |
| Dysphagia Symptom, CFB to Cycle 11 Day 1, Worsened | 13 | 9 |
| Dysphagia Symptom, CFB to Cycle 13 Day 1, Improved | 9 | 5 |
| Dysphagia Symptom, CFB to Cycle 13 Day 1, Stable | 70 | 62 |
| Dysphagia Symptom, CFB to Cycle 13 Day 1, Worsened | 7 | 8 |
| Dysphagia Symptom, CFB to Cycle 15 Day 1, Improved | 7 | 6 |
| Dysphagia Symptom, CFB to Cycle 15 Day 1, Stable | 64 | 59 |
| Dysphagia Symptom, CFB to Cycle 15 Day 1, Worsened | 6 | 8 |
| Dysphagia Symptom, CFB to Cycle 17 Day 1, Improved | 7 | 5 |
| Dysphagia Symptom, CFB to Cycle 17 Day 1, Stable | 55 | 55 |
| Dysphagia Symptom, CFB to Cycle 17 Day 1, Worsened | 6 | 7 |
| Dysphagia Symptom, CFB to Cycle 19 Day 1, Improved | 9 | 5 |
| Dysphagia Symptom, CFB to Cycle 19 Day 1, Stable | 57 | 47 |
| Dysphagia Symptom, CFB to Cycle 19 Day 1, Worsened | 1 | 8 |
| Dysphagia Symptom, CFB to Cycle 21 Day 1, Improved | 6 | 4 |
| Dysphagia Symptom, CFB to Cycle 21 Day 1, Stable | 54 | 49 |
| Dysphagia Symptom, CFB to Cycle 21 Day 1, Worsened | 1 | 8 |
| Dysphagia Symptom, CFB to Cycle 23 Day 1, Improved | 4 | 2 |
| Dysphagia Symptom, CFB to Cycle 23 Day 1, Stable | 47 | 48 |
| Dysphagia Symptom, CFB to Cycle 23 Day 1, Worsened | 3 | 8 |
| Dysphagia Symptom, CFB to Cycle 25 Day 1, Improved | 6 | 4 |
| Dysphagia Symptom, CFB to Cycle 25 Day 1, Stable | 42 | 43 |
| Dysphagia Symptom, CFB to Cycle 25 Day 1, Worsened | 2 | 5 |
| Dysphagia Symptom, CFB to Cycle 27 Day 1, Improved | 5 | 3 |
| Dysphagia Symptom, CFB to Cycle 27 Day 1, Stable | 38 | 40 |
| Dysphagia Symptom, CFB to Cycle 27 Day 1, Worsened | 4 | 8 |
| Dysphagia Symptom, CFB to Cycle 29 Day 1, Improved | 4 | 3 |
| Dysphagia Symptom, CFB to Cycle 29 Day 1, Stable | 38 | 39 |
| Dysphagia Symptom, CFB to Cycle 29 Day 1, Worsened | 3 | 3 |
| Dysphagia Symptom, CFB to Cycle 31 Day 1, Improved | 6 | 3 |
| Dysphagia Symptom, CFB to Cycle 31 Day 1, Stable | 29 | 28 |
| Dysphagia Symptom, CFB to Cycle 31 Day 1, Worsened | 2 | 5 |
| Dysphagia Symptom, CFB to Cycle 33 Day 1, Improved | 2 | 2 |
| Dysphagia Symptom, CFB to Cycle 33 Day 1, Stable | 29 | 30 |
| Dysphagia Symptom, CFB to Cycle 33 Day 1, Worsened | 0 | 5 |
| Dysphagia Symptom, CFB to Cycle 35 Day 1, Improved | 2 | 2 |
| Dysphagia Symptom, CFB to Cycle 35 Day 1, Stable | 26 | 24 |
| Dysphagia Symptom, CFB to Cycle 35 Day 1, Worsened | 1 | 5 |
| Dysphagia Symptom, CFB to Cycle 37 Day 1, Improved | 3 | 4 |
| Dysphagia Symptom, CFB to Cycle 37 Day 1, Stable | 19 | 22 |
| Dysphagia Symptom, CFB to Cycle 37 Day 1, Worsened | 3 | 3 |
| Dysphagia Symptom, CFB to Cycle 39 Day 1, Improved | 4 | 3 |
| Dysphagia Symptom, CFB to Cycle 39 Day 1, Stable | 20 | 23 |
| Dysphagia Symptom, CFB to Cycle 39 Day 1, Worsened | 0 | 4 |
| Dysphagia Symptom, CFB to Cycle 41 Day 1, Improved | 4 | 2 |
| Dysphagia Symptom, CFB to Cycle 41 Day 1, Stable | 16 | 21 |
| Dysphagia Symptom, CFB to Cycle 41 Day 1, Worsened | 0 | 4 |
| Dysphagia Symptom, CFB to Cycle 43 Day 1, Improved | 2 | 3 |
| Dysphagia Symptom, CFB to Cycle 43 Day 1, Stable | 17 | 19 |
| Dysphagia Symptom, CFB to Cycle 43 Day 1, Worsened | 0 | 4 |
| Dysphagia Symptom, CFB to Cycle 45 Day 1, Improved | 4 | 2 |
| Dysphagia Symptom, CFB to Cycle 45 Day 1, Stable | 11 | 16 |
| Dysphagia Symptom, CFB to Cycle 45 Day 1, Worsened | 0 | 3 |
| Dysphagia Symptom, CFB to Cycle 47 Day 1, Improved | 2 | 1 |
| Dysphagia Symptom, CFB to Cycle 47 Day 1, Stable | 8 | 13 |
| Dysphagia Symptom, CFB to Cycle 47 Day 1, Worsened | 0 | 3 |
| Dysphagia Symptom, CFB to Cycle 49 Day 1, Improved | 1 | 1 |
| Dysphagia Symptom, CFB to Cycle 49 Day 1, Stable | 9 | 11 |
| Dysphagia Symptom, CFB to Cycle 49 Day 1, Worsened | 0 | 1 |
| Dysphagia Symptom, CFB to Cycle 51 Day 1, Improved | 2 | 2 |
| Dysphagia Symptom, CFB to Cycle 51 Day 1, Stable | 3 | 8 |
| Dysphagia Symptom, CFB to Cycle 51 Day 1, Worsened | 1 | 1 |
| Dysphagia Symptom, CFB to Cycle 53 Day 1, Improved | 1 | 1 |
| Dysphagia Symptom, CFB to Cycle 53 Day 1, Stable | 3 | 4 |
| Dysphagia Symptom, CFB to Cycle 53 Day 1, Worsened | 1 | 1 |
| Dysphagia Symptom, CFB to Cycle 55 Day 1, Improved | 1 | 0 |
| Dysphagia Symptom, CFB to Cycle 55 Day 1, Stable | 4 | 4 |
| Dysphagia Symptom, CFB to Cycle 55 Day 1, Worsened | 0 | 1 |
| Dysphagia Symptom, CFB to Cycle 57 Day 1, Improved | 1 | 0 |
| Dysphagia Symptom, CFB to Cycle 57 Day 1, Stable | 4 | 2 |
| Dysphagia Symptom, CFB to Cycle 57 Day 1, Worsened | 0 | 1 |
| Dysphagia Symptom, CFB to Cycle 59 Day 1, Improved | 1 | 0 |
| Dysphagia Symptom, CFB to Cycle 59 Day 1, Stable | 2 | 3 |
| Dysphagia Symptom, CFB to Cycle 59 Day 1, Worsened | 1 | 0 |
| Dysphagia Symptom, CFB to Cycle 61 Day 1, Improved | 1 | 0 |
| Dysphagia Symptom, CFB to Cycle 61 Day 1, Stable | 2 | 2 |
| Dysphagia Symptom, Cycle 61 Day 1, Worsened | 0 | 0 |
| Dysphagia Symptom, CFB to Cycle 63 Day 1, Improved | 0 | 0 |
| Dysphagia Symptom, CFB to Cycle 63 Day 1, Stable | 2 | 1 |
| Dysphagia Symptom, CFB to Cycle 63 Day 1, Worsened | 0 | 0 |
| Dysphagia Symptom, CFB to Cycle 65 Day 1, Improved | 0 | — |
| Dysphagia Symptom, CFB to Cycle 65 Day 1, Stable | 1 | — |
| Dysphagia Symptom, CFB to Cycle 65 Day 1, Worsened | 0 | — |
| Dysphagia Symptom, CFB to Cycle 67 Day 1, Improved | 0 | — |
| Dysphagia Symptom, CFB to Cycle 67 Day 1, Stable | 1 | — |
| Dysphagia Symptom, CFB to Cycle 67 Day 1, Worsened | 0 | — |
| Dysphagia Symptom, CFB to End of Treatment, Improved | 15 | 10 |
| Dysphagia Symptom, CFB to End of Treatment, Stable | 126 | 125 |
| Dysphagia Symptom, CFB to End of Treatment, Worsened | 28 | 19 |
| Dysphagia Symptom, CFB to Safety Follow-up 1, Improved | 11 | 5 |
| Dysphagia Symptom, CFB to Safety Follow-up 1, Stable | 67 | 75 |
| Dysphagia Symptom, CFB to Safety Follow-up 1, Worsened | 16 | 15 |
| Dysphagia Symptom, CFB to Safety Follow-up 2, Improved | 8 | 7 |
| Dysphagia Symptom, CFB to Safety Follow-up 2, Stable | 67 | 72 |
| Dysphagia Symptom, CFB to Safety Follow-up 2, Worsened | 10 | 12 |
| Peripheral Neuropathy Symptom, CFB to Cycle 2 Day 1, Improved | 31 | 36 |
| Peripheral Neuropathy Symptom, CFB to Cycle 2 Day 1, Stable | 139 | 142 |
| Peripheral Neuropathy Symptom, CFB to Cycle 2 Day 1, Worsened | 28 | 33 |
| Peripheral Neuropathy Symptom, CFB to Cycle 3 Day 1, Improved | 39 | 27 |
| Peripheral Neuropathy Symptom, CFB to Cycle 3 Day 1, Stable | 115 | 131 |
| Peripheral Neuropathy Symptom, CFB to Cycle 3 Day 1, Worsened | 33 | 28 |
| Peripheral Neuropathy Symptom, CFB to Cycle 4 Day 1, Improved | 28 | 27 |
| Peripheral Neuropathy Symptom, CFB to Cycle 4 Day 1, Stable | 106 | 103 |
| Peripheral Neuropathy Symptom, CFB to Cycle 4 Day 1, Worsened | 23 | 27 |
| Peripheral Neuropathy Symptom, CFB to Cycle 5 Day 1, Improved | 31 | 25 |
| Peripheral Neuropathy Symptom, CFB to Cycle 5 Day 1, Stable | 101 | 94 |
| Peripheral Neuropathy Symptom, CFB to Cycle 5 Day 1, Worsened | 19 | 27 |
| Peripheral Neuropathy Symptom, CFB to Cycle 7 Day 1, Improved | 36 | 22 |
| Peripheral Neuropathy Symptom, CFB to Cycle 7 Day 1, Stable | 75 | 79 |
| Peripheral Neuropathy Symptom, CFB to Cycle 7 Day 1, Worsened | 18 | 18 |
| Peripheral Neuropathy Symptom, CFB to Cycle 9 Day 1, Improved | 30 | 19 |
| Peripheral Neuropathy Symptom, CFB to Cycle 9 Day 1, Stable | 69 | 73 |
| Peripheral Neuropathy Symptom, CFB to Cycle 9 Day 1, Worsened | 14 | 13 |
| Peripheral Neuropathy Symptom, CFB to Cycle 11 Day 1, Improved | 27 | 13 |
| Peripheral Neuropathy Symptom, CFB to Cycle 11 Day 1, Stable | 55 | 62 |
| Peripheral Neuropathy Symptom, CFB to Cycle 11 Day 1, Worsened | 13 | 14 |
| Peripheral Neuropathy Symptom, CFB to Cycle 13 Day 1, Improved | 23 | 11 |
| Peripheral Neuropathy Symptom, CFB to Cycle 13 Day 1, Stable | 51 | 52 |
| Peripheral Neuropathy Symptom, CFB to Cycle 13 Day 1, Worsened | 10 | 11 |
| Peripheral Neuropathy Symptom, CFB to Cycle 15 Day 1, Improved | 25 | 14 |
| Peripheral Neuropathy Symptom, CFB to Cycle 15 Day 1, Stable | 44 | 47 |
| Peripheral Neuropathy Symptom, CFB to Cycle 15 Day 1, Worsened | 7 | 12 |
| Peripheral Neuropathy Symptom, CFB to Cycle 17 Day 1, Improved | 17 | 10 |
| Peripheral Neuropathy Symptom, CFB to Cycle 17 Day 1, Stable | 40 | 49 |
| Peripheral Neuropathy Symptom, CFB to Cycle 17 Day 1, Worsened | 10 | 8 |
| Peripheral Neuropathy Symptom, CFB to Cycle 19 Day 1, Improved | 21 | 12 |
| Peripheral Neuropathy Symptom, CFB to Cycle 19 Day 1, Stable | 41 | 38 |
| Peripheral Neuropathy Symptom, CFB to Cycle 19 Day 1, Worsened | 4 | 10 |
| Peripheral Neuropathy Symptom, CFB to Cycle 21 Day 1, Improved | 20 | 13 |
| Peripheral Neuropathy Symptom, CFB to Cycle 21 Day 1, Stable | 34 | 39 |
| Peripheral Neuropathy Symptom, CFB to Cycle 21 Day 1, Worsened | 7 | 9 |
| Peripheral Neuropathy Symptom, CFB to Cycle 23 Day 1, Improved | 16 | 13 |
| Peripheral Neuropathy Symptom, CFB to Cycle 23 Day 1, Stable | 29 | 32 |
| Peripheral Neuropathy Symptom, CFB to Cycle 23 Day 1, Worsened | 9 | 13 |
| Peripheral Neuropathy Symptom, CFB to Cycle 25 Day 1, Improved | 15 | 15 |
| Peripheral Neuropathy Symptom, CFB to Cycle 25 Day 1, Stable | 27 | 29 |
| Peripheral Neuropathy Symptom, CFB to Cycle 25 Day 1, Worsened | 8 | 8 |
| Peripheral Neuropathy Symptom, CFB to Cycle 27 Day 1, Improved | 15 | 14 |
| Peripheral Neuropathy Symptom, CFB to Cycle 27 Day 1, Stable | 23 | 31 |
| Peripheral Neuropathy Symptom, CFB to Cycle 27 Day 1, Worsened | 8 | 6 |
| Peripheral Neuropathy Symptom, CFB to Cycle 29 Day 1, Improved | 12 | 12 |
| Peripheral Neuropathy Symptom, CFB to Cycle 29 Day 1, Stable | 26 | 28 |
| Peripheral Neuropathy Symptom, CFB to Cycle 29 Day 1, Worsened | 6 | 5 |
| Peripheral Neuropathy Symptom, CFB to Cycle 31 Day 1, Improved | 11 | 10 |
| Peripheral Neuropathy Symptom, CFB to Cycle 31 Day 1, Stable | 23 | 21 |
| Peripheral Neuropathy Symptom, CFB to Cycle 31 Day 1, Worsened | 4 | 5 |
| Peripheral Neuropathy Symptom, CFB to Cycle 33 Day 1, Improved | 8 | 10 |
| Peripheral Neuropathy Symptom, CFB to Cycle 33 Day 1, Stable | 15 | 21 |
| Peripheral Neuropathy Symptom, CFB to Cycle 33 Day 1, Worsened | 7 | 6 |
| Peripheral Neuropathy Symptom, CFB to Cycle 35 Day 1, Improved | 8 | 8 |
| Peripheral Neuropathy Symptom, CFB to Cycle 35 Day 1, Stable | 14 | 17 |
| Peripheral Neuropathy Symptom, CFB to Cycle 35 Day 1, Worsened | 6 | 6 |
| Peripheral Neuropathy Symptom, CFB to Cycle 37 Day 1, Improved | 8 | 9 |
| Peripheral Neuropathy Symptom, CFB to Cycle 37 Day 1, Stable | 11 | 17 |
| Peripheral Neuropathy Symptom, CFB to Cycle 37 Day 1, Worsened | 5 | 4 |
| Peripheral Neuropathy Symptom, CFB to Cycle 39 Day 1, Improved | 8 | 9 |
| Peripheral Neuropathy Symptom, CFB to Cycle 39 Day 1, Stable | 11 | 16 |
| Peripheral Neuropathy Symptom, CFB to Cycle 39 Day 1, Worsened | 5 | 5 |
| Peripheral Neuropathy Symptom, CFB to Cycle 41 Day 1, Improved | 10 | 9 |
| Peripheral Neuropathy Symptom, CFB to Cycle 41 Day 1, Stable | 7 | 15 |
| Peripheral Neuropathy Symptom, CFB to Cycle 41 Day 1, Worsened | 3 | 3 |
| Peripheral Neuropathy Symptom, CFB to Cycle 43 Day 1, Improved | 9 | 6 |
| Peripheral Neuropathy Symptom, CFB to Cycle 43 Day 1, Stable | 8 | 17 |
| Peripheral Neuropathy Symptom, CFB to Cycle 43 Day 1, Worsened | 2 | 3 |
| Peripheral Neuropathy Symptom, CFB to Cycle 45 Day 1, Improved | 7 | 8 |
| Peripheral Neuropathy Symptom, CFB to Cycle 45 Day 1, Stable | 7 | 10 |
| Peripheral Neuropathy Symptom, CFB to Cycle 45 Day 1, Worsened | 1 | 3 |
| Peripheral Neuropathy Symptom, CFB to Cycle 47 Day 1, Improved | 5 | 5 |
| Peripheral Neuropathy Symptom, CFB to Cycle 47 Day 1, Stable | 5 | 11 |
| Peripheral Neuropathy Symptom, CFB to Cycle 47 Day 1, Worsened | 0 | 1 |
| Peripheral Neuropathy Symptom, CFB to Cycle 49 Day 1, Improved | 4 | 5 |
| Peripheral Neuropathy Symptom, CFB to Cycle 49 Day 1, Stable | 6 | 6 |
| Peripheral Neuropathy Symptom, CFB to Cycle 49 Day 1, Worsened | 0 | 2 |
| Peripheral Neuropathy Symptom, CFB to Cycle 51 Day 1, Improved | 3 | 3 |
| Peripheral Neuropathy Symptom, CFB to Cycle 51 Day 1, Stable | 2 | 6 |
| Peripheral Neuropathy Symptom, CFB to Cycle 51 Day 1, Worsened | 0 | 2 |
| Peripheral Neuropathy Symptom, CFB to Cycle 53 Day 1, Improved | 2 | 1 |
| Peripheral Neuropathy Symptom, CFB to Cycle 53 Day 1, Stable | 3 | 4 |
| Peripheral Neuropathy Symptom, CFB to Cycle 53 Day 1, Worsened | 0 | 1 |
| Peripheral Neuropathy Symptom, CFB to Cycle 55 Day 1, Improved | 2 | 2 |
| Peripheral Neuropathy Symptom, CFB to Cycle 55 Day 1, Stable | 2 | 1 |
| Peripheral Neuropathy Symptom, CFB to Cycle 55 Day 1, Worsened | 1 | 2 |
| Peripheral Neuropathy Symptom, Cycle 57 Day 1, Improved | 1 | 1 |
| Peripheral Neuropathy Symptom, CFB to Cycle 57 Day 1, Stable | 4 | 1 |
| Peripheral Neuropathy Symptom, CFB to Cycle 57 Day 1, Worsened | 0 | 1 |
| Peripheral Neuropathy Symptom, CFB to Cycle 59 Day 1, Improved | 1 | 1 |
| Peripheral Neuropathy Symptom, CFB to Cycle 59 Day 1, Stable | 3 | 1 |
| Peripheral Neuropathy Symptom, CFB to Cycle 59 Day 1, Worsened | 0 | 1 |
| Peripheral Neuropathy Symptom, CFB to Cycle 61 Day 1, Improved | 3 | 0 |
| Peripheral Neuropathy Symptom, CFB to Cycle 61 Day 1, Stable | 0 | 1 |
| Peripheral Neuropathy Symptom, CFB to Cycle 61 Day 1, Worsened | 0 | 1 |
| Peripheral Neuropathy Symptom, CFB to Cycle 63 Day 1, Improved | 1 | 0 |
| Peripheral Neuropathy Symptom, CFB to Cycle 63 Day 1, Stable | 0 | 0 |
| Peripheral Neuropathy Symptom, CFB to Cycle 63 Day 1, Worsened | 1 | 1 |
| Peripheral Neuropathy Symptom, CFB to Cycle 65 Day 1, Improved | 0 | — |
| Peripheral Neuropathy Symptom, CFB to Cycle 65 Day 1, Stable | 1 | — |
| Peripheral Neuropathy Symptom, CFB to Cycle 65 Day 1, Worsened | 0 | — |
| Peripheral Neuropathy Symptom, CFB to Cycle 67 Day 1, Improved | 0 | — |
| Peripheral Neuropathy Symptom, CFB to Cycle 67 Day 1, Stable | 1 | — |
| Peripheral Neuropathy Symptom, CFB to Cycle 67 Day 1, Worsened | 0 | — |
| Peripheral Neuropathy Symptom, CFB to End of Treatment, Improved | 36 | 33 |
| Peripheral Neuropathy Symptom, CFB to End of Treatment, Stable | 94 | 98 |
| Peripheral Neuropathy Symptom, CFB to End of Treatment, Worsened | 38 | 22 |
| Peripheral Neuropathy Symptom, CFB to Safety Follow-up 1, Improved | 27 | 20 |
| Peripheral Neuropathy Symptom, CFB to Safety Follow-up 1, Stable | 48 | 61 |
| Peripheral Neuropathy Symptom, CFB to Safety Follow-up 1, Worsened | 19 | 13 |
| Peripheral Neuropathy Symptom, CFB to Safety Follow-up 2, Improved | 21 | 21 |
| Peripheral Neuropathy Symptom, CFB to Safety Follow-up 2, Stable | 45 | 47 |
| Peripheral Neuropathy Symptom, CFB to Safety Follow-up 2, Worsened | 18 | 22 |
| Alopecia Symptom, CFB to Cycle 2 Day 1, Improved | 48 | 52 |
| Alopecia Symptom, CFB to Cycle 2 Day 1, Stable | 134 | 139 |
| Alopecia Symptom, CFB to Cycle 2 Day 1, Worsened | 17 | 19 |
| Alopecia Symptom, CFB to Cycle 3 Day 1, Improved | 58 | 56 |
| Alopecia Symptom, CFB to Cycle 3 Day 1, Stable | 117 | 117 |
| Alopecia Symptom, CFB to Cycle 3 Day 1, Worsened | 12 | 13 |
| Alopecia Symptom, CFB to Cycle 4 Day 1, Improved | 44 | 51 |
| Alopecia Symptom, CFB to Cycle 4 Day 1, Stable | 104 | 95 |
| Alopecia Symptom, CFB to Cycle 4 Day 1, Worsened | 9 | 10 |
| Alopecia Symptom, CFB to Cycle 5 Day 1, Improved | 45 | 53 |
| Alopecia Symptom, CFB to Cycle 5 Day 1, Stable | 100 | 86 |
| Alopecia Symptom, CFB to Cycle 5 Day 1, Worsened | 6 | 6 |
| Alopecia Symptom, CFB to Cycle 7 Day 1, Improved | 44 | 48 |
| Alopecia Symptom, CFB to Cycle 7 Day 1, Stable | 81 | 66 |
| Alopecia Symptom, CFB to Cycle 7 Day 1, Worsened | 5 | 5 |
| Alopecia Symptom, CFB to Cycle 9 Day 1, Improved | 40 | 40 |
| Alopecia Symptom, CFB to Cycle 9 Day 1, Stable | 68 | 62 |
| Alopecia Symptom, CFB to Cycle 9 Day 1, Worsened | 5 | 3 |
| Alopecia Symptom, CFB to Cycle 11 Day 1, Improved | 37 | 32 |
| Alopecia Symptom, CFB to Cycle 11 Day 1, Stable | 55 | 54 |
| Alopecia Symptom, CFB to Cycle 11 Day 1, Worsened | 3 | 3 |
| Alopecia Symptom, CFB to Cycle 13 Day 1, Improved | 31 | 23 |
| Alopecia Symptom, CFB to Cycle 13 Day 1, Stable | 51 | 48 |
| Alopecia Symptom, CFB to Cycle 13 Day 1, Worsened | 2 | 3 |
| Alopecia Symptom, CFB to Cycle 15 Day 1, Improved | 30 | 26 |
| Alopecia Symptom, CFB to Cycle 15 Day 1, Stable | 45 | 44 |
| Alopecia Symptom, CFB to Cycle 15 Day 1, Worsened | 1 | 3 |
| Alopecia Symptom, CFB to Cycle 17 Day 1, Improved | 27 | 25 |
| Alopecia Symptom, CFB to Cycle 17 Day 1, Stable | 39 | 39 |
| Alopecia Symptom, CFB to Cycle 17 Day 1, Worsened | 1 | 3 |
| Alopecia Symptom, CFB to Cycle 19 Day 1, Improved | 28 | 20 |
| Alopecia Symptom, CFB to Cycle 19 Day 1, Stable | 36 | 38 |
| Alopecia Symptom, CFB to Cycle 19 Day 1, Worsened | 1 | 2 |
| Alopecia Symptom, CFB to Cycle 21 Day 1, Improved | 26 | 22 |
| Alopecia Symptom, CFB to Cycle 21 Day 1, Stable | 33 | 37 |
| Alopecia Symptom, CFB to Cycle 21 Day 1, Worsened | 2 | 3 |
| Alopecia Symptom, CFB to Cycle 23 Day 1, Improved | 22 | 19 |
| Alopecia Symptom, CFB to Cycle 23 Day 1, Stable | 31 | 35 |
| Alopecia Symptom, CFB to Cycle 23 Day 1, Worsened | 1 | 4 |
| Alopecia Symptom, CFB to Cycle 25 Day 1, Improved | 19 | 17 |
| Alopecia Symptom, CFB to Cycle 25 Day 1, Stable | 30 | 35 |
| Alopecia Symptom, CFB to Cycle 25 Day 1, Worsened | 1 | 0 |
| Alopecia Symptom, CFB to Cycle 27 Day 1, Improved | 20 | 16 |
| Alopecia Symptom, CFB to Cycle 27 Day 1, Stable | 23 | 33 |
| Alopecia Symptom, CFB to Cycle 27 Day 1, Worsened | 3 | 2 |
| Alopecia Symptom, CFB to Cycle 29 Day 1, Improved | 20 | 14 |
| Alopecia Symptom, CFB to Cycle 29 Day 1, Stable | 23 | 31 |
| Alopecia Symptom, CFB to Cycle 29 Day 1, Worsened | 1 | 0 |
| Alopecia Symptom, CFB to Cycle 31 Day 1, Improved | 19 | 11 |
| Alopecia Symptom, CFB to Cycle 31 Day 1, Stable | 17 | 25 |
| Alopecia Symptom, CFB to Cycle 31 Day 1, Worsened | 2 | 0 |
| Alopecia Symptom, CFB to Cycle 33 Day 1, Improved | 13 | 12 |
| Alopecia Symptom, CFB to Cycle 33 Day 1, Stable | 16 | 24 |
| Alopecia Symptom, CFB to Cycle 33 Day 1, Worsened | 1 | 1 |
| Alopecia Symptom, CFB to Cycle 35 Day 1, Improved | 12 | 11 |
| Alopecia Symptom, CFB to Cycle 35 Day 1, Stable | 15 | 15 |
| Alopecia Symptom, CFB to Cycle 35 Day 1, Worsened | 1 | 4 |
| Alopecia Symptom, CFB to Cycle 37 Day 1, Improved | 12 | 10 |
| Alopecia Symptom, CFB to Cycle 37 Day 1, Stable | 12 | 19 |
| Alopecia Symptom, CFB to Cycle 37 Day 1, Worsened | 0 | 1 |
| Alopecia Symptom, CFB to Cycle 39 Day 1, Improved | 11 | 12 |
| Alopecia Symptom, CFB to Cycle 39 Day 1, Stable | 11 | 17 |
| Alopecia Symptom, CFB to Cycle 39 Day 1, Worsened | 1 | 1 |
| Alopecia Symptom, CFB to Cycle 41 Day 1, Improved | 12 | 9 |
| Alopecia Symptom, CFB to Cycle 41 Day 1, Stable | 8 | 17 |
| Alopecia Symptom, CFB to Cycle 41 Day 1, Worsened | 0 | 1 |
| Alopecia Symptom, CFB to Cycle 43 Day 1, Improved | 9 | 11 |
| Alopecia Symptom, CFB to Cycle 43 Day 1, Stable | 10 | 12 |
| Alopecia Symptom, CFB to Cycle 43 Day 1, Worsened | 0 | 3 |
| Alopecia Symptom, CFB to Cycle 45 Day 1, Improved | 6 | 10 |
| Alopecia Symptom, CFB to Cycle 45 Day 1, Stable | 8 | 10 |
| Alopecia Symptom, CFB to Cycle 45 Day 1, Worsened | 0 | 1 |
| Alopecia Symptom, CFB to Cycle 47 Day 1, Improved | 7 | 5 |
| Alopecia Symptom, CFB to Cycle 47 Day 1, Stable | 3 | 12 |
| Alopecia Symptom, CFB to Cycle 47 Day 1, Worsened | 0 | 0 |
| Alopecia Symptom, CFB to Cycle 49 Day 1, Improved | 5 | 5 |
| Alopecia Symptom, CFB to Cycle 49 Day 1, Stable | 4 | 8 |
| Alopecia Symptom, Cycle 49 Day 1, Worsened | 1 | 0 |
| Alopecia Symptom, CFB to Cycle 51 Day 1, Improved | 2 | 4 |
| Alopecia Symptom, CFB to Cycle 51 Day 1, Stable | 4 | 7 |
| Alopecia Symptom, CFB to Cycle 51 Day 1, Worsened | 0 | 0 |
| Alopecia Symptom, CFB to Cycle 53 Day 1, Improved | 3 | 4 |
| Alopecia Symptom, CFB to Cycle 53 Day 1, Stable | 2 | 2 |
| Alopecia Symptom, CFB to Cycle 53 Day 1, Worsened | 0 | 0 |
| Alopecia Symptom, CFB to Cycle 55 Day 1, Improved | 4 | 2 |
| Alopecia Symptom, CFB to Cycle 55 Day 1, Stable | 1 | 3 |
| Alopecia Symptom, CFB to Cycle 55 Day 1, Worsened | 0 | 0 |
| Alopecia Symptom, CFB to Cycle 57 Day 1, Improved | 4 | 2 |
| Alopecia Symptom, CFB to Cycle 57 Day 1, Stable | 1 | 1 |
| Alopecia Symptom, CFB to Cycle 57 Day 1, Worsened | 0 | 0 |
| Alopecia Symptom, CFB to Cycle 59 Day 1, Improved | 2 | 2 |
| Alopecia Symptom, CFB to Cycle 59 Day 1, Stable | 2 | 1 |
| Alopecia Symptom, CFB to Cycle 59 Day 1, Worsened | 0 | 0 |
| Alopecia Symptom, CFB to Cycle 61 Day 1, Improved | 3 | 2 |
| Alopecia Symptom, CFB to Cycle 61 Day 1, Stable | 0 | 0 |
| Alopecia Symptom, CFB to Cycle 61 Day 1, Worsened | 0 | 0 |
| Alopecia Symptom, CFB to Cycle 63 Day 1, Improved | 2 | 0 |
| Alopecia Symptom, CFB to Cycle 63 Day 1, Stable | 0 | 1 |
| Alopecia Symptom, CFB to Cycle 63 Day 1, Worsened | 0 | 0 |
| Alopecia Symptom, CFB to Cycle 65 Day 1, Improved | 1 | — |
| Alopecia Symptom, CFB to Cycle 65 Day 1, Stable | 0 | — |
| Alopecia Symptom, CFB to Cycle 65 Day 1, Worsened | 0 | — |
| Alopecia Symptom, CFB to Cycle 67 Day 1, Improved | 1 | — |
| Alopecia Symptom, CFB to Cycle 67 Day 1, Stable | 0 | — |
| Alopecia Symptom, CFB to Cycle 67 Day 1, Worsened | 0 | — |
| Alopecia Symptom, CFB to End of Treatment, Improved | 57 | 60 |
| Alopecia Symptom, CFB to End of Treatment, Stable | 99 | 80 |
| Alopecia Symptom, CFB to End of Treatment, Worsened | 11 | 14 |
| Alopecia Symptom, CFB to Safety Follow-up 1, Improved | 34 | 39 |
| Alopecia Symptom, CFB to Safety Follow-up 1, Stable | 53 | 44 |
| Alopecia Symptom, CFB to Safety Follow-up 1, Worsened | 7 | 12 |
| Alopecia Symptom, CFB to Safety Follow-up 2, Improved | 24 | 28 |
| Alopecia Symptom, CFB to Safety Follow-up 2, Stable | 37 | 38 |
| Alopecia Symptom, CFB to Safety Follow-up 2, Worsened | 23 | 24 |
| Pain in Chest Symptom, CFB to Cycle 2 Day 1, Improved | 26 | 21 |
| Pain in Chest Symptom, CFB to Cycle 2 Day 1, Stable | 146 | 173 |
| Pain in Chest Symptom, CFB to Cycle 2 Day 1, Worsened | 27 | 22 |
| Pain in Chest Symptom, CFB to Cycle 3 Day 1, Improved | 25 | 27 |
| Pain in Chest Symptom, CFB to Cycle 3 Day 1, Stable | 144 | 138 |
| Pain in Chest Symptom, CFB to Cycle 3 Day 1, Worsened | 16 | 24 |
| Pain in Chest Symptom, CFB to Cycle 4 Day 1, Improved | 25 | 19 |
| Pain in Chest Symptom, CFB to Cycle 4 Day 1, Stable | 116 | 119 |
| Pain in Chest Symptom, CFB to Cycle 4 Day 1, Worsened | 16 | 21 |
| Pain in Chest Symptom, CFB to Cycle 5 Day 1, Improved | 29 | 18 |
| Pain in Chest Symptom, CFB to Cycle 5 Day 1, Stable | 108 | 112 |
| Pain in Chest Symptom, CFB to Cycle 5 Day 1, Worsened | 14 | 18 |
| Pain in Chest Symptom, CFB to Cycle 7 Day 1, Improved | 17 | 18 |
| Pain in Chest Symptom, CFB to Cycle 7 Day 1, Stable | 94 | 93 |
| Pain in Chest Symptom, CFB to Cycle 7 Day 1, Worsened | 16 | 13 |
| Pain in Chest Symptom, CFB to Cycle 9 Day 1, Improved | 12 | 12 |
| Pain in Chest Symptom, CFB to Cycle 9 Day 1, Stable | 82 | 81 |
| Pain in Chest Symptom, CFB to Cycle 9 Day 1, Worsened | 14 | 14 |
| Pain in Chest Symptom, CFB to Cycle 11 Day 1, Improved | 10 | 13 |
| Pain in Chest Symptom, CFB to Cycle 11 Day 1, Stable | 73 | 72 |
| Pain in Chest Symptom, CFB to Cycle 11 Day 1, Worsened | 10 | 8 |
| Pain in Chest Symptom, CFB to Cycle 13 Day 1, Improved | 13 | 14 |
| Pain in Chest Symptom, CFB to Cycle 13 Day 1, Stable | 67 | 55 |
| Pain in Chest Symptom, CFB to Cycle 13 Day 1, Worsened | 3 | 10 |
| Pain in Chest Symptom, CFB to Cycle 15 Day 1, Improved | 9 | 13 |
| Pain in Chest Symptom, CFB to Cycle 15 Day 1, Stable | 62 | 57 |
| Pain in Chest Symptom, CFB to Cycle 15 Day 1, Worsened | 6 | 5 |
| Pain in Chest Symptom, CFB to Cycle 17 Day 1, Improved | 8 | 10 |
| Pain in Chest Symptom, CFB to Cycle 17 Day 1, Stable | 52 | 51 |
| Pain in Chest Symptom, CFB to Cycle 17 Day 1, Worsened | 7 | 7 |
| Pain in Chest Symptom, CFB to Cycle 19 Day 1, Improved | 8 | 11 |
| Pain in Chest Symptom, CFB to Cycle 19 Day 1, Stable | 56 | 44 |
| Pain in Chest Symptom, CFB to Cycle 19 Day 1, Worsened | 2 | 6 |
| Pain in Chest Symptom, CFB to Cycle 21 Day 1, Improved | 9 | 11 |
| Pain in Chest Symptom, CFB to Cycle 21 Day 1, Stable | 46 | 44 |
| Pain in Chest Symptom, CFB to Cycle 21 Day 1, Worsened | 4 | 9 |
| Pain in Chest Symptom, CFB to Cycle 23 Day 1, Improved | 7 | 10 |
| Pain in Chest Symptom, CFB to Cycle 23 Day 1, Stable | 41 | 44 |
| Pain in Chest Symptom, CFB to Cycle 23 Day 1, Worsened | 4 | 4 |
| Pain in Chest Symptom, CFB to Cycle 25 Day 1, Improved | 5 | 12 |
| Pain in Chest Symptom, CFB to Cycle 25 Day 1, Stable | 41 | 39 |
| Pain in Chest Symptom, CFB to Cycle 25 Day 1, Worsened | 3 | 3 |
| Pain in Chest Symptom, CFB to Cycle 27 Day 1, Improved | 5 | 10 |
| Pain in Chest Symptom, CFB to Cycle 27 Day 1, Stable | 37 | 39 |
| Pain in Chest Symptom, CFB to Cycle 27 Day 1, Worsened | 3 | 4 |
| Pain in Chest Symptom, CFB to Cycle 29 Day 1, Improved | 4 | 10 |
| Pain in Chest Symptom, CFB to Cycle 29 Day 1, Stable | 34 | 32 |
| Pain in Chest Symptom, CFB to Cycle 29 Day 1, Worsened | 5 | 4 |
| Pain in Chest Symptom, CFB to Cycle 31 Day 1, Improved | 5 | 4 |
| Pain in Chest Symptom, CFB to Cycle 31 Day 1, Stable | 31 | 32 |
| Pain in Chest Symptom, CFB to Cycle 31 Day 1, Worsened | 2 | 2 |
| Pain in Chest Symptom, CFB to Cycle 33 Day 1, Improved | 4 | 6 |
| Pain in Chest Symptom, CFB to Cycle 33 Day 1, Stable | 25 | 30 |
| Pain in Chest Symptom, CFB to Cycle 33 Day 1, Worsened | 1 | 3 |
| Pain in Chest Symptom, CFB to Cycle 35 Day 1, Improved | 4 | 8 |
| Pain in Chest Symptom, CFB to Cycle 35 Day 1, Stable | 21 | 22 |
| Pain in Chest Symptom, CFB to Cycle 35 Day 1, Worsened | 2 | 3 |
| Pain in Chest Symptom, CFB to Cycle 37 Day 1, Improved | 4 | 6 |
| Pain in Chest Symptom, CFB to Cycle 37 Day 1, Stable | 19 | 23 |
| Pain in Chest Symptom, CFB to Cycle 37 Day 1, Worsened | 1 | 3 |
| Pain in Chest Symptom, CFB to Cycle 39 Day 1, Improved | 4 | 6 |
| Pain in Chest Symptom, CFB to Cycle 39 Day 1, Stable | 18 | 24 |
| Pain in Chest Symptom, CFB to Cycle 39 Day 1, Worsened | 1 | 2 |
| Pain in Chest Symptom, CFB to Cycle 41 Day 1, Improved | 1 | 6 |
| Pain in Chest Symptom, CFB to Cycle 41 Day 1, Stable | 17 | 22 |
| Pain in Chest Symptom, CFB to Cycle 41 Day 1, Worsened | 1 | 1 |
| Pain in Chest Symptom, CFB to Cycle 43 Day 1, Improved | 3 | 6 |
| Pain in Chest Symptom, CFB to Cycle 43 Day 1, Stable | 13 | 20 |
| Pain in Chest Symptom, CFB to Cycle 43 Day 1, Worsened | 2 | 2 |
| Pain in Chest Symptom, CFB to Cycle 45 Day 1, Improved | 2 | 4 |
| Pain in Chest Symptom, CFB to Cycle 45 Day 1, Stable | 12 | 16 |
| Pain in Chest Symptom, CFB to Cycle 45 Day 1, Worsened | 0 | 3 |
| Pain in Chest Symptom, CFB to Cycle 47 Day 1, Improved | 2 | 5 |
| Pain in Chest Symptom, CFB to Cycle 47 Day 1, Stable | 8 | 13 |
| Pain in Chest Symptom, CFB to Cycle 47 Day 1, Worsened | 0 | 1 |
| Pain in Chest Symptom, CFB to Cycle 49 Day 1, Improved | 2 | 6 |
| Pain in Chest Symptom, CFB to Cycle 49 Day 1, Stable | 6 | 7 |
| Pain in Chest Symptom, CFB to Cycle 49 Day 1, Worsened | 2 | 1 |
| Pain in Chest Symptom, CFB to Cycle 51 Day 1, Improved | 2 | 4 |
| Pain in Chest Symptom, CFB to Cycle 51 Day 1, Stable | 4 | 7 |
| Pain in Chest Symptom, CFB to Cycle 51 Day 1, Worsened | 0 | 2 |
| Pain in Chest Symptom, CFB to Cycle 53 Day 1, Improved | 1 | 1 |
| Pain in Chest Symptom, CFB to Cycle 53 Day 1, Stable | 4 | 5 |
| Pain in Chest Symptom, CFB to Cycle 53 Day 1, Worsened | 0 | 0 |
| Pain in Chest Symptom, CFB to Cycle 55 Day 1, Improved | 2 | 2 |
| Pain in Chest Symptom, CFB to Cycle 55 Day 1, Stable | 3 | 3 |
| Pain in Chest Symptom, CFB to Cycle 55 Day 1, Worsened | 0 | 1 |
| Pain in Chest Symptom, CFB to Cycle 57 Day 1, Improved | 1 | 0 |
| Pain in Chest Symptom, CFB to Cycle 57 Day 1, Stable | 4 | 4 |
| Pain in Chest Symptom, CFB to Cycle 57 Day 1, Worsened | 0 | 0 |
| Pain in Chest Symptom, CFB to Cycle 59 Day 1, Improved | 1 | 1 |
| Pain in Chest Symptom, CFB to Cycle 59 Day 1, Stable | 3 | 3 |
| Pain in Chest Symptom, CFB to Cycle 59 Day 1, Worsened | 0 | 0 |
| Pain in Chest Symptom, CFB to Cycle 61 Day 1, Improved | 1 | 2 |
| Pain in Chest Symptom, CFB to Cycle 61 Day 1, Stable | 1 | 2 |
| Pain in Chest Symptom, CFB to Cycle 61 Day 1, Worsened | 1 | 0 |
| Pain in Chest Symptom, CFB to Cycle 63 Day 1, Improved | 0 | 0 |
| Pain in Chest Symptom, CFB to Cycle 63 Day 1, Stable | 2 | 1 |
| Pain in Chest Symptom, CFB to Cycle 63 Day 1, Worsened | 0 | 0 |
| Pain in Chest Symptom, CFB to Cycle 65 Day 1, Improved | 0 | — |
| Pain in Chest Symptom, CFB to Cycle 65 Day 1, Stable | 0 | — |
| Pain in Chest Symptom, CFB to Cycle 65 Day 1, Worsened | 1 | — |
| Pain in Chest Symptom, CFB to Cycle 67 Day 1, Improved | 0 | — |
| Pain in Chest Symptom, CFB to Cycle 67 Day 1, Stable | 1 | — |
| Pain in Chest Symptom, CFB to Cycle 67 Day 1, Worsened | 0 | — |
| Pain in Chest Symptom, CFB to End of Treatment, Improved | 19 | 12 |
| Pain in Chest Symptom, CFB to End of Treatment, Stable | 120 | 113 |
| Pain in Chest Symptom, CFB to End of Treatment, Worsened | 26 | 31 |
| Pain in Chest Symptom, CFB to Safety Follow-up 1, Improved | 6 | 11 |
| Pain in Chest Symptom, CFB to Safety Follow-up 1, Stable | 71 | 68 |
| Pain in Chest Symptom, CFB to Safety Follow-up 1, Worsened | 16 | 18 |
| Pain in Chest Symptom, CFB to Safety Follow-up 2, Improved | 10 | 7 |
| Pain in Chest Symptom, CFB to Safety Follow-up 2, Stable | 59 | 72 |
| Pain in Chest Symptom, CFB to Safety Follow-up 2, Worsened | 16 | 12 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 2 Day 1, Improved | 28 | 23 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 2 Day 1, Stable | 145 | 164 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 2 Day 1, Worsened | 26 | 28 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 3 Day 1, Improved | 27 | 24 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 3 Day 1, Stable | 133 | 140 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 3 Day 1, Worsened | 25 | 24 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 4 Day 1, Improved | 16 | 20 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 4 Day 1, Stable | 112 | 112 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 4 Day 1, Worsened | 28 | 27 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 5 Day 1, Improved | 19 | 20 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 5 Day 1, Stable | 103 | 96 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 5 Day 1, Worsened | 29 | 33 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 7 Day 1, Improved | 14 | 21 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 7 Day 1, Stable | 87 | 79 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 7 Day 1, Worsened | 28 | 24 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 9 Day 1, Improved | 17 | 15 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 9 Day 1, Stable | 76 | 70 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 9 Day 1, Worsened | 17 | 22 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 11 Day 1, Improved | 17 | 14 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 11 Day 1, Stable | 58 | 67 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 11 Day 1, Worsened | 19 | 12 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 13 Day 1, Improved | 13 | 10 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 13 Day 1, Stable | 56 | 58 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 13 Day 1, Worsened | 13 | 10 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 15 Day 1, Improved | 15 | 10 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 15 Day 1, Stable | 50 | 58 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 15 Day 1, Worsened | 12 | 6 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 17 Day 1, Improved | 6 | 10 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 17 Day 1, Stable | 49 | 53 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 17 Day 1, Worsened | 12 | 5 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 19 Day 1, Improved | 6 | 8 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 19 Day 1, Stable | 46 | 46 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 19 Day 1, Worsened | 11 | 7 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 21 Day 1, Improved | 7 | 8 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 21 Day 1, Stable | 48 | 44 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 21 Day 1, Worsened | 6 | 12 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 23 Day 1, Improved | 5 | 9 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 23 Day 1, Stable | 43 | 40 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 23 Day 1, Worsened | 5 | 10 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 25 Day 1, Improved | 6 | 8 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 25 Day 1, Stable | 33 | 39 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 25 Day 1, Worsened | 11 | 7 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 27 Day 1, Improved | 6 | 7 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 27 Day 1, Stable | 32 | 38 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 27 Day 1, Worsened | 8 | 7 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 29 Day 1, Improved | 9 | 6 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 29 Day 1, Stable | 29 | 34 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 29 Day 1, Worsened | 6 | 6 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 31 Day 1, Improved | 6 | 4 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 31 Day 1, Stable | 26 | 27 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 31 Day 1, Worsened | 6 | 7 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 33 Day 1, Improved | 3 | 7 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 33 Day 1, Stable | 24 | 23 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 33 Day 1, Worsened | 3 | 9 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 35 Day 1, Improved | 5 | 4 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 35 Day 1, Stable | 18 | 23 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 35 Day 1, Worsened | 5 | 6 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 37 Day 1, Improved | 5 | 6 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 37 Day 1, Stable | 16 | 21 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 37 Day 1, Worsened | 3 | 5 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 39 Day 1, Improved | 4 | 6 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 39 Day 1, Stable | 17 | 21 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 39 Day 1, Worsened | 3 | 5 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 41 Day 1, Improved | 3 | 6 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 41 Day 1, Stable | 12 | 19 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 41 Day 1, Worsened | 5 | 4 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 43 Day 1, Improved | 3 | 4 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 43 Day 1, Stable | 12 | 18 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 43 Day 1, Worsened | 4 | 6 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 45 Day 1, Improved | 1 | 3 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 45 Day 1, Stable | 10 | 16 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 45 Day 1, Worsened | 4 | 4 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 47 Day 1, Improved | 2 | 4 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 47 Day 1, Stable | 7 | 12 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 47 Day 1, Worsened | 1 | 3 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 49 Day 1, Improved | 1 | 4 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 49 Day 1, Stable | 8 | 8 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 49 Day 1, Worsened | 1 | 3 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 51 Day 1, Improved | 2 | 2 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 51 Day 1, Stable | 3 | 10 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 51 Day 1, Worsened | 1 | 1 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 53 Day 1, Improved | 1 | 0 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 53 Day 1, Stable | 3 | 6 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 53 Day 1, Worsened | 1 | 0 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 55 Day 1, Improved | 2 | 1 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 55 Day 1, Stable | 2 | 3 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 55 Day 1, Worsened | 1 | 2 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 57 Day 1, Improved | 2 | 0 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 57 Day 1, Stable | 1 | 2 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 57 Day 1, Worsened | 2 | 2 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 59 Day 1, Improved | 2 | 0 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 59 Day 1, Stable | 1 | 4 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 59 Day 1, Worsened | 1 | 0 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 61 Day 1, Improved | 2 | 1 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 61 Day 1, Stable | 0 | 2 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 61 Day 1, Worsened | 1 | 1 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 63 Day 1, Improved | 1 | 0 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 63 Day 1, Stable | 0 | 1 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 63 Day 1, Worsened | 1 | 0 |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 65 Day 1, Improved | 1 | — |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 65 Day 1, Stable | 0 | — |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 65 Day 1, Worsened | 0 | — |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 67 Day 1, Improved | 1 | — |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 67 Day 1, Stable | 0 | — |
| Pain in Arm or Shoulder Symptom, CFB to Cycle 67 Day 1, Worsened | 0 | — |
| Pain in Arm or Shoulder Symptom, CFB to End of Treatment, Improved | 19 | 16 |
| Pain in Arm or Shoulder Symptom, CFB to End of Treatment, Stable | 111 | 110 |
| Pain in Arm or Shoulder Symptom, CFB to End of Treatment, Worsened | 35 | 30 |
| Pain in Arm or Shoulder Symptom, CFB to Safety Follow-up 1, Improved | 10 | 10 |
| Pain in Arm or Shoulder Symptom, CFB to Safety Follow-up 1, Stable | 59 | 64 |
| Pain in Arm or Shoulder Symptom, CFB to Safety Follow-up 1, Worsened | 24 | 23 |
| Pain in Arm or Shoulder Symptom, CFB to Safety Follow-up 2, Improved | 13 | 10 |
| Pain in Arm or Shoulder Symptom, CFB to Safety Follow-up 2, Stable | 56 | 60 |
| Pain in Arm or Shoulder Symptom, CFB to Safety Follow-up 2, Worsened | 15 | 21 |
| Pain in Other Parts Symptom, CFB to Cycle 2 Day 1, Improved | 38 | 39 |
| Pain in Other Parts Symptom, CFB to Cycle 2 Day 1, Stable | 125 | 140 |
| Pain in Other Parts Symptom, CFB to Cycle 2 Day 1, Worsened | 36 | 37 |
| Pain in Other Parts Symptom, CFB to Cycle 3 Day 1, Improved | 44 | 33 |
| Pain in Other Parts Symptom, CFB to Cycle 3 Day 1, Stable | 111 | 120 |
| Pain in Other Parts Symptom, CFB to Cycle 3 Day 1, Worsened | 30 | 36 |
| Pain in Other Parts Symptom, CFB to Cycle 4 Day 1, Improved | 33 | 29 |
| Pain in Other Parts Symptom, CFB to Cycle 4 Day 1, Stable | 92 | 105 |
| Pain in Other Parts Symptom, CFB to Cycle 4 Day 1, Worsened | 31 | 25 |
| Pain in Other Parts Symptom, CFB to Cycle 5 Day 1, Improved | 33 | 23 |
| Pain in Other Parts Symptom, CFB to Cycle 5 Day 1, Stable | 96 | 99 |
| Pain in Other Parts Symptom, CFB to Cycle 5 Day 1, Worsened | 22 | 25 |
| Pain in Other Parts Symptom, CFB to Cycle 7 Day 1, Improved | 26 | 26 |
| Pain in Other Parts Symptom, CFB to Cycle 7 Day 1, Stable | 85 | 78 |
| Pain in Other Parts Symptom, CFB to Cycle 7 Day 1, Worsened | 16 | 20 |
| Pain in Other Parts Symptom, CFB to Cycle 9 Day 1, Improved | 23 | 27 |
| Pain in Other Parts Symptom, CFB to Cycle 9 Day 1, Stable | 64 | 63 |
| Pain in Other Parts Symptom, CFB to Cycle 9 Day 1, Worsened | 21 | 17 |
| Pain in Other Parts Symptom, CFB to Cycle 11 Day 1, Improved | 18 | 21 |
| Pain in Other Parts Symptom, CFB to Cycle 11 Day 1, Stable | 60 | 54 |
| Pain in Other Parts Symptom, CFB to Cycle 11 Day 1, Worsened | 16 | 18 |
| Pain in Other Parts Symptom, CFB to Cycle 13 Day 1, Improved | 19 | 13 |
| Pain in Other Parts Symptom, CFB to Cycle 13 Day 1, Stable | 44 | 61 |
| Pain in Other Parts Symptom, CFB to Cycle 13 Day 1, Worsened | 19 | 5 |
| Pain in Other Parts Symptom, CFB to Cycle 15 Day 1, Improved | 17 | 23 |
| Pain in Other Parts Symptom, CFB to Cycle 15 Day 1, Stable | 50 | 43 |
| Pain in Other Parts Symptom, CFB to Cycle 15 Day 1, Worsened | 9 | 8 |
| Pain in Other Parts Symptom, CFB to Cycle 17 Day 1, Improved | 15 | 14 |
| Pain in Other Parts Symptom, CFB to Cycle 17 Day 1, Stable | 41 | 47 |
| Pain in Other Parts Symptom, CFB to Cycle 17 Day 1, Worsened | 11 | 7 |
| Pain in Other Parts Symptom, CFB to Cycle 19 Day 1, Improved | 13 | 10 |
| Pain in Other Parts Symptom, CFB to Cycle 19 Day 1, Stable | 44 | 42 |
| Pain in Other Parts Symptom, CFB to Cycle 19 Day 1, Worsened | 9 | 9 |
| Pain in Other Parts Symptom, CFB to Cycle 21 Day 1, Improved | 10 | 15 |
| Pain in Other Parts Symptom, CFB to Cycle 21 Day 1, Stable | 45 | 40 |
| Pain in Other Parts Symptom, CFB to Cycle 21 Day 1, Worsened | 6 | 9 |
| Pain in Other Parts Symptom, CFB to Cycle 23 Day 1, Improved | 12 | 14 |
| Pain in Other Parts Symptom, CFB to Cycle 23 Day 1, Stable | 35 | 37 |
| Pain in Other Parts Symptom, CFB to Cycle 23 Day 1, Worsened | 6 | 8 |
| Pain in Other Parts Symptom, CFB to Cycle 25 Day 1, Improved | 9 | 12 |
| Pain in Other Parts Symptom, CFB to Cycle 25 Day 1, Stable | 37 | 37 |
| Pain in Other Parts Symptom, CFB to Cycle 25 Day 1, Worsened | 4 | 5 |
| Pain in Other Parts Symptom, CFB to Cycle 27 Day 1, Improved | 5 | 11 |
| Pain in Other Parts Symptom, CFB to Cycle 27 Day 1, Stable | 36 | 32 |
| Pain in Other Parts Symptom, CFB to Cycle 27 Day 1, Worsened | 5 | 9 |
| Pain in Other Parts Symptom, CFB to Cycle 29 Day 1, Improved | 11 | 9 |
| Pain in Other Parts Symptom, CFB to Cycle 29 Day 1, Stable | 29 | 28 |
| Pain in Other Parts Symptom, CFB to Cycle 29 Day 1, Worsened | 4 | 9 |
| Pain in Other Parts Symptom, CFB to Cycle 31 Day 1, Improved | 9 | 6 |
| Pain in Other Parts Symptom, CFB to Cycle 31 Day 1, Stable | 23 | 27 |
| Pain in Other Parts Symptom, CFB to Cycle 31 Day 1, Worsened | 6 | 5 |
| Pain in Other Parts Symptom, CFB to Cycle 33 Day 1, Improved | 5 | 7 |
| Pain in Other Parts Symptom, CFB to Cycle 33 Day 1, Stable | 21 | 26 |
| Pain in Other Parts Symptom, CFB to Cycle 33 Day 1, Worsened | 4 | 6 |
| Pain in Other Parts Symptom, CFB to Cycle 35 Day 1, Improved | 5 | 4 |
| Pain in Other Parts Symptom, CFB to Cycle 35 Day 1, Stable | 18 | 24 |
| Pain in Other Parts Symptom, CFB to Cycle 35 Day 1, Worsened | 5 | 5 |
| Pain in Other Parts Symptom, CFB to Cycle 37 Day 1, Improved | 6 | 7 |
| Pain in Other Parts Symptom, CFB to Cycle 37 Day 1, Stable | 13 | 19 |
| Pain in Other Parts Symptom, CFB to Cycle 37 Day 1, Worsened | 5 | 6 |
| Pain in Other Parts Symptom, CFB to Cycle 39 Day 1, Improved | 6 | 7 |
| Pain in Other Parts Symptom, CFB to Cycle 39 Day 1, Stable | 15 | 20 |
| Pain in Other Parts Symptom, CFB to Cycle 39 Day 1, Worsened | 3 | 5 |
| Pain in Other Parts Symptom, CFB to Cycle 41 Day 1, Improved | 6 | 7 |
| Pain in Other Parts Symptom, CFB to Cycle 41 Day 1, Stable | 12 | 16 |
| Pain in Other Parts Symptom, CFB to Cycle 41 Day 1, Worsened | 2 | 5 |
| Pain in Other Parts Symptom, CFB to Cycle 43 Day 1, Improved | 4 | 5 |
| Pain in Other Parts Symptom, CFB to Cycle 43 Day 1, Stable | 14 | 16 |
| Pain in Other Parts Symptom, CFB to Cycle 43 Day 1, Worsened | 1 | 7 |
| Pain in Other Parts Symptom, CFB to Cycle 45 Day 1, Improved | 4 | 4 |
| Pain in Other Parts Symptom, CFB to Cycle 45 Day 1, Stable | 9 | 16 |
| Pain in Other Parts Symptom, CFB to Cycle 45 Day 1, Worsened | 2 | 3 |
| Pain in Other Parts Symptom, CFB to Cycle 47 Day 1, Improved | 2 | 2 |
| Pain in Other Parts Symptom, CFB to Cycle 47 Day 1, Stable | 7 | 14 |
| Pain in Other Parts Symptom, CFB to Cycle 47 Day 1, Worsened | 1 | 3 |
| Pain in Other Parts Symptom, CFB to Cycle 49 Day 1, Improved | 2 | 3 |
| Pain in Other Parts Symptom, CFB to Cycle 49 Day 1, Stable | 8 | 7 |
| Pain in Other Parts Symptom, CFB to Cycle 49 Day 1, Worsened | 0 | 5 |
| Pain in Other Parts Symptom, CFB to Cycle 51 Day 1, Improved | 1 | 2 |
| Pain in Other Parts Symptom, CFB to Cycle 51 Day 1, Stable | 5 | 7 |
| Pain in Other Parts Symptom, CFB to Cycle 51 Day 1, Worsened | 0 | 4 |
| Pain in Other Parts Symptom, CFB to Cycle 53 Day 1, Improved | 0 | 1 |
| Pain in Other Parts Symptom, CFB to Cycle 53 Day 1, Stable | 4 | 4 |
| Pain in Other Parts Symptom, CFB to Cycle 53 Day 1, Worsened | 1 | 1 |
| Pain in Other Parts Symptom, CFB to Cycle 55 Day 1, Improved | 1 | 1 |
| Pain in Other Parts Symptom, CFB to Cycle 55 Day 1, Stable | 2 | 5 |
| Pain in Other Parts Symptom, CFB to Cycle 55 Day 1, Worsened | 2 | 0 |
| Pain in Other Parts Symptom, CFB to Cycle 57 Day 1, Improved | 1 | 0 |
| Pain in Other Parts Symptom, CFB to Cycle 57 Day 1, Stable | 4 | 4 |
| Pain in Other Parts Symptom, CFB to Cycle 57 Day 1, Worsened | 0 | 0 |
| Pain in Other Parts Symptom, CFB to Cycle 59 Day 1, Improved | 0 | 0 |
| Pain in Other Parts Symptom, CFB to Cycle 59 Day 1, Stable | 3 | 4 |
| Pain in Other Parts Symptom, CFB to Cycle 59 Day 1, Worsened | 1 | 0 |
| Pain in Other Parts Symptom, CFB to Cycle 61 Day 1, Improved | 1 | 0 |
| Pain in Other Parts Symptom, CFB to Cycle 61 Day 1, Stable | 1 | 4 |
| Pain in Other Parts Symptom, CFB to Cycle 61 Day 1, Worsened | 1 | 0 |
| Pain in Other Parts Symptom, CFB to Cycle 63 Day 1, Improved | 1 | 1 |
| Pain in Other Parts Symptom, CFB to Cycle 63 Day 1, Stable | 1 | 0 |
| Pain in Other Parts Symptom, CFB to Cycle 63 Day 1, Worsened | 0 | 0 |
| Pain in Other Parts Symptom, CFB to Cycle 65 Day 1, Improved | 0 | — |
| Pain in Other Parts Symptom, CFB to Cycle 65 Day 1, Stable | 1 | — |
| Pain in Other Parts Symptom, CFB to Cycle 65 Day 1, Worsened | 0 | — |
| Pain in Other Parts Symptom, CFB to Cycle 67 Day 1, Improved | 0 | — |
| Pain in Other Parts Symptom, CFB to Cycle 67 Day 1, Stable | 0 | — |
| Pain in Other Parts Symptom, CFB to Cycle 67 Day 1, Worsened | 1 | — |
| Pain in Other Parts Symptom, CFB to End of Treatment, Improved | 30 | 27 |
| Pain in Other Parts Symptom, CFB to End of Treatment, Stable | 99 | 90 |
| Pain in Other Parts Symptom, CFB to End of Treatment, Worsened | 35 | 39 |
| Pain in Other Parts Symptom, CFB to Safety Follow-up 1, Improved | 18 | 16 |
| Pain in Other Parts Symptom, CFB to Safety Follow-up 1, Stable | 56 | 66 |
| Pain in Other Parts Symptom, CFB to Safety Follow-up 1, Worsened | 18 | 15 |
| Pain in Other Parts Symptom, CFB to Safety Follow-up 2, Improved | 20 | 16 |
| Pain in Other Parts Symptom, CFB to Safety Follow-up 2, Stable | 52 | 55 |
| Pain in Other Parts Symptom, CFB to Safety Follow-up 2, Worsened | 12 | 20 |
TTD in lung symptoms is defined as the time from randomization to first onset of ≥10 point increase from baseline with confirmation by a second adjacent ≥10 point increase in the same symptom domain for any of the three symptoms: dyspnea, chest pain, and cough, on the EORTC QLQ-LC13 were scored on a 4-point scale (1=Not at All to 4=Very Much). Using linear transformation, raw scores are standardized, so that scores range from 0-100. A lower score indicates a better outcome. A longer TTD indicates a better outcome.
| Months | Niraparib + Pembrolizumab | Placebo + Pembrolizumab |
|---|---|---|
| Composite Endpoint of Dyspnea, Cough and Chest Pain | 5.72 (3.06 to 8.90) | 5.45 (3.84 to 9.95) |
| Dyspnea Symptom | 21.09 (12.42 to NA) | 19.29 (11.14 to NA) |
| Chest Pain Symptom | NA (NA to NA) | NA (NA to NA) |
| Cough Symptom | NA (33.28 to NA) | NA (28.12 to NA) |
An AE is any untoward medical occurrence in a participant or clinical investigation participant, temporally associated with the use of a medicinal product, whether or not considered related to the medicinal product. SAE is defined as any untoward medical occurrence that, at any dose resulted in death, is life threatening, required hospitalization or prolongation of existing hospitalization, resulted in disability/incapacity, is a congenital anomaly/birth defect, other situations and is associated with liver injury or impaired liver function. SAEs are subsets of AEs. TEAE is an event that emerged during treatment having been absent pretreatment or worsened relative to the pretreatment state. AESI is any AE (serious or nonserious) that is of scientific and medical concern specific to niraparib for which ongoing monitoring and rapid communication by the Investigator to the Sponsor is warranted. AEs were coded using the Medical Dictionary for Regulatory Activities (MedDRA) coding system.
| Participants | Niraparib + Pembrolizumab | Placebo + Pembrolizumab |
|---|---|---|
| TEAEs | 304 | 302 |
| Serious TEAEs | 97 | 81 |
| Adverse Events of Special Interest (AESIs) | 18 | 17 |
Blood samples were collected for plasma concentrations of niraparib.
| Nanogram/ millilitre (ng/mL) | Niraparib + Pembrolizumab |
|---|---|
| Cycle 1 Day 1, Pre-dose | 6.384 ± 57.1536 |
| Cycle 1 Day 1, 3 hours | 278.181 ± 215.4662 |
| Cycle 1 Day 15, Pre-dose | 535.634 ± 334.8631 |
| Cycle 1 Day 15, 3 hours | 829.325 ± 433.8605 |
| Cycle 2 Day 1, Pre-dose | 467.949 ± 292.1295 |
| Cycle 2 Day 1, 3 hours | 749.447 ± 403.6555 |
| Cycle 4 Day 1, Pre-dose | 424.534 ± 278.3712 |
| Cycle 7 Day 1, Pre-dose | 345.886 ± 239.9295 |
| End of Treatment (up to 49 months), Pre-dose | 306.103 ± 355.6721 |
Collected over All cause mortality, non-serious adverse events (Non-SAEs) and serious adverse events (SAEs) were collected up to 52 months.. Non-serious events are listed at a 5% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Niraparib + Pembrolizumab | 196/329 (59.6%) | 97/329 (29.5%) | 293/329 (89.1%) |
| Placebo + Pembrolizumab | 177/329 (53.8%) | 81/329 (24.6%) | 261/329 (79.3%) |
| Event | Niraparib + Pembrolizumab | Placebo + Pembrolizumab |
|---|---|---|
| PneumoniaInfections and infestations | 13/329 | 8/329 |
| AnaemiaBlood and lymphatic system disorders | 13/329 | 0/329 |
| Respiratory failureRespiratory, thoracic and mediastinal disorders | 2/329 | 5/329 |
| FatigueGeneral disorders | 5/329 | 0/329 |
| COVID-19Infections and infestations | 2/329 | 4/329 |
| DyspnoeaRespiratory, thoracic and mediastinal disorders | 4/329 | 4/329 |
| PneumonitisRespiratory, thoracic and mediastinal disorders | 4/329 | 3/329 |
| ThrombocytopeniaBlood and lymphatic system disorders | 4/329 | 0/329 |
| Back painMusculoskeletal and connective tissue disorders | 4/329 | 0/329 |
| Respiratory tract infectionInfections and infestations | 3/329 | 0/329 |
| Event | Niraparib + Pembrolizumab | Placebo + Pembrolizumab |
|---|---|---|
| AnaemiaBlood and lymphatic system disorders | 109/329 | 46/329 |
| NauseaGastrointestinal disorders | 87/329 | 42/329 |
| FatigueGeneral disorders | 57/329 | 51/329 |
| ThrombocytopeniaBlood and lymphatic system disorders | 55/329 | 13/329 |
| Decreased appetiteMetabolism and nutrition disorders | 54/329 | 26/329 |
| CoughRespiratory, thoracic and mediastinal disorders | 51/329 | 48/329 |
| DiarrhoeaGastrointestinal disorders | 45/329 | 50/329 |
| ConstipationGastrointestinal disorders | 50/329 | 18/329 |
| PruritusSkin and subcutaneous tissue disorders | 33/329 | 46/329 |
| ArthralgiaMusculoskeletal and connective tissue disorders | 45/329 | 43/329 |
| Age, Continuous(YEARS) | Niraparib + Pembrolizumab | Placebo + Pembrolizumab | Total |
|---|---|---|---|
| Mean | 65.1 ± 8.75 | 65.4 ± 9.08 | 65.2 ± 8.91 |
| Sex: Female, Male(Participants) | Niraparib + Pembrolizumab | Placebo + Pembrolizumab | Total |
|---|---|---|---|
| Female | 106 | 112 | 218 |
| Male | 225 | 223 | 448 |
| Race/Ethnicity, Customized(Participants) | Niraparib + Pembrolizumab | Placebo + Pembrolizumab | Total |
|---|---|---|---|
| White | 317 | 322 | 639 |
| Black or African American | 2 | 0 | 2 |
| Asian | 6 | 9 | 15 |
| American Indian or Alaska Native | 5 | 3 | 8 |
| Unknown | 1 | 0 | 1 |
| Not Reported | 0 | 1 | 1 |
Showing the first 100 of 188 sites across 27 countries. Choose a country and city above to see the rest.
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: Yes — Qualified researchers may request access to anonymized individual patient-level data (IPD) and related study documents of the eligible studies via the Data Sharing Portal. Details on GSK's data sharing criteria can be found at: https://www.gsk.com/en-gb/innovation/trials/data-transparency/
Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report
Time frame: Anonymized IPD will be made available within 6 months of publication of primary, key secondary and safety results for studies in product with approved indication(s) or terminated asset(s) across all indications.
Access criteria: Anonymized IPD is shared with researchers whose proposals are approved by an Independent Review Panel and after a Data Sharing Agreement is in place. Access is provided for an initial period of 12 months but an extension may be granted, when justified, for up to 6 months.
Data sharing details ↗ · www.gsk.com
Ran from Oct 2020 to primary completion in Feb 2025, 52 months.
Results were first posted in May 2026, 1 year 2 months after primary completion.
Of 315 industry-sponsored phase 3 interventional studies under Carcinoma, Non-Small-Cell Lung, half reached primary completion within 39 months of starting (the median), counting those still running; a quarter within 27 and three quarters within 57. This study's 52 months is above that.
Counting every sponsor, half of 424 studies reached it within 45 months; a quarter within 30 and three quarters within 69.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Niraparib
Carcinoma, Non-Small-Cell Lung →